10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 2, 2016

 OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-22874

Viavi Solutions Inc.

(Exact name of Registrant as specified in its charter)

Delaware	94-2579683
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

430 North McCarthy Boulevard, Milpitas, California 95035

(Address of principal executive offices including Zip code)

(408) 404-3600

(Registrant’s telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x  No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a

smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer x Accelerated filer o Non-accelerated filer (Do not check if a smaller reporting company) o Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o No x

As of January 30, 2016 the Registrant had 231,734,846shares of common stock outstanding.

TABLE OF CONTENTS			Page
PART I - FINANCIAL INFORMATION			2
	Item1.	Financial Statements (Unaudited)	2
		Consolidated Statements of Operations for the Three and Six Months Ended January 2, 2016 and December 27, 2014	2
		Consolidated Statements of Comprehensive Income (Loss) for the Three and Six Months Ended January 2, 2016 and December 27, 2014	3
		Consolidated Balance Sheets as of January 2, 2016 and June 27, 2015	4
		Consolidated Statements of Cash Flows for the Six Months Ended January 2, 2016 and December 27, 2014	5
		Notes to Consolidated Financial Statements	6
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
	Item 3.	Quantitative and Qualitative Disclosure About Market Risks	42
	Item 4.	Controls and Procedures	44
PART II - OTHER INFORMATION			44
	Item 1.	Legal Proceedings	44
	Item 1A.	Risk Factors	44
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	44
	Item 3.	Defaults Upon Senior Securities	44
	Item 4.	Mine Safety Disclosures	45
	Item 5.	Other Information	45
	Item 6.	Exhibits	45
SIGNATURE			46

1

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)

VIAVI SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share data)

(unaudited)

	Three Months Ended						Six Months Ended
	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Revenues:
Product revenue	$	208.4		$	196.0		$	408.6		$	387.5
Service revenue	23.7			30.4			53.2			54.2
Total net revenues	232.1			226.4			461.8			441.7
Cost of revenues:
Product cost of revenues	71.2			67.5			139.1			128.3
Service cost of revenues	14.5			16.6			31.5			34.1
Amortization of acquired technologies	4.6			9.2			8.9			17.3
Total cost of revenues	90.3			93.3			179.5			179.7
Gross profit	141.8			133.1			282.3			262.0
Operating expenses:
Research and development	41.7			44.2			86.0			85.8
Selling, general and administrative	85.8			96.1			180.7			189.7
Amortization of other intangibles	3.7			4.9			7.5			9.9
Restructuring and related charges	1.4			9.1			1.8			10.2
Total operating expenses	132.6			154.3			276.0			295.6
Income (loss) from operations	9.2			(21.2		)	6.3			(33.6		)
Interest and other income (expense), net	1.7			0.3			0.6			0.9
Interest expense	(8.8		)	(8.3		)	(17.6		)	(16.5		)
Income (loss) from continuing operations before taxes	2.1			(29.2		)	(10.7		)	(49.2		)
(Benefit from) provision for income taxes	(1.2		)	8.5			(0.4		)	14.3
Income (loss) from continuing operations, net of taxes	$	3.3		$	(37.7	)	$	(10.3	)	$	(63.5	)
Income (loss) from discontinued operations, net of taxes	3.0			12.6			(50.4		)	28.7
Net income (loss)	$	6.3		$	(25.1	)	$	(60.7	)	$	(34.8	)
Net income (loss) per share from - basic and diluted:
Continuing operations	$	0.02		$	(0.16	)	$	(0.04	)	$	(0.27	)
Discontinued operations	0.01			0.05			(0.22		)	0.12
Net income (loss)	$	0.03		$	(0.11	)	$	(0.26	)	$	(0.15	)
Shares used in per-share calculation - basic	234.9			232.1			235.5			231.5
Shares used in per-share calculation - diluted	237.1			232.1			235.5			231.5

See accompanying notes to consolidated financial statements.

2

VIAVI SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in millions)

(unaudited)

	Three Months Ended						Six months ended
	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Net income (loss)	$	6.3		$	(25.1	)	$	(60.7	)	$	(34.8	)
Other comprehensive income (loss):
Net change in cumulative translation adjustment, net of tax	(11.8		)	(17.4		)	(21.8		)	(35.9		)
Net change in available-for-sale investments, net of tax:
Unrealized holding gains (losses) arising during period	71.4			(0.3		)	153.1			(0.5		)
Net change in defined benefit obligation, net of tax:
Amortization of actuarial losses	0.1			0.2			0.3			0.3
Net change in Accumulated other comprehensive income (loss)	59.7			(17.5		)	131.6			(36.1		)
Comprehensive income (loss)	$	66.0		$	(42.6	)	$	70.9		$	(70.9	)

See accompanying notes to consolidated financial statements.

3

VIAVI SOLUTIONS INC.

CONSOLIDATED BALANCE SHEETS

(in millions, except share and par value data)

(unaudited) 

	January 2, 2016			June 27, 2015
ASSETS
Current assets:
Cash and cash equivalents	$	329.0		$	334.5
Short-term investments	585.5			464.9
Restricted cash	11.5			26.2
Accounts receivable, net (Note 6)	181.8			152.3
Inventories, net	57.6			53.8
Prepayments and other current assets	34.1			38.2
Current assets of discontinued operations	—			310.2
Total current assets	1,199.5			1,380.1
Property, plant and equipment, net	136.5			149.2
Goodwill	246.1			255.5
Intangibles, net	77.6			90.6
Deferred income taxes	103.3			117.3
Other non-current assets	19.4			20.9
Non-current assets of discontinued operations	—			204.2
Total assets	$	1,782.4		$	2,217.8
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	37.5		$	42.0
Accrued payroll and related expenses	54.7			52.6
Income taxes payable	18.2			3.1
Deferred revenue	93.3			80.6
Accrued expenses	29.8			23.7
Other current liabilities	30.8			43.5
Current liabilities of discontinued operations	—			130.0
Total current liabilities	264.3			375.5
Long-term debt	574.8			561.6
Other non-current liabilities	162.3			168.4
Non-current liabilities of discontinued operations	—			10.9
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred Stock, $0.001 par value; 1 million shares authorized; 1 share at January 2, 2016 and June 27, 2015, issued and outstanding	—			—
Common Stock, $0.001 par value; 1 billion shares authorized; 233 million shares at January 2, 2016 and 235 million shares at June 27, 2015, issued and outstanding	0.2			0.2
Additional paid-in capital	70,034.3			70,022.7
Accumulated deficit	(69,329.3		)	(68,873.5		)
Accumulated other comprehensive income (loss)	75.8			(48.0		)
Total stockholders’ equity	781.0			1,101.4
Total liabilities and stockholders’ equity	$	1,782.4		$	2,217.8

See accompanying notes to consolidated financial statements.

4

VIAVI SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)

	Six Months Ended
	January 2, 2016			December 27, 2014
OPERATING ACTIVITIES:
Net loss	$	(60.7	)	$	(34.8	)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation expense	21.7			40.2
Amortization of acquired technologies and other intangibles	17.0			31.2
Stock-based compensation	26.5			30.7
Amortization of debt issuance costs and accretion of debt discount	14.2			13.5
Amortization of discount and premium on investments, net	0.8			1.9
Other	(0.2		)	3.1
Changes in operating assets and liabilities, net of impact of Lumentum distribution:
Accounts receivable	(6.1		)	(23.7		)
Inventories	(6.5		)	(2.4		)
Other current and non-currents assets	2.6			(2.6		)
Accounts payable	(10.9		)	1.1
Income taxes payable	10.9			4.3
Deferred revenue, current and non-current	11.8			0.8
Deferred taxes, net	7.4			13.5
Accrued payroll and related expenses	(11.4		)	(8.5		)
Accrued expenses and other current and non-current liabilities	(18.4		)	(10.9		)
Net cash (used in) provided by operating activities	(1.3		)	57.4
INVESTING ACTIVITIES:
Purchases of available-for-sale investments	(185.6		)	(300.2		)
Maturities of available-for-sale investments	250.3			265.9
Sales of available-for-sale investments	71.9			39.2
Changes in restricted cash	14.7			2.6
Capital expenditures	(19.4		)	(50.4		)
Proceeds from the sale of assets	3.4			4.2
Acquisition of a business	(0.9		)	—
Net cash provided by (used in) investing activities	134.4			(38.7		)
FINANCING ACTIVITIES:
Proceeds from sale of Lumentum Holdings Inc. Series A Preferred Stock	35.8			—
Cash contribution to Lumentum Holdings Inc.	(136.7		)	—
Repurchase and retirement of common stock	(40.0		)	(4.7		)
Payment of financing obligations	(1.3		)	(12.9		)
Proceeds from exercise of employee stock options and employee stock purchase plan	0.8			6.9
Net cash used in financing activities	(141.4		)	(10.7		)
Effect of exchange rates on cash and cash equivalents	(10.6		)	(11.6		)
Net decrease in cash and cash equivalents	(18.9		)	(3.6		)
Cash and cash equivalents at the beginning of the period	347.9		*	297.2
Cash and cash equivalents at the end of the period	$	329.0		$	293.6

*Cash and cash equivalents at June 27, 2015 included $13.4 million in current assets of the discontinued operations of Lumentum Holdings Inc.

See accompanying notes to consolidated financial statements.

5

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Basis of Presentation

The financial information for Viavi Solutions Inc. (“Viavi” also referred to as “the Company”, “we”, “our” and “us”) as of January 2, 2016 and for the three and six months endedJanuary 2, 2016 and December 27, 2014 is unaudited, and includes all normal and recurring adjustments Company management (“Management”) considers necessary for a fair statement of the financial information set forth herein, in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, such information does not include all of the information and footnotes required by U.S. GAAP for annual financial statements. For further information, please refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 27, 2015.

The balance sheet as of June 27, 2015 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The results for the three and six months endedJanuary 2, 2016 and December 27, 2014 may not be indicative of results for the year ending July 2, 2016 or any future periods.

Fiscal Years

The Company utilizes a 52-53 week fiscal year ending on the Saturday closest to June 30th. The Company’s fiscal 2016 is a 53-week year ending on July 2, 2016. The Company’s fiscal 2015 was a 52-week year ending on June 27, 2015.

Lumentum Separation

On August 1, 2015 (the “Separation Date”), Viavi, formerly known as JDS Uniphase Corporation (“JDSU”), completed the distribution of approximately 80.1% of the outstanding shares of Lumentum Holdings Inc. (“Lumentum”) common stock (the “Distribution”). Concurrent with the Distribution, JDSU was renamed Viavi Solutions Inc. and, at the time of the Distribution, retained ownership of approximately 19.9% of Lumentum’s outstanding shares. Lumentum was formed to hold Viavi’s communications and commercial optical products business segment (“CCOP”) and the WaveReady product line and, as a result of the Distribution, is now an independent public company trading under the symbol “LITE” on The Nasdaq Stock Market (“NASDAQ”). The Distribution was made to Viavi’s stockholders of record as of the close of business on July 27, 2015 (the “Record Date”), who received one share of Lumentum common stock for every five shares of Viavi common stock held as of the close of business on the Record Date and not sold prior to August 4, 2015, the ex-dividend date. The historical results of operations and the financial position have been recasted to present the Lumentum business as discontinued operations as described in “Note 3. Discontinued Operations.” Unless noted otherwise, discussion in the Notes to Consolidated Financial Statements pertain to continuing operations.

Principles of Consolidation

The amounts presented in the consolidated financial statements have been prepared in accordance with U.S. GAAP and include the Company and its wholly-owned subsidiaries. All inter-company accounts and transactions have been eliminated.

Use of Estimates

The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires Management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements, the reported amount of Net revenues and expenses and the disclosure of commitments and contingencies during the reporting periods. The Company bases estimates on historical experience and on various assumptions about the future believed to be reasonable based on available information. The Company’s reported financial position or results of operations may be materially different under changed conditions or when using different estimates and assumptions, particularly with respect to significant accounting policies. If estimates or assumptions differ from actual results, subsequent periods are adjusted to reflect more current information.

Note 2. Recently Issued Accounting Pronouncements

In January 2016, the FASB (“Financial Accounting Standards Board”) issued guidance that requires an entity to measure equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, it requires entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes and requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It also eliminates the requirement to disclose

6

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The guidance is effective for the company in the first quarter of fiscal 2019. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In November 2015, the FASB issued guidance requiring deferred tax assets and liabilities, and any related valuation allowance, to be classified as non-current on the balance sheet. This classification eliminates the need to separately identify the net current and net non-current deferred tax asset or liability in each jurisdiction. The Company elected to prospectively adopt the guidance in the beginning of the second quarter of fiscal 2016. Refer to “Note 12. Income Taxes” for more information regarding the impact of adopting this guidance.

In July 2015, the FASB issued guidance to change the subsequent measurement of inventory from lower of cost or market to lower of cost and net realizable value. The guidance is effective for the Company in the first quarter of fiscal 2018. Earlier application is permitted as of the beginning of an interim or annual reporting period. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In May 2015, the FASB issued guidance to remove the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using net asset value per share practical expedient. The guidance is effective for the Company in the first quarter of fiscal 2017 and may apply to certain pension assets. The guidance will be applied retrospectively and earlier adoption is permitted. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In April 2015, the FASB issued new authoritative guidance to provide a practical expedient that permits the entity to measure defined benefit plan assets and obligations using the month-end that is closest to the entity’s fiscal year-end and apply that practical expedient consistently from year to year. Prospective application is required and early adoption is permitted. This guidance is effective for the Company in the first quarter of fiscal 2017 and may apply to the qualified and the non-qualified pension plans in certain countries. The Company will not early adopt and is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In April 2015, the FASB issued new authoritative guidance to simplify the presentation of debt issuance costs by requiring debt issuance costs to be presented as a deduction from the corresponding liability, consistent with debt discounts or premiums. This guidance is effective for the Company in the first quarter of fiscal 2017 for its convertible debt, and will be applied retrospectively. The consolidated balance sheet of each individual period presented will be adjusted to reflect the period-specific effects of applying this new guidance.

In May 2014, the FASB issued new authoritative guidance related to revenue recognition. This guidance will replace current U.S. GAAP guidance on this topic and eliminate industry-specific guidance. The new revenue recognition guidance provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance allows for either full retrospective adoption or modified retrospective adoption. The FASB deferred the effective date for this guidance by one year to December 15, 2017 for annual reporting periods beginning after such date. Earlier application of this guidance is permitted but not before the original date of December 15, 2016. The guidance is effective for the company in the first quarter of fiscal 2019. The Company is evaluating the impact that this new accounting guidance will have on its consolidated financial statements and related disclosures.

Note 3. Discontinued Operations

On August 1, 2015, the Company completed the separation of the Lumentum business (the “Separation”) and made a tax-free distribution of approximately 80.1% of the outstanding shares of Lumentum common stock to Viavi shareholders who received one share of Lumentum common stock for every five shares of Viavi common stock held as of the close of business on July 27, 2015 (the “Record Date”) and not sold prior to August 4, 2015 (the “ex-dividend date”). In connection with the Separation Viavi agreed to contribute $137.6 million of total cash, of which $0.9 million remains to be contributed as of January 2, 2016. As of the Distribution, Viavi retained ownership of approximately 19.9%, or 11.7 million shares, of Lumentum’s outstanding shares. Lumentum was formed to hold Viavi’s CCOP business and the Waveready product line. As a result of the Distribution, Lumentum is now an independent public company.

In connection with the Separation, the Company entered into a Contribution Agreement, Separation and Distribution Agreement, a Tax Matters Agreement, Employee Matters Agreement, Securities Purchase Agreement, a Supply Agreement, and an Intellectual Property Matters Agreement with Lumentum and others.

7

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The Contribution Agreement identifies the assets to be transferred, the liabilities to be assumed and the contracts to be assigned and it provides for when and how these transfers, assumptions and assignments will occur.

The Separation and Distribution Agreement governs the separation of the CCOP and Waveready business, the transfer of assets and other matters related to Viavi’s relationship with Lumentum.

The Tax Matters Agreement governs the respective rights, responsibilities and obligations of Lumentum and Viavi with respect to tax liabilities and benefits, tax attributes, tax contests, tax returns, and certain other tax matters.

The Employee Matters Agreement governs the compensation and employee benefit obligations with respect to the current and former employees and non-employee directors of Lumentum and Viavi, and generally allocates liabilities and responsibilities relating to employee compensation, benefit plans and programs. The Employee Matters Agreement provides that employees of Lumentum will no longer participate in benefit plans sponsored or maintained by Viavi.

The Securities Purchase Agreement with the Company, Lumentum and Amada Holdings Co., Ltd. (“Amada”) set forth terms whereby the Company received 40,000 shares of Lumentum’s Series A Preferred Stock (“Series A Preferred Stock”) pursuant to a binding commitment to sell the Series A Preferred Stock to Amada following the Separation. Upon Separation, in connection with the agreement, during the first quarter of fiscal 2016 the Company sold 35,805 shares of the Series A Preferred Stock to Amada for $35.8 million and the remaining 4,195 shares of the Series A Preferred Stock were canceled. The $35.8 million is included as a part of financing activities in the Statement of Cash Flows.

The Supply Agreement outlines that Viavi will supply test equipment to Lumentum and Lumentum will supply components related to the Company’s metro, fiber and optical product lines and development services related to smart transceivers. The most significant component of the Supply Agreement is $15 million related to the sale of certain optical test equipment to Lumentum during the 12 month period from the date of the agreement through July 31, 2016, of which the company recorded $3.8 million and $8.3 million of net revenue during the three and six months endedJanuary 2, 2016, respectively.

The Intellectual Property Matters Agreement outlines the intellectual property rights and technology transferred to Lumentum upon the Separation, as well as the intellectual property and technology both companies can license from each other. In addition it outlines non-compete restrictions between Viavi and Lumentum.

As the separation of the Lumentum business represents a strategic shift that has and will have a major effect on the Company’s operations and financial results, the results of operations and net assets of the Lumentum business are presented separately as discontinued operations for the three and six months endedJanuary 2, 2016 and December 27, 2014 and as of June 27, 2015, in accordance with the authoritative guidance.

Lumentum is now a stand-alone public company that separately reports it financial results. Due to the difference between the basis of presentation for discontinued operations and the basis of presentation as a stand-alone company, the financial results of Lumentum included within discontinued operations for the Company may not be indicative of actual financial results of Lumentum as a stand-alone company.

8

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table presents the carrying amounts of the major classes of the assets and liabilities of the Lumentum business which are presented as discontinued operation on the Consolidated Balance Sheets (in millions).

	June 27, 2015
Assets:
Cash and cash equivalents	$	13.4
Accounts receivable, net	150.2
Inventories, net	100.0
Prepayments and other current assets	46.6
Current assets of discontinued operations	310.2
Property, plant and equipment, net	145.4
Goodwill	5.6
Intangibles, net	21.8
Other non-current assets	31.4
Non-current assets of discontinued operations	204.2
Total assets of discontinued operations	$	514.4
Liabilities:
Accounts payable	$	79.1
Accrued payroll and related expenses	18.3
Income taxes payable	3.7
Accrued expenses	17.5
Other current liabilities	11.4
Current liabilities of discontinued operations	130.0
Non-current liabilities of discontinued operations	10.9
Total liabilities of discontinued operations	$	140.9

In connection with the Separation, $7.8 million of accumulated other comprehensive loss, net of income taxes, related to foreign currency translation adjustments and the pension plan obligation was transferred to Lumentum on the Separation Date. Refer to “Note 5. Accumulated Other Comprehensive (Loss) Income” for more information.

The Company also transferred deferred tax assets of $29.5 million, deferred tax liabilities of $1.0 million, current income tax payables of $3.3 million, an income tax receivable of $1.3 million and other long-term liabilities related to uncertain tax positions totaling $0.1 million on the Separation date. The Company utilized approximately $1.0 billion of federal net operating losses to offset income recognized as a result of the Separation and the license of Lumentum’s intellectual property to a foreign subsidiary.

The removal of Lumentum’s net assets and equity related adjustments upon the Separation are presented as an increase of Viavi's accumulated deficit and represents a non-cash financing activity, excluding the cash transferred. Refer to “Note 14. Stock-Based Compensation” for information on modifications to stock-based compensation awards as a result of the Distribution.

9

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table summarizes results from discontinued operations of the Lumentum business included in the condensed Consolidated Statement of Operations (in millions):

	Three Months Ended (1)			Six Months Ended
	December 27, 2014			January 2, 2016			December 27, 2014
Net revenues	$	210.7		$	66.5		$	429.0
Cost of revenues	141.4			49.7			287.4
Amortization of acquired technologies	1.9			0.6			3.8
Gross profit	67.4			16.2			137.8
Operating expenses:
Research and development	35.0			12.5			69.8
Selling, general and administrative	18.8			24.0			36.0
Restructuring charges	0.6			0.1			2.4
Total operating expenses	54.4			36.6			108.2
(Loss) income from operations	13.0			(20.4		)	29.6
Interest and other income (expense), net	(0.1		)	0.5			(0.3		)
(Loss) income before income taxes	12.9			(19.9		)	29.3
Income tax provision	0.3			30.5			0.6
Net (loss) income from discontinued operations	$	12.6		$	(50.4	)	$	28.7

(1)  Net income from discontinued operations for the three months endedJanuary 2, 2016 of $3.0 million is comprised of costs to complete the separation offset by a benefit from income taxes from discontinued operations of $4.5 million. No income or expense relating to the Lumentum business has been recorded after the separation from Viavi on August 1, 2015.

During the six months endedJanuary 2, 2016, the income tax provision for discontinued operation of $30.5 million, included approximately $5.6 million of cash taxes that are due to federal and state authorities as a result of the Separation. In addition, approximately $25.2 million of the income tax provision for discontinued operations related to the income tax intraperiod tax allocation rules in relation to continuing operations and other comprehensive income.

Net (loss) income from discontinued operations also includes costs incurred by the Company to separate Lumentum such as transaction charges, advisory and consulting fees. Net income (loss) from discontinued operations for the three and six months endedJanuary 2, 2016 included $1.5 million and $15.5 million of costs to complete the separation, respectively. Net income (loss) from discontinued operations for the three and six months endedDecember 27, 2014 included $3.3 million and $3.7 million of costs to complete the separation, respectively.

The following table presents supplemental cash flow information: depreciation expense, amortization expense, stock based compensation expense and capital expenditures of the Lumentum business (in millions):

	Six Months Ended
	January 2, 2016		December 27, 2014
Operating activities:
Depreciation expense	$	3.7	$	21.3
Amortization expense	0.6		4.0
Stock-based compensation expense	1.6		9.7
Investing activities:
Capital expenditures	$	5.8	$	23.1

10

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 4. Earnings Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share (in millions, except per share data):

	Three Months Ended					Six Months Ended
	January 2, 2016		December 27, 2014			January 2, 2016			December 27, 2014
Numerator:
Income (loss) from continuing operations, net of taxes	$	3.3	$	(37.7	)	$	(10.3	)	$	(63.5	)
Income (loss) from discontinued operations, net of taxes	3.0		12.6			(50.4		)	28.7
Net income (loss)	$	6.3	$	(25.1	)	$	(60.7	)	$	(34.8	)
Denominator:
Weighted-average number of common shares outstanding
Basic	234.9		232.1			235.5			231.5
Effect of dilutive securities from stock-based benefit plans	2.2		—			—			—
Diluted	237.1		232.1			235.5			231.5
Net income (loss) per share - basic and diluted:
Continuing operations	$	0.02	$	(0.16	)	$	(0.04	)	$	(0.27	)
Discontinued operations	0.01		0.05			(0.22		)	0.12
Net income (loss) per share	$	0.03	$	(0.11	)	$	(0.26	)	$	(0.15	)

The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net income (loss) per share because their effect would have been anti-dilutive (in millions):

	Three Months Ended		Six Months Ended
	January 2, 2016 (2)	December 27, 2014 (1)(2)	January 2, 2016 (1)(2)	December 27, 2014 (1)(2)
Stock options and ESPP	0.9	3.8	3.4	3.8
Restricted Stock Units	4.5	11.1	11.0	10.8
Total potentially dilutive securities	5.4	14.9	14.4	14.6

(1)  As the Company incurred a net loss in the period, potential dilutive securities from employee stock options, employee stock purchase plan (“ESPP”) and Restricted Stock Units (“RSUs”) have been excluded from the diluted net loss per share computations as their effects were deemed anti-dilutive.

(2)  The Company’s 0.625% Senior Convertible 2033 Notes are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $11.28 per share is payable in cash, shares of the Company’s common stock or a combination of both. Refer to “Note 10. Debts and Letters of Credit” for more details.

Note 5. Accumulated Other Comprehensive (Loss) Income

The Company’s accumulated other comprehensive income (loss) consists of the accumulated net unrealized gains and losses on available-for-sale investments, foreign currency translation adjustments and defined benefit obligations.

11

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the six months endedJanuary 2, 2016 the changes in accumulated other comprehensive income (loss) by component net of tax were as follows (in millions):

	Unrealized (losses) on available-for sale investments (2)			Foreign  currency translation adjustments			Defined benefit obligation, net of tax (3)			Total
Beginning balance as of June 27, 2015	$	(3.2	)	$	(29.2	)	$	(15.6	)	$	(48.0	)
Transferred to Lumentum (1)	—			(8.9		)	1.1			(7.8		)
Other comprehensive (loss) income before reclassification	153.1			(21.8		)	—			131.3
Amounts reclassified from accumulated other comprehensive income (loss)	—			—			0.3			0.3
Net current-period other comprehensive (loss) income	153.1			(21.8		)	0.3			131.6
Ending balance as of January 2, 2016	$	149.9		$	(59.9	)	$	(14.2	)	$	75.8

(1) Amount represents the transfer of accumulated other comprehensive balances to Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information.

(2) Activity during the six months ended primarily relates to a $157.2 million unrealized gain on the marketable equity securities of Lumentum held by Viavi, net of a $3.7 million income tax effect related to the intraperiod tax allocation rules.

(3) Amount represents the amortization of actuarial losses included as a component of Selling, general and administrative expense (“SG&A”) in the Consolidated Statement of Operations for the six months endedJanuary 2, 2016. There was no tax impact. Refer to “Note 15. Employee Pension and Other Benefit Plans” for more details on the computation of net periodic cost for pension plans.

Note 6. Balance Sheet and Other Details

Accounts receivable reserves and allowances

The components of accounts receivable reserves and allowances were as follows (in millions):

	June 27, 2015		Charged to Costs and Expenses		Adjustments (1)			January 2, 2016
Allowance for doubtful accounts	$	2.4	$	0.3	$	(0.1	)	$	2.6
Allowance for sales returns	0.7		1.6		(1.2		)	1.1
Total accounts receivable reserves	$	3.1	$	1.9	$	(1.3	)	$	3.7

 (1) Represents the effect of currency translation adjustments and write-offs of uncollectible accounts, net of recoveries.

Inventories, net

The components of Inventories, net were as follows (in millions):

	January 2, 2016		June 27, 2015
Finished goods	$	33.0	$	31.5
Work in process	5.6		6.8
Raw materials	19.0		15.5
Inventories, net	$	57.6	$	53.8

12

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Prepayments and other current assets

The components of Prepayments and other current assets were as follows (in millions):

	January 2, 2016		June 27, 2015
Prepayments	$	13.2	$	15.7
Other current assets	20.9		22.5
Prepayments and other current assets	$	34.1	$	38.2

Other current liabilities

The components of Other current liabilities were as follows (in millions):

	January 2, 2016		June 27, 2015
Deferred compensation plan	$	3.3	$	3.0
Warranty	2.5		2.3
Value-added tax	3.2		1.7
Restructuring	9.4		19.1
Deferred income taxes	—		7.1
Other	12.4		10.3
Other current liabilities	30.8		$	43.5

Other non-current liabilities

The components of Other non-current liabilities were as follows (in millions):

	January 2, 2016		June 27, 2015
Pension and post-employment benefits	$	83.3	$	86.9
Financing obligation	29.2		29.1
Restructuring accrual	5.9		8.2
Long-term deferred revenue	22.5		23.6
Other	21.4		20.6
Other non-current liabilities	$	162.3	$	168.4

13

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 7. Investments and Fair Value Measurements

The Company’s investments in marketable debt and equity securities were primarily classified as available-for-sale securities. As of January 2, 2016, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Debt securities:
U.S. treasuries	$	46.3	$	—	$	—		$	46.3
U.S. agencies	59.7		—		(0.1		)	59.6
Municipal bonds and sovereign debt instruments	2.3		—		—			2.3
Asset-backed securities	49.8		—		(0.4		)	49.4
Corporate securities	183.8		—		(0.2		)	183.6
Total debt securities	341.9		—		(0.7		)	341.2
Marketable equity securities	100.3		157.2		—			257.5
Total available-for-sale securities	$	442.2	$	157.2	$	(0.7	)	$	598.7

The Company generally classifies debt securities as cash equivalents, short-term investments or other non-current assets based on the stated maturities; however, certain securities with stated maturities of longer than twelve months which are highly liquid and available to support current operations are also classified as short-term investments. As of January 2, 2016, of the total fair value, $15.8 million was classified as cash equivalents, $324.7 million was classified as short-term investments and $0.7 million was classified as other non-current assets.

Marketable equity securities consist of the Company’s ownership of 11.7 million shares of Lumentum common stock retained in connection with the Separation. These securities are stated at fair value, with unrealized gains and losses reported in other comprehensive income, net of tax and are classified as short-term investments on the Consolidated Balance Sheet as of January 2, 2016 at $257.5 million. The Company has not recognized any realized gains or losses related to these securities.

 In addition to the amounts presented above, as of January 2, 2016, the Company’s short-term investments classified as trading securities related to the deferred compensation plan were $3.3 million, of which $0.6 million was invested in debt securities, $0.7 million was invested in money market instruments and funds and $2.0 million was invested in equity securities. Trading securities are reported at fair value, with the unrealized gains or losses resulting from changes in fair value recognized in Interest and other income (expense), net.

During the three and six months endedJanuary 2, 2016 and December 27, 2014, the Company recorded no other-than-temporary impairment charges in each respective period.

As of January 2, 2016, contractual maturities of the Company’s debt securities classified as available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Estimated Fair Value
Amounts maturing in less than 1 year	$	233.9	$	233.8
Amounts maturing in 1 - 5 years	105.5		105.3
Amounts maturing in more than 5 years	2.5		2.1
Total debt available-for-sale securities	$	341.9	$	341.2

14

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

 As of June 27, 2015, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Debt securities:
U.S. treasuries	$	51.9	$	—	$	—		$	51.9
U.S. agencies	96.0		—		—			96.0
Municipal bonds and sovereign debt instruments	4.0		—		—			4.0
Asset-backed securities	70.6		—		(0.2		)	70.4
Corporate securities	274.1		0.1		(0.1		)	274.1
Total debt available-for-sale securities	$	496.6	$	0.1	$	(0.3	)	$	496.4

As of June 27, 2015, of the total fair value, $33.7 million was classified as cash equivalents, $461.9 million was classified as short-term investments and $0.8 million was classified as other non-current assets.

In addition to the amounts presented above, as of June 27, 2015, the Company’s short-term investments classified as trading securities, related to the deferred compensation plan, were $3.4 million, of which $0.6 million was invested in debt securities, $0.7 million was invested in money market instruments and funds and $2.1 million was invested in equity securities. Trading securities are reported at fair value, with the unrealized gains or losses resulting from changes in fair value recognized in Interest and other income (expense), net.

Fair Value Measurements

Assets measured at fair value as of January 2, 2016 are summarized below (in millions):

	Fair value measurement as of
	January 2, 2016
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Debt available-for-sale securities
U.S. treasuries	$	46.3	$	46.3	$	—
U.S. agencies	59.6		—		59.6
Municipal bonds and sovereign debt instruments	2.3		—		2.3
Asset-backed securities	49.4		—		49.4
Corporate securities	183.6		—		183.6
Total debt available-for-sale securities	341.2		46.3		294.9
Marketable equity securities	257.5		257.5		—
Money market funds	203.0		203.0		—
Trading securities	3.3		3.3		—
Total assets (1)	$	805.0	$	510.1	$	294.9

(1) $204.5 million in cash and cash equivalents, $585.5 million in short-term investments, $10.5 million in restricted cash, and $4.5 million in other non-current assets on the Company’s Consolidated Balance Sheets.

Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. There is an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the assumptions about the factors that market participants would use in valuing the asset or liability.

15

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The Company’s cash and investment instruments are classified within Level 1 or Level 2 of the fair value hierarchy based on quoted prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.

• Level 1 includes financial instruments for which quoted market prices for identical instruments are available in active markets. Level 1 assets of the Company include money market funds, U.S. Treasury securities and marketable equity securities as they are traded with sufficient volume and frequency of transactions. 

• Level 2 includes financial instruments for which the valuations are based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 2 instruments of the Company generally include certain U.S. and foreign government and agency securities, commercial paper, corporate and municipal bonds and notes, asset-backed securities, and foreign currency forward contracts. To estimate their fair value, the Company utilizes pricing models based on market data. The significant inputs for the valuation model usually include benchmark yields, reported trades, broker and dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data, and industry and economic events. 

• Level 3 includes financial instruments for which fair value is derived from valuation based on inputs that are unobservable and significant to the overall fair value measurement. As of June 27, 2015 and during the three and six months endedJanuary 2, 2016 and December 27, 2014 the Company did not hold any Level 3 investment securities.

Foreign Currency Forward Contracts

The Company has foreign subsidiaries that operate and sell the Company’s products in various markets around the world. As a result, the Company is exposed to foreign exchange risks. The Company utilizes foreign exchange forward contracts and other instruments to manage foreign currency risk associated with foreign currency denominated monetary assets and liabilities, primarily certain short-term intercompany receivables and payables, and to reduce the volatility of earnings and cash flows related to foreign-currency transactions.

The forward contracts, most with a term of less than 120 days, were transacted near quarter end; therefore, the fair value of the contracts as of both January 2, 2016 and June 27, 2015 is not material. The change in the fair value of these foreign currency forward contracts is recorded as gain or loss in the Company’s Consolidated Statements of Operations as a component of Interest and other income (expense), net.

Note 8. Goodwill

The following table presents the changes in goodwill allocated to the Company’s reportable segments (in millions):

	Network Enablement			Service Enablement			Optical Security and Performance Products		Total
Balance as of June 27, 2015	$	154.5		$	92.7		$	8.3	$	255.5
Currency translation and other adjustments	(2.2		)	(1.2		)	—		(3.4		)
Goodwill allocation - WaveReady (1)	(6.0		)	—			—		(6.0		)
Balance as of January 2, 2016	$	146.3		$	91.5		$	8.3	$	246.1

(1) Amount represents a release of the relative fair value of goodwill in our NE reporting unit related to the WaveReady products line, which is now a part of Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information.

The Company reviews goodwill for impairment during the fourth quarter of each fiscal year, or more frequently if events or circumstances indicate that an impairment loss may have occurred. In the fourth quarter of fiscal 2015, the Company completed the annual impairment test of goodwill with no goodwill impairments. There were no events or changes in circumstances which triggered an impairment review during the three and six months ended months ended January 2, 2016.

16

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 9. Acquired Developed Technology and Other Intangibles

The following tables present details of the Company’s acquired developed technology, customer relationships and other intangibles (in millions):

As of January 2, 2016	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	420.6	$	(379.3	)	$	41.3
Customer relationships	174.7		(139.6		)	35.1
Other	19.2		(18.8		)	0.4
Total intangibles subject to amortization	$	614.5	$	(537.7	)	$	76.8
In-process research and development assets	$	0.8	-			$	0.8
Total intangibles	$	615.3	$	(537.7	)	$	77.6

As of June 27, 2015	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	418.9	$	(373.6	)	$	45.3
Customer relationships	178.7		(135.8		)	42.9
Other	19.5		(18.9		)	0.6
Total intangibles subject to amortization	617.1		(528.3		)	88.8
In-process research and development assets	1.8		—			1.8
Total intangibles	$	618.9	$	(528.3	)	$	90.6

During the three months ended October 3, 2015, the Company completed its in-process research and development (“IPR&D”) project related to the fiscal 2014 acquisition of Trendium. Accordingly, $1.8 million was transferred from indefinite life intangible assets to acquired developed technology intangible assets with a useful life of thirty-six months.

The following table presents the amortization recorded relating to acquired developed technology, customer relationships and other intangibles (in millions):

	Three Months Ended				Six Months Ended
	January 2, 2016		December 27, 2014		January 2, 2016		December 27, 2014
Amortization of acquired developed technologies	$	4.6	$	9.2	$	8.9	$	17.3
Amortization of other intangibles	3.7		4.9		7.5		9.9
Total amortization of intangible assets	$	8.3	$	14.1	$	16.4	$	27.2

Based on the carrying amount of acquired developed technology, customer relationships and other intangibles as of January 2, 2016, and assuming no future impairment of the underlying assets, the estimated future amortization is as follows (in millions):

Fiscal Years
Remainder of 2016	$	15.4
2017	29.5
2018	20.9
2019	9.3
2020	1.3
Thereafter	0.4
Total amortization	$	76.8

17

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The acquired developed technology, customer relationships and other intangibles balance are adjusted quarterly to record the effect of currency translation adjustments.

Note 10. Debts and Letters of Credit

As of January 2, 2016 and June 27, 2015, the Company’s long-term debt on the Consolidated Balance Sheets represented the carrying amount of the liability component of the 0.625% Senior Convertible Notes as discussed below. The following table presents the carrying amounts of the liability and equity components (in millions):

	January 2, 2016			June 27, 2015
Principal amount of 0.625% Senior Convertible Notes	$	650.0		$	650.0
Unamortized discount of liability component	(75.2		)	(88.4		)
Carrying amount of liability component	$	574.8		$	561.6
Carrying amount of equity component (1)	$	134.4		$	134.4

(1) Included in Accumulated paid-in-capital on the Consolidated Balance Sheets.

The Company was in compliance with all debt covenants and held no short term debt as of January 2, 2016 and June 27, 2015.

0.625% Senior Convertible Notes

On August 21, 2013, the Company issued $650.0 million aggregate principal amount of 0.625% Senior Convertible Notes due 2033 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The proceeds from the 2033 Notes amounted to $636.3 million after issuance costs. The 2033 Notes are an unsecured obligation of the Company and bear interest at an annual rate of 0.625% payable in cash semi-annually in arrears on February 15 and August 15 of each year. The 2033 Notes mature on August 15, 2033 unless earlier converted, redeemed or repurchased. The 2033 Notes and its terms are described in “Note 10. Debts and Letters of Credit” of the Company’s Annual Report on Form 10-K for the year ended June 27, 2015.

Following the separation of the Lumentum business on August 1, 2015, the conversion price per share was adjusted pursuant to the terms of the 2033 Notes relating to the occurrence of a spin-off event. Effective as of the end of the business day on August 17, 2015, the initial conversion price per share was adjusted to $11.28 per share of the Company’s common stock traded on NASDAQ under the ticker symbol “VIAV.”

In accordance with the authoritative accounting guidance, the Company separated the 2033 Notes into liability and equity components. The carrying value of the liability component at issuance was calculated as the present value of its cash flows using a discount rate of 5.4% based on the 5-year swap rate plus credit spread as of the issuance date. The credit spread for the Company is based on the historical average “yield to worst” rate for BB rated issuers. The difference between the 2033 Notes principal and the carrying value of the liability component, representing the value of conversion premium assigned to the equity component, was recorded as a debt discount on the issuance date and is being accreted using the effective interest rate of 5.4% over the period from the issuance date through August 15, 2018 as a non-cash charge to interest expense. The carrying value of the liability component was determined to be $515.6 million, and the equity component, or debt discount, of the 2033 Notes was determined to be $134.4 million. As of January 2, 2016, the expected remaining term of the 2033 Notes is 2.6 years.

In connection with the issuance of the 2033 Notes, the Company incurred $13.7 million of issuance costs, which were bifurcated into the debt issuance costs, attributable to the liability component of $10.9 million and the equity issuance costs, attributable to the equity component of $2.8 million based on their relative values. The debt issuance costs were capitalized and are being amortized to interest expense using the effective interest rate method from issuance date through August 15, 2018. The equity issuance costs were netted against the equity component in additional paid-in capital at the issuance date. As of January 2, 2016, the unamortized portion of the debt issuance costs related to the 2033 Notes was $6.1 million, which was included in Other non-current assets on the Consolidated Balance Sheets.

Based on quoted market prices as of January 2, 2016 and June 27, 2015, the fair value of the 2033 Notes was approximately $610.1 million and $644.0 million. The 2033 Notes are classified within Level 2 as they are not actively traded in markets.

18

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table presents the effective interest rate and the interest expense for the contractual interest and the accretion of debt discount (in millions, except for the effective interest rate):

	Three Months Ended						Six Months Ended
	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Effective interest rate	5.4		%	5.4		%	5.4		%	5.4		%
Interest expense-contractual interest	$	1.0		$	1.0		$	2.0		$	2.0
Accretion of debt discount	6.6			6.3			13.2			12.5

Outstanding Letters of Credit

As of January 2, 2016, the Company had 10 standby letters of credit totaling $14.3 million.

Note 11. Restructuring and Related Charges

The Company has initiated various strategic restructuring events primarily intended to reduce its costs, consolidate its operations, rationalize the manufacturing of its products and align its businesses in response to market conditions. As of January 2, 2016 and June 27, 2015, the Company’s total restructuring accrual was $15.3 million and $27.2 million. During the three and six months endedJanuary 2, 2016 the Company recorded restructuring and related charges of $1.4 million and $1.8 million, respectively. During the three and six months endedDecember 27, 2014 the Company recorded restructuring and related charges of $9.1 million and $10.2 million, respectively. The Company’s restructuring charges can include severance and benefit costs to eliminate a specified number of positions, facilities and equipment costs to vacate facilities and consolidate operations, and lease termination costs. The timing of associated cash payments is dependent upon the type of restructuring charge and can extend over multiple periods.

Summary of Restructuring Plans

The adjustments to the accrued restructuring expenses related to all of the Company’s restructuring plans described below for the three and six months endedJanuary 2, 2016 were as follows (in millions):

	Balance June 27, 2015		Six Months Ended January 2, 2016 Charges			Cash Settlements			Non-cash Settlements and Other Adjustments			Balance January 2, 2016		Three Months Ended January 2, 2016 Charges
Fiscal 2016 Plan
NE and SE Agile Restructuring Plan (Workforce Reduction)	$	—	$	3.0		$	(0.4	)	$	—		$	2.6	$	3.0
Fiscal 2015 Plan
NE, SE and Shared Service Separation Restructuring Plan (Workforce Reduction)	14.9		(0.5		)	(10.3		)	(0.2		)	3.9		(0.8		)
Fiscal 2014 Plans
NE Realignment Plan (Workforce Reduction)	0.6		(0.1		)	(0.5		)	—			—		(0.1		)
Shared Services Restructuring Plan (Workforce Reduction)	0.7		—			(0.7		)	—			—		—
NE Product Strategy Restructuring Plan (Workforce Reduction)	2.3		—			(0.4		)	(0.1		)	1.8		—
NE Lease Restructuring Plan	5.2		0.2			(0.7		)	—			4.7		0.1
Central Finance and IT Restructuring Plan (Workforce Reduction)	1.1		(0.7		)	(0.1		)	—			0.3		(0.7		)
Plans Prior to Fiscal 2014	2.4		(0.1		)	(0.3		)	—			2.0		(0.1		)
Total	$	27.2	$	1.8		$	(13.4	)	$	(0.3	)	$	15.3	$	1.4

As of January 2, 2016 and June 27, 2015, $5.9 million and $8.2 million, respectively, of our restructuring liability was long-term in nature and included as a component of Other non-current liabilities, with the remaining short-term portion included as a component of Other current liabilities on the Consolidated Balance Sheets.

19

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Fiscal 2016 Plans

NE and SE Agile Restructuring Plan

During the second quarter of fiscal 2016, Management approved a plan primarily impacting the NE and SE business segment as part of Viavi’s ongoing commitment for an agile and more efficient operating structure. As a result, a restructuring charge of $3.0 million was recorded for severance and employee benefits for approximately 50 employees primarily in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2017.

Fiscal 2015 Plans

NE, SE and Shared Service Separation Restructuring Plan

During the second, third and fourth quarters of fiscal 2015, Management approved a plan to eliminate certain positions in its shared services functions in connection with the Company’s plan to split into two separate public companies. Further, Management consolidated its operations, sales and R&D organizations and eliminated positions within the NE and SE segments to align to the Company’s product market strategy and lower manufacturing costs in connection with the separation. As a result, approximately 340 employees in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the third quarter of fiscal 2018.

Fiscal 2014 Plans

NE Realignment Plan

During the fourth quarter of fiscal 2014, Management approved a NE plan to realign its operations and strategy to allow for greater investment in high-growth areas. As a result, approximately 100 employees in manufacturing, R&D and SG&A functions located in United States, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual were paid by the end of the second quarter of fiscal 2016.

Shared Services Restructuring Plan

During the fourth quarter of fiscal 2014, Management approved a plan to eliminate positions and re-define roles and responsibilities in its shared services functions in order to reduce cost, standardize global processes and establish a more efficient organization. As a result, approximately 40 employees primarily in the general and administrative functions located in the United States, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual were paid by the end of the second quarter of fiscal 2016.

NEProduct Strategy Restructuring Plan

During the third quarter of fiscal 2014, Management approved a NE plan to realign its services, support and product resources in response to market conditions in the mobile assurance market and to increase focus on software products and next generation solutions through acquisitions and R&D. As a result, approximately 60 employees primarily in SG&A and manufacturing functions located in North America, Latin America, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2020.

NE Lease Restructuring Plan

During the second quarter of fiscal 2014, Management approved a NE plan to exit the remaining space in Germantown, Maryland. As of June 28, 2014, the Company exited the space in Germantown under the plan. The fair value of the remaining contractual obligations, net of sublease income, as of January 2, 2016 was $4.7 million. Payments related to the Germantown lease costs are expected to be paid by the end of the second quarter of fiscal 2019.

Central Finance and Information Technology (“IT”) Restructuring Plan

During the second quarter of fiscal 2014, Management approved a plan to eliminate positions and re-define roles and responsibilities in the Finance and IT organization to align with the future state of the organizations under new executive management and move positions to lower-cost locations where appropriate. As a result, approximately 20 employees primarily in SG&A functions

20

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

located in North America, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the fourth quarter of fiscal 2019.

Plans Prior to Fiscal 2014

The restructuring accrual for plans that commenced prior to fiscal year 2014 was $2.0 million, which consists of immaterial accruals from various restructuring plans.

Note 12. Income Taxes

The Company recorded an income tax benefit of $1.2 million and $0.4 million related to the income (loss) from continuing operations for the three and six months ended months ended January 2, 2016, respectively. The Company recorded an income tax expense of $8.5 million and $14.3 million related to the loss from continuing operations for the three and six months ended December 27, 2014, respectively.

The income tax benefit related to the income (loss) from continuing operations recorded for the three and six months ended January 2, 2016 and December 27, 2014 primarily relates to income tax in certain foreign and state jurisdictions based on the Company’s forecasted pre-tax income or loss for the respective year. In addition, for the three and six months ended January 2, 2016 the Company’s income tax provision includes a tax benefit of $8.8 million and $22.2 million, respectively, related to the income tax intraperiod tax allocation rules for discontinued operations and other comprehensive income. The income tax benefit related to the loss from continuing operations for the six months ended January 2, 2016 also includes a tax expense of $8.9 million related to a one-time increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the Separation.

The income tax expense (benefit) related to the income (loss) from continuing operations recorded differs from the expected tax expense (benefit) that would be calculated by applying the federal statutory rate to the Company’s income (loss) from continuing operations before taxes primarily due to the increases in valuation allowance for deferred tax assets attributable to the Company’s domestic and foreign losses from continuing operations, the income tax benefit recorded in continuing operations under the income tax intraperiod tax allocation rules, and the increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the separation.

At the beginning of the second quarter of fiscal 2016, the Company prospectively adopted the authoritative guidance on balance sheet classification of deferred taxes, which requires deferred tax assets and liabilities, and any related valuation allowance, to be classified as non-current on the balance sheet. The adoption resulted in a reclass of $3.1 million of current net deferred tax assets and $0.7 million of current net deferred tax liabilities to non-current deferred assets and liabilities netted on a jurisdiction by jurisdiction basis.

As of January 2, 2016 and June 27, 2015, the Company’s unrecognized tax benefits totaled $37.0 million and $37.4 million, respectively, and are included in deferred taxes and other non-current tax liabilities, net. The Company had $1.6 million accrued for the payment of interest and penalties at January 2, 2016. The unrecognized tax benefits that may be recognized during the next twelve months are approximately $0.1 million.

Note 13. Stockholders' Equity

Repurchase of Common Stock

In May 2014, the Company's Board of Directors authorized a stock repurchase program under which the Company may purchase shares of its common stock worth up to an aggregate purchase price of $100.0 million through open market or private transactions. In October 2015, the Board extended the previously authorized repurchase program to utilize the remaining unused dollar amount from the program of approximately $40 million.

In November 2015, the Company entered into a $40.0 million accelerated share repurchase agreement (the “ASR”) with a financial institution that was completed during the third quarter of fiscal 2016. Upon making the upfront payment of $40.0 million, the Company received an initial delivery of 5.3 million shares from the financial institution during the second quarter of fiscal 2016, which were retired and recorded as a $32.0 million reduction to stockholder’s equity on the Consolidated Balance Sheet. As of January 2, 2016, the ASR was evaluated as an unsettled forward contract indexed to the Company’s own stock, with $8.0 million classified within stockholders’ equity. The Company reflects the repurchase of common stock under the ASR in the period the shares are delivered for the purposes of calculating earnings per share and as a forward contract indexed to its own common

21

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

stock. The ASR met all of the applicable criteria for equity classification and therefore was not accounted for as a derivative instrument.

During the third quarter of fiscal 2016, the ASR was completed and a final delivery of 1.3 million shares was delivered based on the final settlement price of $6.05 per share. All common shares repurchased under this program have been canceled and retired.

Note 14. Stock-Based Compensation

Overview

The impact on the Company’s results of operations of recording stock-based compensation by function for the three and six months endedJanuary 2, 2016 and December 27, 2014 was as follows (in millions):

	Three Months Ended				Six Months Ended
	January 2, 2016		December 27, 2014		January 2, 2016		December 27, 2014
Cost of sales	$	1.4	$	1.0	$	2.6	$	2.0
Research and development	1.9		2.0		4.7		3.9
Selling, general and administrative	5.6		7.5		17.6		15.1
Stock-based compensation	$	8.9	$	10.5	$	24.9	$	21.0

Approximately $0.9 million of stock-based compensation was capitalized to inventory at January 2, 2016.

Full Value Awards

Full Value Awards refer to RSUs and Performance Units that are granted with the exercise price equal to zero and are converted to shares immediately upon vesting. These Full Value Awards are performance-based, time-based or a combination of both and expected to vest over one to four years. The fair value of the time-based Full Value Awards is based on the closing market price of the Company’s common stock on the date of award.

During the six months endedJanuary 2, 2016 and December 27, 2014, the Company granted 5.3 million and 5.2 million RSUs, of which 0.5 million and 0.7 million, respectively, are performance-based RSUs with market conditions (“MSUs”). These MSU shares represent the target amount of grants, and the actual number of shares awarded upon vesting of the MSUs may be higher or lower depending upon the achievement of the relevant market conditions. The majority of MSUs vest in equal annual installments over three years based on the attainment of certain total shareholder return performance measures and the employee’s continued service through the vest date. The aggregate grant-date fair value of MSUs granted during the first quarter of fiscal 2016 and fiscal 2015 was estimated to be $2.9 million and $8.5 million, respectively, and was calculated using a Monte Carlo simulation. The remaining 4.8 million and 4.5 million granted during the six months endedJanuary 2, 2016 and December 27, 2014 are mainly time-based RSUs. The majority of these time-based RSUs vest over three years, with 33% vesting after one year and the balance vesting quarterly over the remaining two years. The grant amounts and grant-date fair values during the three and six months endedDecember 27, 2014 represent the Company’s historical grant information and have not been adjusted to remove grants made to employees who transferred to Lumentum as part of the Separation.

As of January 2, 2016, $52.3 million of unrecognized stock-based compensation cost related to Full Value Awards remains to be amortized. That cost is expected to be recognized over an estimated amortization period of 2.2 years.

Full Value Awards are converted into shares upon vesting. Shares equivalent in value to the minimum withholding taxes liability on the vested shares are withheld by the Company for the payment of such taxes. During the six months ended January 2, 2016 and December 27, 2014, the Company paid $7.8 million and $11.9 million, respectively, and classified the payments as operating cash outflows in the Consolidated Statement of Cash Flows.

Impact on Stock-based Compensation Due to Separation

In connection with the separation of the Lumentum business on August 1, 2015 and in accordance with the Employee Matters Agreement, the Company made certain adjustments to the exercise price and number of shares underlying stock-based compensation awards with the intention of preserving the economic value of the awards for Viavi employees. These adjustments resulted in a modification of equity awards with total incremental stock-based compensation of $13.6 million, of which $8.3 million was

22

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

expensed in the first two quarters of fiscal 2016. The remaining $5.3 million will be amortized over the remaining requisite service period from Separation Date to the end of the vesting term.

Valuation Assumptions

The Company estimates the fair value of the new MSUs granted using a Monte Carlo simulation based on the assumptions described below for the following periods:

	Six Months Ended
	January 2, 2016		December 27, 2014
Volatility of common stock	33.0	%	40.8	%
Average volatility of peer companies	52.6	%	53.4	%
Average correlation coefficient of peer companies	0.0887		0.2156
Risk-free interest rate	0.8	%	0.6	%

Note 15. Employee Pension and Other Benefit Plans

In connection with the separation of Lumentum on August 1, 2015, the Company transferred the liabilities and assets of the Switzerland defined benefit pension plans to Lumentum in the amount of $6.7 million and $4.6 million, respectively.

The Company sponsors significant qualified and non-qualified pension plans for certain past and present employees in the United Kingdom (“U.K.”) and Germany. The Company also is responsible for the non-pension post-retirement benefit obligation assumed from a past acquisition. Most of the plans have been closed to new participants and no additional service costs are being accrued, except for certain plans in Germany assumed in connection with acquisitions during fiscal 2010. Benefits are generally based upon years of service and compensation or stated amounts for each year of service.

As of January 2, 2016 the U.K. plan was partially funded while the other plans were unfunded. The Company’s policy for funded plans is to make contributions equal to or greater than the requirements prescribed by law or regulation. For unfunded plans, the Company pays the post-retirement benefits when due. During the six months ended January 2, 2016, the Company contributed $0.7 million to the U.K. plan. The funded plans assets consist primarily of managed investments.

The following table presents the components of the net periodic cost for the pension and benefits plans (in millions):

	Three Months Ended						Six Months Ended
Pension Benefits	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Service cost	$	0.1		$	—		$	0.2		$	0.1
Interest cost	0.7			1.0			1.5			2.0
Expected return on plan assets	(0.4		)	(0.4		)	(0.8		)	(0.8		)
Recognized net actuarial losses	0.1			0.1			0.3			0.2
Net periodic benefit cost	$	0.5		$	0.7		$	1.2		$	1.5

Both the calculation of the projected benefit obligation and net periodic cost are based upon actuarial valuations. These valuations use participant-specific information such as salary, age, years of service, and assumptions about interest rates, pension increases and other factors. At a minimum, the Company evaluates these assumptions annually and makes changes as necessary.

The Company expects to incur cash outlays of approximately $5.9 million related to its defined benefit pension plans during fiscal 2016 to make current benefit payments and fund future obligations. As of January 2, 2016, approximately $2.3 million had been incurred. These payments have been estimated based on the same assumptions used to measure the Company’s projected benefit obligation at June 27, 2015.

23

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 16. Commitments and Contingencies

Legal Proceedings

The Company is subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against the Company, individually or in aggregate, will not have a material adverse impact on its financial position, results of operations or statement of cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. Were an unfavorable final outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

Guarantees

In accordance with authoritative guidance which requires that upon issuance of a guarantee, the guarantor must recognize a liability for the fair value of the obligation it assumes under that guarantee. In addition, disclosures about the guarantees that an entity has issued, including a tabular reconciliation of the changes of the entity’s product warranty liabilities, are required.

The Company from time to time enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. These contracts primarily relate to: (i) divestiture agreements, under which the Company may provide customary indemnifications to purchasers of the Company’s businesses or assets; (ii) certain real estate leases, under which the Company may be required to indemnify property owners for environmental and other liabilities, and other claims arising from the Company’s use of the applicable premises; and (iii) certain agreements with the Company’s officers, directors and employees, under which the Company may be required to indemnify such persons for liabilities arising out of their employment relationship.

The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, the Company has not been obligated to make significant payments for these obligations, and no liabilities have been recorded for these obligations on the consolidated balance sheet as of January 2, 2016 and June 27, 2015.

Product Warranties

In general, the Company offers a three-year warranty for most of its products. The Company provides reserves for the estimated costs of product warranties at the time revenue is recognized. The Company estimates the costs of its warranty obligations based on its historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise with specific products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.

The following table presents the changes in the Company’s warranty reserve during fiscal 2016 and fiscal 2015 (in millions):

	Three Months Ended						Six Months Ended
	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Balance as of beginning of period	$	4.0		$	3.6		$	3.7		$	3.6
Provision for warranty	0.8			1.0			1.7			1.9
Utilization of reserve	(0.7		)	(1.2		)	(1.5		)	(2.1		)
Adjustments related to pre-existing warranties (including changes in estimates)	0.2			0.1			0.4			0.1
Balance as of end of period	$	4.3		$	3.5		$	4.3		$	3.5

Note 17. Operating Segments

The Company evaluates its reportable segments in accordance with the authoritative guidance on segment reporting. The Company’s Interim Chief Executive Officer, Richard Belluzzo, is the Company’s Chief Operating Decision Maker (“CODM”) pursuant to the guidance. The CODM allocates resources to the segments based on their business prospects, competitive factors, net revenue and operating results.

24

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The Company provides software and hardware platforms and instruments that deliver end-to-end visibility across physical, virtual and hybrid networks. Viavi’s solutions provide intelligence and insight across the network ecosystem to optimize networks and support more profitable, higher-performing networks for our customers. Viavi is also a leader in anti-counterfeiting solutions for currency authentication and high-value optical components and instruments for diverse government and commercial applications.

The Company’s reportable segments are:

(i) Network Enablement (“NE”):

NE provides testing solutions that access the network to perform build out and maintenance tasks. These solutions include instruments and software to design, build, turn-up, certify, troubleshoot, and optimize networks.

(ii) Service Enablement (“SE”):

SE solutions are embedded systems that yield network, service and application performance data. These solutions—including microprobes and software—monitor, collect and analyze network data to reveal the actual customer experience and to identify opportunities for new revenue streams and network optimization.

(iii) Optical Security and Performance Products (“OSP”):

OSP provides innovative optical security solutions, with a strategic focus on serving the anti-counterfeiting market through advanced security pigments, thread substrates and printed features for the currency, pharmaceutical and consumer electronic segments. OSP also provides thin-film coating solutions for 3D sensing applications.

Changes to Segment Reporting

Following the Separation in the first quarter of fiscal 2016, the Company made changes to its segment measures to reflect how the CODM manages the business post-separation as described below.

The CODM manages the Company in two broad business categories: Network and Service Enablement ("NSE") and OSP. NSE operates in two segments, NE and SE, whereas OSP operates as a single segment. The CODM evaluates segment performance of the NSE business based on NE and SE segment gross margin and NSE operating margin as a whole. Operating expenses associated with the NSE business are not allocated to the NE and SE segments within NSE, as they are managed centrally at the business unit level. The CODM evaluates segment performance of the OSP business based on OSP segment operating margin. In addition, prior to the first quarter of fiscal 2016 the Company did not allocate certain corporate-level operating expenses associated with its shared-service function to its segment results. Beginning in the first quarter of fiscal 2016, the Company has allocated these corporate-level operating expenses to its segment results, with the exception of certain non-recurring activities and other items as discussed below.

The Company does not allocate stock-based compensation, acquisition-related charges and amortization of intangibles, restructuring and related charges, non-operating income and expenses, or other non-recurring charges to our segments because Management does not include this information in its measurement of the performance of the operating segments. These items are presented as “Reconciling Items” in the table below.

As a result of the Separation, the Company excluded the results of the Lumentum business which historically consisted of the CCOP segment and the WaveReady product line within the NE segment for all periods presented. Refer to “Note 3. Discontinued Operations” for more information on the Separation. Additionally, the Company’s Video Assurance product line was moved out of its NE segment and into its SE segment during the first quarter of fiscal 2016.

The segment information for all periods presented has been revised to be comparable with the changes in the Company’s segment reporting measures.

25

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Information on reportable segments is as follows (in millions):

	Three Months Ended January 2, 2016
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	136.4		$	36.9		$	173.3		$	58.8		$	232.1		$	—		$	232.1
Gross profit	90.6			24.5			115.1			32.8			147.9			(6.1		)	141.8
Gross margin	66.4		%	66.4		%	66.4		%	55.8		%	63.7		%				61.1		%
Operating income (loss)							8.0			22.5			30.5			(21.3		)	9.2
Operating margin							4.6		%	38.3		%	13.1		%				4.0		%

	Three Months Ended December 27, 2014
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	129.0		$	46.8		$	175.8		$	50.6		$	226.4		$	—		$	226.4
Gross profit	84.6			32.4			117.0			26.7			143.7			(10.6		)	133.1
Gross margin	65.6		%	69.2		%	66.6		%	52.8		%	63.5		%				58.8		%
Operating income (loss)							2.0			17.1			19.1			(40.3		)	(21.2		)
Operating margin							1.1		%	33.8		%	8.4		%				(9.4		)%

	Three Months Ended
	January 2, 2016			December 27, 2014
Corporate reconciling items impacting gross profit:
Total segment gross profit	$	147.9		$	143.7
Stock-based compensation	(1.4		)	(1.0		)
Amortization of intangibles	(4.6		)	(9.2		)
Other charges related to non-recurring activities	(0.1		)	(0.4		)
GAAP gross profit	$	141.8		133.1
Corporate reconciling items impacting operating income (loss):
Total segment operating income	$	30.5		$	19.1
Stock-based compensation	(8.9		)	(10.5		)
Amortization of intangibles	(8.3		)	(14.1		)
Other charges related to non-recurring activities (1)	(2.7		)	(6.6		)
Restructuring and related charges	(1.4		)	(9.1		)
GAAP operating income (loss) from continuing operations	$	9.2		$	(21.2	)

(1) During the three months endedJanuary 2, 2016, other charges related to non-recurring activities primarily consisted of incremental expenses related to post-separation activities such as site consolidations, reorganizations, insourcing or outsourcing of activities. During the three months endedDecember 27, 2014, other charges related to non-recurring activities primarily consisted of incremental expenses related to Viavi-specific activities to complete the separation such as professional fees and additional personnel and related costs.

26

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

	Six Months Ended January 2, 2016
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	254.0		$	84.8		$	338.8		$	123.0		$	461.8		$	—		$	461.8
Gross profit	166.3			57.9			224.2			69.8			294.0			(11.7		)	282.3
Gross margin	65.5		%	68.3		%	66.2		%	56.7		%	63.7		%				61.1		%
Operating income (loss)							10.4			48.8			59.2			(52.9		)	6.3
Operating margin							3.1		%	39.7		%	12.8		%				1.4		%

	Six Months Ended December 27, 2014
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	250.5		$	97.3		$	347.8		$	93.9		$	441.7		$	—		$	441.7
Gross profit	164.8			67.4			232.2			49.8			282.0			(20.0		)	262.0
Gross margin	65.8		%	69.3		%	66.8		%	53.0		%	63.8		%				59.3		%
Operating income (loss)							0.7			31.4			32.1			(65.7		)	(33.6		)
Operating margin							0.2		%	33.4		%	7.3		%				(7.6		)%

	Six Months Ended
	January 2, 2016			December 27, 2014
Corporate reconciling items impacting gross profit:
Total segment gross profit	$	294.0		$	282.0
Stock-based compensation	(2.6		)	(2.0		)
Amortization of intangibles	(8.9		)	(17.3		)
Other charges related to non-recurring activities	(0.2		)	(0.7		)
GAAP gross profit	$	282.3		262.0
Corporate reconciling items impacting operating income (loss):
Total segment operating income	$	59.2		$	32.1
Stock-based compensation	(24.9		)	(21.0		)
Amortization of intangibles	(16.4		)	(27.2		)
Other charges related to non-recurring activities (1)	(9.8		)	(7.3		)
Restructuring and related charges	(1.8		)	(10.2		)
GAAP operating income (loss) from continuing operations	$	6.3		$	(33.6	)

(1) During the six months endedJanuary 2, 2016, other charges related to non-recurring activities primarily consisted of a) incremental expenses of $5.6 million related to post-separation activities such as site consolidations, reorganizations, insourcing or outsourcing of activities and b) $3.5 million of non-recurring incremental severance and related costs upon the exit of a key executive. During the six months endedDecember 27, 2014, other charges related to non-recurring activities primarily consisted of incremental expenses related to Viavi-specific activities to complete the separation, such as professional fees and additional personnel and related costs.

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Statements contained in this Quarterly report on Form 10-Q which are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. A forward-looking statement may contain words such as “anticipates,” “believes,” “can,” “can impact,” “could,” “continue,” “estimates,” “expects,” “intends,” “may,” “ongoing,” “plans,” “potential,” “projects,” “should,” “will,” “will continue to be,” “would,” or the negative thereof or other comparable terminology regarding beliefs, plans, expectations or intentions regarding the future. Forward-looking statements include statements such as:

• Our expectations regarding demand for our products, including continued trends in end-user behavior and technological advancements that may drive such demand and the role we will play in those advancements;

• Our plans for growth and innovation opportunities;

• The anticipated costs, benefits and other impacts of the separation of the Lumentum business;

• Financial projections and expectations, including profitability of certain business units, plans to reduce costs and improve efficiencies, the effects of seasonality on certain business units, continued reliance on key customers for a significant portion of our revenue, future sources of revenue, competition and pricing pressures, the future impact of certain accounting pronouncements and our estimation of the potential impact and materiality of litigation;

• Our plans for continued development, use and protection of our intellectual property;

• Our strategies for achieving our current business objectives, including related risks and uncertainties;

• Our plans or expectations relating to investments, acquisitions, partnerships and other strategic opportunities;

• Our strategies for reducing our dependence on sole suppliers or otherwise mitigating the risk of supply chain interruptions;

• Our research and development plans and the expected impact of such plans on our financial performance; and

• Our expectations related to our products, including costs associated with the development of new products, product yields, quality and other issues.

Management cautions that forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause our actual results to differ materially from those projected in such forward-looking statements. These forward-looking statements are only predictions and are subject to risks and uncertainties including those set forth in Part II, Item 1A “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q and in other documents we file with the Securities and Exchange Commission. Moreover, neither we assume nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. Forward-looking statements are made only as of the date of this Report and subsequent facts or circumstances may contradict, obviate, undermine or otherwise fail to support or substantiate such statements. We are under no duty to update any of the forward-looking statements after the date of this Form 10-Q to conform such statements to actual results or to changes in our expectations.

In addition, Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended June 27, 2015.

28

OUR INDUSTRIES AND QUARTERLY DEVELOPMENTS

Viavi Solutions Inc. (“Viavi,” also referred to as “the Company,” “we,” “our,” and “us”), formerly JDS Uniphase Corporation (“JDSU”), is a leading provider of software and hardware platforms and instruments that deliver end-to-end visibility across physical, virtual and hybrid networks. Our solutions provide precise intelligence and actionable insight from across the network ecosystem to optimize networks and support more profitable, higher-performing networks and quicker transition to next-generation technologies for our customers. Viavi is also a leader in anti-counterfeiting solutions for currency authentication and high-value optical components and instruments for diverse government and commercial applications.

On September 10, 2014, we announced plans to separate into two publicly traded companies:

• an optical components and commercial lasers company, Lumentum Holdings Inc. (“Lumentum”), consisting of our Communications and Commercial Optical Products (“CCOP”) segment and the WaveReady product line formerly within our Network Enablement (“NE”) segment; and

• a network and service enablement and optical coatings company, renamed Viavi, consisting of our NE, Service Enablement (“SE”) and Optical Security and Performance Products (“OSP”) segments.

On August 1, 2015, we completed the distribution of approximately 80.1% of the outstanding shares of Lumentum common stock to our stockholders (the “Separation”). We were renamed Viavi and, at the time of the distribution, retained ownership of approximately 19.9% of Lumentum’s outstanding shares. Following the Separation in the first quarter of fiscal 2016, the Company made changes to its segment measures to reflect how the CODM manages the business post-separation as described in “Note 17. Operating Segments.” These changes include a) the evaluation of NE and SE segment performance based on gross margin and the evaluation of the Network and Service Enablement business (“NSE”) as a whole on operating margin, b) the movement of the Video Assurance product line out of the NE segment and into the SE segment, and c) the allocation of previously unallocated corporate-level costs associated with the shared-services function to our segment’s results. In addition, the historical results of operations and net assets have been recast to present the Lumentum business as discontinued operations as described in “Note 3. Discontinued Operations.” The results of the CCOP segment and the WaveReady product line within the NE segment have been excluded from the accompanying discussion and analysis within our results of operations. Segment information for all periods presented has been revised to be comparable with the above changes in the Company’s segment reporting measures.

To serve our markets we operate in the following business segments:

• Network Enablement

• Service Enablement

• Optical Security and Performance Products

Network Enablement

NE provides an integrated portfolio of testing solutions that access the network to perform build-out and maintenance tasks. These solutions include instruments, software and services to design, build, turn-up, certify, troubleshoot, and optimize networks. They also support more profitable, higher-performing networks and help speed time-to-revenue.

Our solutions address lab and production environments, field deployment and service assurance for wireless and wireline networks, including storage networks. Our test instrument portfolio is one of the largest in the industry, with hundreds of thousands of units in active use by major NEMs, operators and services providers worldwide. Designed to be mobile, these products include instruments and software that access the network to perform installation and maintenance tasks that help service provider technicians assess the performance of network elements and segments and verify the integrity of the information being transmitted across the network. These instruments are highly intelligent and have user interfaces that are designed to simplify operations and minimize the training required to operate them. Our NE solutions are also used by NEMs in the design and production of next-generation network equipment.

Viavi also offers a range of product support and professional services designed to comprehensively address our customers’ requirements. These services include repair, calibration, software support and technical assistance for our products. We offer product and technology training as well as consulting services. Our professional services, provided in conjunction with system integration projects, include project management, installation and implementation.

NE customers include wireless and fixed services providers, NEMs, government organizations and large corporate customers, such as major telecom, mobility and cable operators, chip and infrastructure vendors, storage-device manufacturers, storage-network and switch vendors, and deployed private enterprise customers. Our customers include Alcatel-Lucent International,

29

América Móvil, S.A.B. de C.V., AT&T Inc., CenturyLink, Inc., Cisco Systems, Inc., Comcast Corporation, Lumentum Holdings Inc., Time Warner Inc., and Verizon Communications Inc.

During the first quarter of fiscal 2016, we re-grouped our NE products and associated services from seven product groupings to three as described below:

Wireline: Primarily consisting of (a) Access and Cable products (formerly components of Media, Access and Content); (b) Fiber Instrument products (formerly a component of Fiber) and (c) Metro products (formerly a component of Ethernet).

Wireless: Consisting of Wireless products which were formerly a component of Mobility.

Lab: Primarily consisting of (a) Capacity Advisor products (formerly a component of Mobility); (b) Fiber Optical Transport Products (formerly a component of Fiber); (c) Optical Transport products (formerly a component of Ethernet); and (d) Storage Network Test products (formerly a component of Cloud and Data Center).

Additionally, following the Separation we no longer sell products or services from the WaveReady product line as discussed above. We also moved our Video Assurance products (formerly a component of Media, Access and Content) to our SE segment. For the purposes of providing year-over-year variance analysis in the Results of Operations section below we have reflected these changes for all prior periods presented so that they are comparable with our current groupings.

Service Enablement

SE provides embedded systems and enterprise performance management solutions that give global service providers, enterprises and cloud operators visibility into network, service and application data. These solutions - which primarily consist of instruments, microprobes and software - monitor, collect and analyze network data to reveal the actual customer experience and identify opportunities for new revenue streams and network optimization.

Our portfolio of SE solutions address the same lab and production environments, field deployment and service assurance for wireless and fixed communications networks, including storage networks, as our NE portfolio. Our solutions let carriers remotely monitor performance and quality of network, service and applications performance throughout the entire network. This provides our customers with enhanced network management, control, and optimization that allow network operators to initiate service to new customers faster, decrease the need for technicians to make on-site service calls, help to make necessary repairs faster and, as a result, lower costs while providing higher quality and more reliable services. Remote monitoring decreases operating expenses, while early detection helps increase uptime, preserve revenue, and helps operators better monetize their networks.

SE customers include the same wireless and fixed services providers, NEMs, government organizations, large corporate customers, and storage-segment customers that are served by our NE segment.

During the first quarter of fiscal 2016, we re-grouped our SE products and associated services from five product groupings to three as described below:

Enterprise:Consisting of our Enterprise products (no change from our former Enterprise group).

Wireless: Consisting of our Location Intelligence and RAN Solutions products.

Assurance: Primarilyconsisting of our (a) Legacy Assurance, Protocol Test and xSIGHT products (formerly components of Mobile, Assurance and Analytics); (b) Legacy Wireline products (formerly a component of Packet Portal); (c) Packet Portal products (formerly Packet Portal, excluding Legacy Wireline products); and (d) Video Assurance products (formerly included in our NE segment).

For the purposes of providing year-over-year variance analysis in the Results of Operations section below we have reflected these changes for all prior periods presented so that they are comparable with our current groupings.

Optical Security and Performance Products

OSP leverages its core optical coating technologies and volume manufacturing capability to design, manufacture, and sell products targeting anti-counterfeiting, consumer and industrial, government, healthcare and other markets

OSP’s security offerings for the currency market include OVP®, OVMP® and banknote thread substrates. OVP® enables a color-shifting effect used by banknote issuers and security printers worldwide for anti-counterfeiting applications on currency and other high-value documents and products. OVP® protects the currencies of more than 100 countries today. OSP also develops

30

and delivers overt and covert anti-counterfeiting products that utilize its proprietary printing platform and are targeted primarily at the pharmaceutical and consumer-electronics markets.

Leveraging its expertise in spectral management and its unique high-precision coating capabilities, OSP provides a range of products and technologies for the consumer-electronics market, including, for example, optical filters for 3D sensing devices designed for gaming and other platforms.

OSP value-added solutions meet the stringent requirements of commercial and government customers in aerospace and defense. Viavi products are used in a variety of aerospace and defense applications, including optics for guidance systems, laser eye protection and night vision systems. These products, including coatings and optical filters, are optimized for each specific application.

OSP serves customers such as Excelitas Technologies Corporation, FLIR Systems, Lockheed Martin and SICPA.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

Refer to “Note 2. Recently Issued Accounting Pronouncements” regarding the effect of certain recent accounting pronouncements on our consolidated financial statements.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

For a description of the critical accounting policies that affect our more significant judgments and estimates used in the preparation of our consolidated financial statements, refer to Item 7 on Management Discussion and Analysis of Financial Condition and Results of Operations in our Fiscal 2015 Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”).

31

RESULTS OF OPERATIONS

The results of operations for the current period are not necessarily indicative of results to be expected for future periods. As fiscal 2016 is a 53-week year compared to a 52-week year in fiscal 2015, the six months ended January 2, 2016 contains an extra week of activity compared to the six months ended December 27, 2014.

The following table summarizes selected Consolidated Statements of Operations items (in millions, except for percentages):

	Three Months Ended											Six Months Ended
	January 2, 2016			December 27, 2014			Change			Percent Change		January 2, 2016			December 27, 2014			Change			Percent Change
Segment net revenue:
NE	$	136.4		$	129.0		$	7.4		5.7	%	$	254.0		$	250.5		$	3.5		1.4	%
SE	36.9			46.8			(9.9		)	(21.2	)	84.8			97.3			(12.5		)	(12.8	)
OSP	58.8			50.6			8.2			16.2		123.0			93.9			29.1			31.0
Total net revenue	$	232.1		$	226.4		$	5.7		2.5	%	$	461.8		$	441.7		$	20.1		4.6	%
Gross profit	$	141.8		$	133.1		$	8.7		6.5	%	$	282.3		$	262.0		$	20.3		7.7	%
Gross margin	61.1		%	58.8		%						61.1		%	59.3		%
Amortization of acquired technologies	4.6			9.2			(4.6		)	(50.0	)%	8.9			17.3			(8.4		)	(48.6	)%
Percentage of net revenue	2.0		%	4.1		%						1.9		%	3.9		%
Research and development	41.7			44.2			(2.5		)	(5.7	)%	86.0			85.8			0.2			(5.7	)%
Percentage of net revenue	18.0		%	19.5		%						18.6		%	19.4		%
Selling, general and administrative	85.8			96.1			(10.3		)	(10.7	)%	180.7			189.7			(9.0		)	(10.7	)%
Percentage of net revenue	37.0		%	42.4		%						39.1		%	42.9		%
Amortization of other intangibles	3.7			4.9			(1.2		)	(24.5	)%	7.5			9.9			(2.4		)	(24.2	)%
Percentage of net revenue	1.6		%	2.2		%						1.6		%	2.2		%
Restructuring and related charges	1.4			9.1			(7.7		)	(84.6	)%	1.8			10.2			(8.4		)	(82.4	)%
Percentage of net revenue	0.6		%	4.0		%						0.4		%	2.3		%

Net Revenue

Following the Separation, revenue from our service offerings exceeds 10% of our total consolidated net revenue and is presented separately in our Consolidated Statements of Operations. Service revenue primarily consists of maintenance and support, extended warranty, professional services and post-contract support in addition to other services such as rentals, loaners and repair services. When evaluating the performance of our segments, Management focuses on total net revenue, gross profit and operating income and not the product or service categories. Consequently, the following discussion of business segment performance focuses on total net revenue, gross profit, and operating income consistent with our approach for managing the business.

Three months endedJanuary 2, 2016 and December 27, 2014

Net revenue increased by $5.7 million, or 2.5%, during three months endedJanuary 2, 2016 compared to the same period a year ago. This increase was primarily due to increases in our OSP and NE segments, partially offset by a decrease in our SE segment as discussed below.

Product revenues increased $12.4 million, or 6.3%, during the three months endedJanuary 2, 2016 compared to the same period a year ago, primarily due to higher demand for our Anti-Counterfeiting product line in our OSP segment driven by increased bank-note volume and an increase in our Lab and Wireline product portfolio in our NE segment. Service revenues decreased $6.7 million, or 22.0%, during the three months endedJanuary 2, 2016 compared to the same period a year ago primarily due to a decline in support contract renewals for our more mature assurance portfolio solutions in our SE segment.

32

NE net revenue increased by $7.4 million, or 5.7%, during the three months endedJanuary 2, 2016 compared to the same period a year ago. This increase was driven by $9.0 million of net revenue increases from our Lab and Wireline offerings primarily due to increased customer demand leading to 100G deployments in the current period. Lab offerings were strong in the quarter in both lab fiber test and optical transport. This waspartially offset by$1.6 millionof net revenue decreases in our Wireless offerings primarily as theprior period reflected net revenue from a significant ramp for a one-time project from a key customer.

SE net revenue decreased by $9.9 million, or 21.2%, during the three months endedJanuary 2, 2016 compared to the same period a year ago. This decrease was primarily driven by$10.5 millionof net revenuedecreases from our Assurance and Wireless Solutions offerings primarily driven by a decline insupport contract renewals for our more mature Assurance portfolio solutions. This was partially offset by$0.6 millionof net revenueincreases driven by higher demand for our Enterprise offerings.

OSP net revenue increased by $8.2 million, or 16.2%, during the three months endedJanuary 2, 2016 compared to the same period a year ago. This increase was driven by net revenue increases primarily from our Anti-Counterfeiting product line driven by cyclical demand for our currency products resulting from higher bank-note volume in the current period, coupled with net revenue growth in our Consumer and Industrial product line.

Six Months EndedJanuary 2, 2016 and December 27, 2014

Net revenue increased by 20.1 million, or 4.6%, during six months endedJanuary 2, 2016 compared to the same period a year ago. This increase was primarily due to increases in our OSP and NE segments partially offset by a decrease in our SE segment as discussed below.

Product revenues increased $21.1 million, or 5.4%, during the six months endedJanuary 2, 2016 compared to the same period a year ago primarily due to higher demand for our Anti-Counterfeiting product line in our OSP segment driven by increased bank- note volume and an increase in revenue in our Lab and Wireline offerings in our NE segment. Service revenues decreased $1.0 million, or 1.8%, during the six months endedJanuary 2, 2016 compared to the same period a year ago primarily due to a decline in support contract renewals for our mature assurance portfolio solutions in our SE segment.

NE net revenue increased by $3.5 million, or 1.4%, during the six months endedJanuary 2, 2016 compared to the same period a year ago. This increase was driven by $14.3 million of net revenue increases from our Lab and Wireless offerings primarily due to new customers in fiscal 2016 coupled with higher demand for our 100G products in the current period. Lab instruments were strong in the quarter in both lab fiber test and in optical transport. This waspartially offset by$10.8 millionof net revenue decreases from our Wireline offerings primarily due to a decline in Cable net revenue as customers have delayed purchases for an anticipated upgrade cycle in the second half of fiscal 2016, whereas the prior period reflected net revenue from a significant one-time project from a key customer.

SE net revenue decreased by $12.5 million, or 12.8%, during the six months endedJanuary 2, 2016 compared to the same period a year ago. This decrease was primarily driven by$14.8 millionof net revenuedecreases from our Assurance and Wireless Solutions offerings primarily driven by a decline insupport contract renewals for our more mature Assurance portfolio solutions. This was partially offset by$2.3 millionof net revenueincreases driven by higher demand for our Enterprise offerings.

OSP net revenue increased by $29.1 million, or 31.0%, during the six months endedJanuary 2, 2016 compared to the same period a year ago. This increase was driven by net revenue increases primarily from our Anti-Counterfeiting product line driven by cyclical demand for our currency products resulting from higher bank-note volume in the current period, coupled with net revenue growth in our Consumer and Industrial and Government product lines.

Going forward, we expect to continue to encounter a number of industry and market risks and uncertainties that may limit our visibility, and consequently, our ability to predict future revenue, profitability and general financial performance, and that could create quarter over quarter variability in our financial measures. For example, while the majority of our net revenue and expenses are denominated in U.S. dollars, a portion of our international operations are denominated in foreign currencies. Recently, the strengthening of the U.S. dollar relative to certain foreign currencies, namely the Euro, Brazilian Real and Canadian Dollar, negatively impacted reported revenue and reduced our reported expenses. Additionally, we have seen recent demand for our NE and SE products affected by economic uncertainty in Europe, Russia and Brazil. We cannot predict when or to what extent these uncertainties will be resolved. Our revenues, profitability, and general financial performance may also be affected by: (a) strong pricing pressures due to, among other things, a highly concentrated customer base, increasing competition, particularly from Asia-based competitors, and a general commoditization trend for certain products; (b) high product mix variability in our NE and SE markets, which affects revenue and gross margin; (c) fluctuations in customer buying patterns, which cause demand, revenue and profitability volatility; (d) the current trend of communication industry consolidation, which is expected to continue, that directly affects our NE and SE customer bases and adds additional risk and uncertainty to our financial and business projections; and (e) the completion of the recent Separation may result in disruptions to, and negatively impact our relationships with, our customers and other business partners.

33

Revenue by Region and Significant Customers

We operate in three geographic regions: Americas, Asia-Pacific and Europe Middle East and Africa (“EMEA”). Net revenue is assigned to the geographic region and country where our product is initially shipped. For example, certain customers may request shipment of our product to a contract manufacturer in one country, which may differ from the location of their end customers. The following table presents net revenue by geographic region (in millions):

	Three Months Ended								Six Months Ended
	January 2, 2016				December 27, 2014				January 2, 2016				December 27, 2014
Net revenue:
Americas	$	121.3	52.2	%	$	116.9	51.6	%	$	240.3	52.0	%	$	235.5	53.3	%
Asia-Pacific	42.2		18.2	%	42.5		18.8	%	87.7		19.0	%	71.7		16.2	%
EMEA	68.6		29.6	%	67.0		29.6	%	133.8		29.0	%	134.5		30.5	%
Total	$	232.1	100.0	%	$	226.4	100.0	%	$	461.8	100.0	%	$	441.7	100.0	%

Net revenue from customers in the Americas during the three months ended January 2, 2016 and December 27, 2014 included net revenue from the United States of $106.7 million and $90.3 million, respectively. Net revenue from customers in the Americas during the six months ended January 2, 2016 and December 27, 2014 included net revenue from the United States of $207.9 million and $191.7 million, respectively.

Net revenue from customers outside the Americas during the three months ended January 2, 2016 and December 27, 2014 represented 47.8% and 48.4% of net revenue, respectively. Net revenue from customers outside the Americas during the six months ended January 2, 2016 and December 27, 2014 represented 48.0% and 46.7% of net revenue, respectively. We expect revenue from customers outside of North America to continue to be an important part of our overall net revenue and an increasing focus for net revenue growth opportunities.

Gross Margin

Gross margin increased by 2.3 percentage points during the three months endedJanuary 2, 2016 from 58.8% in the same period a year ago to 61.1% in the current period. This increase was primarily due to a $4.6 million reduction in amortization of developed technology driven by certain intangible assets becoming fully amortized during fiscal 2015 and improvement in gross margin within our OSP segment from a favorable product mix with higher anti-counterfeiting revenue in the current period. This was partially offset by a change in overall segment mix as our OSP segment, whose products generally carry a lower gross margin than our NE and SE products, represented a higher percentage of our total net revenue in the current period.

Gross margin increased by 1.8 percentage points during the six months endedJanuary 2, 2016 from 59.3% in the same period a year ago to 61.1% in the current period. This increase was primarily due to an $8.4 millionreduction in amortization of developed technology driven by certain intangible assets becoming fully amortized during fiscal 2015 and improvement in gross margin within our OSP segment from a favorable product mix with higher anti-counterfeiting revenue in the current period. This was partially offset by a change in overall segment mix as our OSP segment, whose products generally carry a lower gross margin than our NE and SE products, represented a higher percentage of our total net revenue in the current period.

As discussed in more detail under “Net Revenue” above, we sell products in certain markets that are consolidating, undergoing product, architectural and business model transitions, have high customer concentrations, are highly competitive (increasingly due to Asia-Pacific-based competition), are price sensitive and/or are affected by customer seasonal and mix variant buying patterns. We expect these factors to continue to result in variability of our gross margin.

Research and Development

R&D expense decreased by $2.5 million, or 5.7%, during the three months endedJanuary 2, 2016 compared to the same period a year ago. This decrease was primarily due to a $1.9 million in-process research and development (“IPR&D”) impairment charge in the prior year related to a fiscal 2014 acquisition, coupled with net cost savings realized from our strategic restructuring activities including reorganizations and the insourcing or outsourcing of R&D activities as we align our investment strategy following the Separation. As a percentage of net revenue R&D decreased by 1.5 percentage points during the three months endedJanuary 2, 2016 compared to the same period a year ago as the Company continues to execute targeted cost savings initiatives.

R&D expense remained relatively flat, increasing by $0.2 million, or 0.2%, during the six months endedJanuary 2, 2016 compared to the same period a year ago. This was primarily driven by incremental expenses of $2.2 million related to site consolidations, reorganizations, and the insourcing or outsourcing of R&D activities to align our investment strategy following the Separation, partially offset by a $1.9 million IPR&D impairment charge in the prior year related to a fiscal 2014 acquisition.

34

As a percentage of net revenue R&D decreased by 0.8 percentage points during the three months ended October 3, 2015 compared to the same period a year ago as the Company continues to execute targeted cost savings initiatives.

We believe that continuing our investments in R&D is critical to attaining our strategic objectives. We plan to continue to invest in R&D and new products that will further differentiate us in the marketplace.

Selling, General and Administrative

SG&A expense decreased by $10.3 million, or 10.7%, during the three months endedJanuary 2, 2016 compared to the same period a year ago. This decrease was primarily due to a $8.5 million reduction in labor and benefit expense driven by lower headcount associated with our restructuring activities and our continuing cost reduction efforts as well as a $2.5 million reduction in costs related to Viavi-specific activities to complete the Separation. As a percentage of net revenue SG&A decreased 5.4 percentage points during the three months endedJanuary 2, 2016 compared to the same period a year ago, driven by our strategic cost reduction efforts to optimize our expense structure.

SG&A expense decreased by $9.0 million, or 4.7%, during the six months endedJanuary 2, 2016 compared to the same period a year ago. The decrease was primarily due to a $12.2 million reduction in labor, benefits and facilities expenses driven by lower headcount and site consolidations associated with our strategic restructuring activities and ongoing cost reduction efforts. This was partially offset by $3.5 million of severance related costs upon the exit of a key executive in the current period. As a percentage of net revenue SG&A decreased 3.8 percentage points during the six months endedJanuary 2, 2016 compared to the same period a year ago, driven by our strategic cost reduction efforts to optimize our expense structure.

We intend to continue to focus on reducing our SG&A expense as a percentage of net revenue. However, we have in the recent past experienced, and may continue to experience in the future, certain non-core expenses, such as mergers and acquisitions-related expenses, expenses related to our separation of the business into two public companies and litigation expenses, which could increase our SG&A expenses and potentially impact our profitability expectations in any particular quarter.

Restructuring and Related Charges

From time to time we have initiated strategic restructuring events primarily intended to reduce costs, consolidate our operations, rationalize the manufacturing of our products and align our businesses in response to market conditions. We estimate annualized gross cost savings of approximately $27 million excluding any one-time charges as a result of the restructuring activities initiated in the past year. We have reinvested and plan to reinvest a portion of our cost savings into R&D and new products that we believe will further differentiate us in the marketplace. Refer to “Note 11. Restructuring and Related Charges” for more information.

During the three and six months ended January 2, 2016, we incurred restructuring and related charges of $1.4 million and $1.8 million, respectively due to new and previously announced restructuring plans. During the three and six months ended December 27, 2014, we incurred restructuring and related charges of $9.1 million and $10.2 million, respectively.

During the second quarter of fiscal 2016, we incurred restructuring and related charges of $1.4 million. The charges are a combination of new and previously announced restructuring plans and are primarily a result of the following:

• During the second quarter of fiscal 2016, Management approved a plan primarily impacting the NE and SE business segments as part of Viavi’s ongoing commitment to an agile and more efficient operating structure. As a result, a restructuring charge of $3.0 million was recorded for severance and employee benefits for approximately 50 employees primarily in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2017. The charge was offset by a $1.6 million benefit primarily related to a reduction in the number of employees impacted by previously announced restructuring plans and underutilization of outplacement services offered to employees as part of their severance package.

During the second quarter of fiscal 2015, we incurred restructuring and related charges of $9.1 million. These charges are primarily the result of the following:

• During the second quarter of fiscal 2015, Management approved a plan to eliminate certain positions in its Shared Service function in connection with the Separation. Further, certain sales and operations positions were eliminated in the NE and SE segments to match product market strategy, lower manufacturing costs, and align with the new go-to-market focus as the Company moved forward with its separation plan. As a result, a restructuring charge of $8.7 million was recorded for

35

severance and employee benefits for approximately 150 employees primarily in manufacturing and SG&A functions located in North America, Latin America, Europe and Asia. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the third quarter of fiscal 2016.

During the six months ended January 2, 2016 we recorded $1.8 million in restructuring and related charges. The charges are a combination of new and previously announced restructuring plans and are primarily the result of the following:

• We incurred a restructuring charge of $3.0 million primarily for severance and benefits for the NE and SE Agile Restructuring Plan announced in the second quarter of fiscal 2016. This charge was offset by a $1.2 million benefit primarily related to a reduction in the number of employees impacted by previously announced restructuring plans.

During the six months ended December 27, 2014, we recorded $10.2 million in restructuring and related charges. These charges are a combination of new and previously announced restructuring plans and are primarily the result of the following:

• We incurred a restructuring charge of $8.7 million primarily for severance and benefits for the JDSU Consolidated Spin Off Restructuring Plan announced in the second quarter of fiscal 2015.

Our restructuring and other lease exit cost obligations are net of sublease income or lease settlement estimates of approximately $3.4 million. Our ability to generate sublease income, as well as our ability to terminate lease obligations and recognize the anticipated related savings, is highly dependent upon the economic conditions, particularly commercial real estate market conditions in certain geographies, at the time we negotiate the lease termination and sublease arrangements with third parties as well as the performances by such third parties of their respective obligations. While the amount we have accrued represents the best estimate of the remaining obligations we expect to incur in connection with these plans, estimates are subject to change. Routine adjustments are required and may be required in the future as conditions and facts change through the implementation period. If adverse macroeconomic conditions continue, particularly as they pertain to the commercial real estate market, or if, for any reason, tenants under subleases fail to perform their obligations, we may be required to reduce estimated future sublease income and adjust the estimated amounts of future settlement agreements, and accordingly, increase estimated costs to exit certain facilities. Amounts related to the lease expense, net of anticipated sublease proceeds, will be paid over the respective lease terms through fiscal 2019.

Interest and Other Income (Expense), Net

Interest and other income (expense), net was $1.7 million during the three months endedJanuary 2, 2016 compared to $0.3 million the same period a year ago. This $1.4 million change was driven by a favorable result from our balance sheet hedging program used to hedge gains or losses generated by the re-measurement of significant foreign currency denominated monetary assets and liabilities. Our hedging program resulted in other income of $0.3 million in the current period compared to a loss of $1.1 million in the prior period.

Interest and other income (expense), net remained relatively flat at $0.6 million during the six months endedJanuary 2, 2016 compared to $0.9 million the same period a year ago.

Interest Expense

Interest expense increased by $0.5 million, or 6.0%, during the three months endedJanuary 2, 2016 compared to the same period a year ago. The increase was primarily due to the accretion of unamortized debt discount related to the 0.625% Convertible Notes due 2033 (the "2033 Notes") resulting in a $0.3 million increase in the current period.

Interest expense increased by $1.1 million, or 6.7%, during the six months endedJanuary 2, 2016 compared to the same period a year ago. The increase was primarily due to the accretion of unamortized debt discount related to the 0.625% the 2033 Notes resulting in a $0.7 million increase in the current period.

Provision for Income Taxes

We recorded an income tax benefit of $1.2 million and $0.4 million related to the income (loss) from continuing operations for the three and six months ended January 2, 2016, respectively. We recorded an income tax expense of $8.5 million and $14.3 million related to the loss from continuing operations for the three and six months ended December 27, 2014, respectively.

The income tax benefit related to the income (loss) from continuing operations recorded for the three and six months ended January 2, 2016 and December 27, 2014 primarily relates to income tax in certain foreign and state jurisdictions based on our forecasted pre-tax income or loss for the respective year. In addition, for the three and six months ended January 2, 2016 our income tax provision includes a tax benefit of $8.8 million and $22.2 million, respectively, related to the income tax intraperiod tax allocation rules for discontinued operations and other comprehensive income. The income tax benefit related to the loss from

36

continuing operations for the six months ended January 2, 2016 also includes a tax expense of $8.9 million related to a one-time increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the Separation.

The income tax expense (benefit) related to the income (loss) from continuing operations recorded differs from the expected tax expense (benefit) that would be calculated by applying the federal statutory rate to our income (loss) from continuing operations before taxes primarily due to the increases in valuation allowance for deferred tax assets attributable to our domestic and foreign losses from continuing operations, the income tax benefit recorded in continuing operations under the income tax intraperiod tax allocation rules, and the increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the Separation.

At the beginning of the second quarter of fiscal 2016, the Company prospectively adopted the authoritative guidance on balance sheet classification of deferred taxes, which requires deferred tax assets and liabilities, and any related valuation allowance, to be classified as non-current on the balance sheet. The adoption resulted in a reclass of $3.1 million of current net deferred tax assets and $0.7 million of current net deferred tax liabilities to non-current deferred assets and liabilities netted on a jurisdiction by jurisdiction basis.

As of January 2, 2016 and June 27, 2015, our unrecognized tax benefits totaled $37.0 million and $37.4 million, respectively, and are included in deferred taxes and other non-current tax liabilities, net. We had $1.6 million accrued for the payment of interest and penalties at January 2, 2016. The unrecognized tax benefits that may be recognized during the next twelve months are approximately $0.1 million.

Discontinued Operations

Our discontinued operations activities during the three and six months ended January 2, 2016 and December 27, 2014, related to the separation of the Lumentum business on August 1, 2015 and current period activities related to the 2013 sale of the hologram business (“Hologram Business”).

Lumentum Separation

As a result of the Separation, the financial results of Lumentum are presented as discontinued operations for the three and six months ended January 2, 2016 and December 27, 2014. Net (loss) income attributable to the Lumentum discontinued operations was $3.0 million and $(50.4) million during the three and six months ended January 2, 2016 and $12.6 million and $28.7 million during the three and six months ended December 27, 2014, respectively.

Holograms Disposition

During the six months ended January 2, 2016, the Company recorded $0.3 million of net income from discontinued operations related to the Hologram Business related to proceeds received following a favorable arbitration ruling to resolve a dispute regarding the amount we were owed under an earnout clause in connection with the sale in 2013.

37

Operating Segment Information (in millions):

	Three Months Ended											Six Months Ended
	January 2, 2016			December 27, 2014			Change			Percentage Change		January 2, 2016			December 27, 2014			Change			Percentage Change
Network Enablement
Net revenue	$	136.4		$	129.0		$	7.4		5.7	%	$	254.0		$	250.5		$	3.5		1.4	%
Gross profit	90.6			84.6			6.0			7.1	%	166.3			164.8			1.5			0.9	%
Gross margin	66.4		%	65.6		%						65.5		%	65.8		%
Service Enablement
Net revenue	36.9			46.8			(9.9		)	(21.2	)%	84.8			97.3			(12.5		)	(12.8	)%
Gross profit	24.5			32.4			(7.9		)	(24.4	)%	57.9			67.4			(9.5		)	(14.1	)%
Gross margin	66.4		%	69.2		%						68.3		%	69.3		%
Network and Service Enablement
Net revenue	173.3			175.8			(2.5		)	(1.4	)%	338.8			347.8			(9.0		)	(2.6	)%
Operating income	8.0			2.0			6.0			300.0	%	10.4			0.7			9.7			1,385.7	%
Operating margin	4.6		%	1.1		%						3.1		%	0.2		%
OSP
Net revenue	$	58.8		$	50.6		$	8.2		16.2	%	$	123.0		$	93.9		$	29.1		31.0	%
Operating income	22.5			17.1			5.4			31.6	%	48.8			31.4			17.4			55.4	%
Operating margin	38.3		%	33.8		%						39.7		%	33.4		%

Network Enablement

During the three months endedJanuary 2, 2016 NE gross margin increased 0.8 percentage points from 65.6% in the same period a year ago to 66.4% in the current period. The increase was primarily due to improved operating efficiencies in the supply chain in the current period.

During the six months endedJanuary 2, 2016 NE gross margin decreased by 0.3 percentage points from 65.8% in the same period a year ago to 65.5% in the current period. The decrease was primarily due to an unfavorable product mix.

Service Enablement

During the three months endedJanuary 2, 2016 SE gross margin decreased 2.8 percentage points from 69.2% in the same period a year ago to 66.4% in the current period. This was primarily driven by a decrease in revenue from our Assurance and Wireless offerings which are dependent upon customer acceptance of our solutions further challenged by the fixed nature of our support costs.

During the six months endedJanuary 2, 2016 SE gross margin decreased 1.0 percentage points from 69.3% in the same period a year ago to 68.3% in the current period. This was primarily driven by a decrease in revenue from our Assurance and Wireless which are dependent upon customer acceptance of our solutions further challenged by the fixed nature of our support costs, partially offset by improved product mix.

Network and Service Enablement (“NSE”)

During the three months endedJanuary 2, 2016 NSE operating margin increased 3.5 percentage points from 1.1% in the same period a year ago to 4.6% in the current period. During the six months endedJanuary 2, 2016 NSE operating margin increased 2.9 percentage points from 0.2% in the same period a year ago to 3.1% in the current period. The increase in operating margin for both the three and six month periods was primarily due to a decrease in operating expenses as a percentage of net revenue driven by lower headcount as a result of strategic restructuring plans initiated in fiscal year 2015 and our ongoing cost reduction initiatives. This was partially offset by a decline in gross margin driven by an unfavorable product mix and lower net revenue.

Optical Security and Performance Products

OSP operating margin increased 4.5% during the three months endedJanuary 2, 2016 from 33.8% in the same period a year ago to 38.3% in the current period. OSP operating margin increased 6.3% during the six months endedJanuary 2, 2016 from 33.4%

38

in the same period a year ago to 39.7% in the current period. The increase in operating margin for both the three and six month periods was primarily due to a significant increase in net revenue, coupled with favorable product mix associated with the increase in Anti-Counterfeiting net revenue.

Liquidity and Capital Resources

Our cash investments are made in accordance with an investment policy approved by the Audit Committee of our Board of Directors. In general, our investment policy requires that securities purchased be rated A-1/P-1, A/A2 or better. Our policy allows an allocation to securities rated A-2/P-2, BBB/Baa2 or better, so long as such allocation below A-1/P-1, A/A2 but minimum A-2/P-2, BBB/Baa2 does not exceed 10% of any investment portfolio. Securities that are downgraded subsequent to purchase are evaluated and may be sold or held at management’s discretion. No security may have an effective maturity that exceeds 37 months, and the average duration of our holdings may not exceed 18 months. At any time, no more than 5.0% or $5.0 million, whichever is greater, of each of our investment portfolios may be concentrated in a single issuer other than the U.S. or sovereign governments or agencies. Our investments in debt securities and marketable equity securities are primarily classified as available-for-sale investments or trading assets and are recorded at fair value. The cost of securities sold is based on the specific identification method. Unrealized gains and losses on available-for-sale investments are recorded as other comprehensive (loss) income and are reported as a separate component of stockholders’ equity. We did not hold any investments in auction rate securities, mortgage backed securities, collateralized debt obligations, or variable rate demand notes at January 2, 2016 and virtually all debt securities held were of investment grade (at least BBB-/Baa3). As of January 2, 2016, U.S. entities owned approximately 73.9% of our cash and cash equivalents, short-term investments and restricted cash.

As of January 2, 2016, the majority of our cash investments have maturities of 90 days or less and are of high credit quality. Although we intend to hold these investments to maturity, in the event that we are required to sell any of these securities under adverse market conditions, losses could be recognized on such sales. During the six months endedJanuary 2, 2016, we have not realized material investment losses but can provide no assurance that the value or the liquidity of our investments will not be impacted by adverse conditions in the financial markets. In addition, we maintain cash balances in operating accounts that are with third party financial institutions. These balances in the U.S. may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. While we monitor the cash balances in our operating accounts and adjust the cash balances as appropriate, these cash balances could be impacted if the underlying financial institutions fail.

Six Months EndedJanuary 2, 2016

As of January 2, 2016 our combined balance of cash and cash equivalents, short-term investments, including marketable equity securities, and restricted cash increased by $100.4 million to $926.0 million from $825.6 million as of June 27, 2015.

During the six months endedJanuary 2, 2016cash used in operating activities was $1.3 million, primarily resulting from $33.4 million of net income adjusted for both non-cash charges (e.g., depreciation, amortization and stock-based compensation) and changes in deferred tax and other tax liabilities balances which are non-cash in nature, partially offset by changes in operating assets and liabilities that used$34.7 million. Cash used by operating activities was also impacted by our separation related activities. Changes in our operating assets and liabilities related primarily to a decrease in accrued expenses and other current and non-current liabilities of $18.4 million mainly due to separation related liabilities paid post spin-off, a decrease in accrued payroll and related expenses of $11.4 million due to the timing of salary and bonus payments, a decrease in accounts payable of $10.9 million driven by the timing of payments and an increase in inventories of $6.5 million and an increase in accounts receivable of $6.1 million primarily due to the timing of billings and delays in customer acceptance on certain projects. This was partially offset by an increase in deferred revenue of $11.8 million.

During the six months endedJanuary 2, 2016cash provided by investing activities was $134.4 million, primarily resulting from $325.6 million of proceeds from the sales and maturities of available-for-sale investments and other assets and a $14.7 million increase in restricted cash, partially offset by $185.6 million of purchases of available-for-sale investments and $19.4 million of cash used for capital expenditures.

During the six months endedJanuary 2, 2016cash used in financing activities was $141.4 million, primarily resulting from activities related to the Separation during the first quarter of fiscal 2016 and a $40.0 million share repurchase program entered into during the second quarter of fiscal 2016. In accordance with the Contribution Agreement, the Company made cash contributions of $136.7 million to Lumentum, which was partially offset by proceeds of $35.8 million from the sale of Lumentum Series A Preferred Stock to Amada Holdings Co., Ltd. (“Amada”) pursuant to a binding commitment under the Securities Purchase Agreement.

39

Six Months EndedDecember 27, 2014

During the six months ended December 27, 2014, cash provided by operating activities was $57.4 million, primarily resulting from $85.8 million of net income adjusted for both non-cash charges (e.g., depreciation, amortization and stock-based compensation), partially offset by changes in operating assets and liabilities that used $28.4 million. Changes in our operating assets and liabilities related primarily to an increase in accounts receivable of $23.7 million primarily due to collections timing, a decrease in accrued expenses and other liabilities of $10.9 million and a decrease in accrued payroll and related expenses of $8.5 million, partially offset by an increase in deferred taxes, net of $13.5 million.

During the six months ended December 27, 2014, cash used in investing activities was $38.7 million, primarily resulting from $300.2 million of purchases of available-for-sale investments and $50.4 million of cash used for capital expenditures, partially offset by $305.1 million of maturities and sales of available-for-sale investments.

During the six months ended December 27, 2014, cash used in financing activities was $10.7 million, primarily resulting from holdback payments of $12.3 million related to our acquisitions in fiscal 2014 and $4.7 million of cash used to repurchase our common stock, partially offset by $6.9 million of proceeds from the exercise of stock options and the issuance of common stock under our employee stock purchase plan.

We believe that our existing cash balances and investments will be sufficient to meet our liquidity and capital spending requirements over the next twelve months. However, there are a number of factors that could positively or negatively impact our liquidity position, including:

• global economic conditions which affect demand for our products and services and impact the financial stability of our suppliers and customers;

• changes in accounts receivable, inventory or other operating assets and liabilities which affect our working capital;

• increase in capital expenditure to support the revenue growth opportunity of our business;

• the tendency of customers to delay payments or to negotiate favorable payment term to manage their own liquidity positions;

• timing of payments to our suppliers;

• factoring or sale of accounts receivable;

• volatility in fixed income and credit market which impact the liquidity and valuation of our investment portfolios;

• volatility in foreign exchange market which impacts our financial results;

• possible investments or acquisitions of complementary businesses, products or technologies;

• issuance or repurchase of debt or equity securities;

• potential funding of pension liabilities either voluntarily or as required by law or regulation; and

• compliance with covenants and other terms and conditions related to our financing arrangements;

Contractual Obligations

Following the separation of Lumentum, our contractual commitments were reduced by the amounts transferred to Lumentum as previously disclosed in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended June 27, 2015. There were no other material changes to our existing contractual commitments during the second quarter of fiscal 2016, except for those occurring in the normal course of business.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements, other than the guarantees discussed in “Note 16. Commitments and Contingencies.”

Employee Equity Incentive Plan

Our stock-based benefit plans are a broad-based, long-term retention program that is intended to attract and retain employees and align stockholder and employee interests. Refer to “Note 14. Stock-Based Compensation” for more information.

40

Pension and Other Post-retirement Benefits

We sponsor significant pension plans for certain past and present employees in the United Kingdom (“U.K.”) and Germany. We are also responsible for the non-pension post-retirement benefit obligation assumed from a past acquisition. Most of these plans have been closed to new participants and no additional service costs are being accrued, except for certain plans in Germany assumed in connection with acquisitions during fiscal 2010. The U.K. plan is partially funded and the German plans, which were initially established as “pay-as-you-go” plans, are unfunded. As of January 2, 2016, our pension plans were under funded by $87.4 million since the PBO exceeded the fair value of its plan assets. Similarly, we had a liability of $1.1 million related to our non-pension post-retirement benefit plan. Pension plan assets are managed by external third parties and we monitor the performance of our investment managers. As of January 2, 2016, the fair value of plan assets had decreased approximately 1.5% since June 27, 2015, our most recent fiscal year end.

A key actuarial assumption in calculating the net periodic cost and the PBO is the discount rate. Changes in the discount rate impact the interest cost component of the net periodic benefit cost calculation and PBO due to the fact that the PBO is calculated on a net present value basis. Decreases in the discount rate will generally increase pre-tax cost, recognized expense and the PBO. Increases in the discount rate tend to have the opposite effect. We estimate a 50 basis point (“BPS”) decrease or increase in the discount rate would cause a corresponding increase or decrease, respectively, in the PBO of approximately $8.2 million based upon data as of June 27, 2015.

In estimating the expected return on plan assets, we consider historical returns on plan assets, adjusted for forward-looking considerations, inflation assumptions and the impact of active management of the plan’s invested assets. While it is not possible to accurately predict future rate movements, we believe our current assumptions are appropriate. Refer to “Note 15. Employee Pension and Other Benefit Plans” for more details.

41

Item 3. Quantitative and Qualitative Disclosure About Market Risks

We are exposed to various market risks, including changes in foreign currency exchange rates and interest rates. Derivatives and other financial instruments are used to mitigate exposures subject to market risk. We do not enter into derivatives or other financial instruments for trading or speculative purposes.

Foreign Exchange Risk

We utilize foreign exchange forward contracts and other instruments, including option contracts, to hedge foreign currency risk associated with foreign currency denominated monetary assets and liabilities, primarily certain short-term intercompany receivables and payables. Our foreign exchange forward contracts and other instruments are accounted for as derivatives whereby the fair value of the contracts are reflected as other current assets or other current liabilities and the associated gains and losses are reflected in Interest and other income (expense), net in the Consolidated Statements of Operations. Our hedging programs reduce, but do not eliminate, the impact of currency exchange rate movements. The gains and losses on those derivatives are expected to be offset by re-measurement gains and losses on the foreign currency denominated monetary assets and liabilities.

The following table provides information about our foreign currency forward contracts outstanding as of January 2, 2016. The forward contracts, most with a term of less than 120 days, were transacted near quarter end; therefore, the fair value of the contracts is not significant.

(in millions)	Contract Amount (Local Currency)		Contract Amount (USD)
Canadian Dollar (contracts to sell CAD / buy USD)	CAD	7.2	$	5.2
Chinese Renmimbi (contracts to buy CNY / sell USD)	CNY	132.2	19.9
British Pound (contracts to buy GBP / sell USD)	GBP	10.4	15.4
Euro (contracts to buy EUR / sell USD)	EUR	84.4	92.7
Singapore Dollar (contracts to sell SGD / buy USD)	SGD	38.6	27.4
Mexican Peso (contracts to buy MXN / sell USD)	MXN	102.0	5.9
Australian Dollar (contracts to sell AUD / buy USD)	AUD	7.8	5.6
Brazilian Real (contracts to sell BRL / buy USD)	BRL	39.5	9.6
Japanese Yen (contracts to sell JPY / buy USD)	JPY	626.7	5.2
Indian Rupee (contracts to sell INR / buy USD)	INR	212.8	3.2
South Korean Won (contracts to buy KRW / sell USD)	KRW	6,200.0	5.3
Swiss Franc (contracts to buy CHF / sell USD)	CHF	2.7	2.7
Swedish Krona (contracts to buy SEK / sell USD)	SEK	20.2	2.4
Total USD notional amount of outstanding foreign exchange contracts			$	200.5

The counterparties to these hedging transactions are creditworthy multinational banks. The risk of counterparty nonperformance associated with these contracts is not considered to be material. Notwithstanding our efforts to mitigate some foreign exchange risks, we do not hedge all of our foreign currency exposures, and there can be no assurances that our mitigating activities related to the exposures that we do hedge will adequately protect us against the risks associated with foreign currency fluctuations.

Investments

We maintain an investment portfolio in a variety of financial instruments, including, but not limited to, U.S. government and agency securities, corporate obligations, money market funds, asset-backed securities, and other investment-grade securities. The majority of these investments pay a fixed rate of interest. The securities in the investment portfolio are subject to market price risk due to changes in interest rates, perceived issuer creditworthiness, marketability, and other factors. These investments are generally classified as available-for-sale and, consequently, are recorded on our Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate component of Other comprehensive (loss) income. We did not hold any investments in auction rate securities, mortgage backed securities, collateralized debt obligations, or variable rate demand notes at January 2, 2016. Investments in both fixed-rate and floating-rate interest earning instruments carry a degree of interest rate risk. The fair values of our fixed-rate securities decline if interest rates rise, while floating-rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may be less than expectations because of changes in interest

42

rates or we may suffer losses in principal if we sell securities that have experienced a decline in market value because of changes in interest rates.

We seek to mitigate the credit risk of our portfolio of fixed-income securities by holding only high-quality, investment-grade obligations with effective maturities of 37 months or less. We also seek to mitigate marketability risk by holding only highly liquid securities with active secondary or resale markets. However, the investments may decline in value or marketability due to changes in perceived credit quality or changes in market conditions.

We are exposed to investment risk as it relates to changes in the market value of our investment in Lumentum’s common stock which is classified as an available-for-sale marketable equity security on the Consolidated Balance Sheet. The fair value of the equity investment in Lumentum will vary over time and is subject to a variety of market risks including: company performance, macro-economic, regulatory, industry, and systemic risks of the equity markets overall.

A sensitivity analysis was performed on our investment in Lumentum to assess the potential impact of fluctuations in stock price. Hypothetical declines in stock price of five percent and ten percent were selected based on potential near-term changes in the stock price that could have an adverse effect on our investment. As of January 2, 2016 the fair value of our investment in Lumentum common stock was $257.5 million. As of January 2, 2016, a decline in Lumentum’s stock price of five percent and ten percent would have resulted in a $12.9 million and $25.7 million decline, respectively, in the total fair value of our investment.

Debt

The fair value of our 2033 Notes is subject to interest rate and market price risk due to the convertible feature of the notes and other factors. Generally, the fair value of fixed interest rate debt will increase as interest rates fall and decrease as interest rates rise. The fair value of the notes may also increase as the market price of Viavi stock rises and decrease as the market price of our stock falls. Changes in interest rates and Viavi stock price affect the fair value of the notes but do not impact our financial position, cash flows or results of operations. Based on quoted market prices, as of January 2, 2016, the fair value of the 2033 Notes was approximately $610.1 million. Refer to “Note 10. Debts and Letters of Credit” for more information.

43

Item 4. Controls and Procedures

Disclosure Controls and Procedures: The Company’s management, with the participation of the Company’s principal executive officer and principal financial officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.

Internal Control Over Financial Reporting: There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II—OTHER INFORMATION

We are subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against us, individually or in aggregate, will not have a material adverse impact on its financial position, results of operations or statement of cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. Were an unfavorable final outcome to occur, there exists the possibility of a material adverse impact on our financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

Item 1A. Risk Factors

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of our Annual Report for the fiscal year ended June 27, 2015.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Share repurchase activity during the three months ended January 2, 2016 was as follows:

Period	Total Number of Shares Purchased		Average Price Paid per share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
October 5, 2015 to October 31, 2015
November 1, 2015 to November 28, 2015	5,254,516.0	(1)			(1)	5,254,516.0	(1)		(1)
November 29, 2015 to January 2, 2016
	5,254,516.0		$	—		5,254,516.0

⁽¹⁾ In May 2014, the Company's Board of Directors authorized a stock repurchase program under which the Company may purchase shares of its common stock worth up to an aggregate purchase price of $100.0 million through open market or private transactions. In October 2015, the Board extended the previously authorized repurchase program to utilize the remaining unused dollar amount from the program of approximately $40 million. In November 2015, the Company entered into a $40.0 million accelerated share repurchase agreement (the “ASR”) with a financial institution that was completed during the third quarter of fiscal 2016. Upon making the upfront payment of $40.0 million, the Company received an initial delivery of 5.3 million shares from the financial institution during the second quarter of fiscal 2016. During the third quarter of fiscal 2016, the ASR was completed and a final delivery of 1.3 million shares was delivered based on the final settlement price of $6.05 per share.

Item 3. Defaults Upon Senior Securities

 None.

44

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None. 

Item 6. Exhibits

The following documents are filed as Exhibits to this report:

		Incorporated by Reference			Filed
Exhibit No.	Exhibit Description	Form	Exhibit	Filing Date	Herewith
10.1	Viavi Solutions Inc. 2015 Change of Control Benefits Plan	8-K	10.1	12/17/15
10.2	Viavi Solutions Inc. Executive Severance and Retention Plan	8-K	10.1	10/19/15
31.1	Certification of the Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X
31.2	Certification of the Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
32.1	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
32.2	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
101.INS	XBRL Instance				X
101.SCH	XBRL Taxonomy Extension Schema				X
101.CAL	XBRL Taxonomy Extension Calculation				X
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document				X
101.LAB	XBRL Taxonomy Extension Label Linkbase				X
101.PRE	XBRL Taxonomy Extension Presentation				X

45

SIGNATURES

 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: February 9, 2016	VIAVI SOLUTIONS INC.
	(Registrant)
	By:	/s/ AMAR MALETIRA
	Name:	Amar Maletira
	Title:	Executive Vice President and Chief Financial Officer
		(Duly Authorized Officer and Principal Financial and Accounting Officer)

46

EX-31.1

Exhibit 31.1

VIAVI SOLUTIONS INC.

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Oleg Khaykin, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Viavi Solutions Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: February 9, 2016

/s/ OLEG KHAYKIN

Oleg Khaykin

Chief Executive Officer

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

VIAVI SOLUTIONS INC.

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Amar Maletira, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Viavi Solutions Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: February 9, 2016

/s/ AMAR MALETIRA

Amar Maletira

Executive Vice President and Chief Financial Officer

(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

VIAVI SOLUTIONS INC.

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Viavi Solutions Inc. (the “Company”) on Form 10-Q for the quarter ended January 2, 2016 as filed with the Securities and Exchange Commission (the “Report”), I, Oleg Khaykin, Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.

Dated: February 9, 2016

/s/ OLEG KHAYKIN

Oleg Khaykin

Chief Executive Officer

(Principal Executive Officer)

EX-32.2

Exhibit 32.2

VIAVI SOLUTIONS INC.

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Viavi Solutions Inc. (the “Company”) on Form 10-Q for the quarter ended January 2, 2016 as filed with the Securities and Exchange Commission (the “Report”), I, Amar Maletira, Executive Vice President and Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.

Dated: February 9, 2016

/s/ AMAR MALETIRA

Amar Maletira

Executive Vice President and Chief Financial Officer

(Principal Financial and Accounting Officer)

XML

Document and Entity Information - shares	6 Months Ended
	Jan. 02, 2016	Jan. 30, 2016
Document and Entity Information
Entity Registrant Name	VIAVI SOLUTIONS INC.
Entity Central Index Key	0000912093
Document Type	10-Q
Document Period End Date	Jan. 02, 2016
Amendment Flag	false
Current Fiscal Year End Date	--07-02
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		231,734,846
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q2

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014
Revenues:
Product revenue	$ 208.4	$ 196.0	$ 408.6	$ 387.5
Service revenue	23.7	30.4	53.2	54.2
Total net revenues	232.1	226.4	461.8	441.7
Cost of revenues:
Product cost of revenues	71.2	67.5	139.1	128.3
Service cost of revenues	14.5	16.6	31.5	34.1
Amortization of acquired technologies	4.6	9.2	8.9	17.3
Total cost of revenues	90.3	93.3	179.5	179.7
Gross profit	141.8	133.1	282.3	262.0
Operating expenses:
Research and development	41.7	44.2	86.0	85.8
Selling, general and administrative	85.8	96.1	180.7	189.7
Amortization of other intangibles	3.7	4.9	7.5	9.9
Restructuring and related charges	1.4	9.1	1.8	10.2
Total operating expenses	132.6	154.3	276.0	295.6
Income (loss) from operations	9.2	(21.2)	6.3	(33.6)
Interest and other income (expense), net	1.7	0.3	0.6	0.9
Interest expense	(8.8)	(8.3)	(17.6)	(16.5)
Income (loss) from continuing operations before taxes	2.1	(29.2)	(10.7)	(49.2)
(Benefit from) provision for income taxes	(1.2)	8.5	(0.4)	14.3
Income (loss) from continuing operations, net of taxes	3.3	(37.7)	(10.3)	(63.5)
Income (loss) from discontinued operations, net of taxes	3.0	12.6	(50.4)	28.7
Net income (loss)	$ 6.3	$ (25.1)	$ (60.7)	$ (34.8)
Net income (loss) per share from - basic and diluted:
Continuing operations (in dollars per share)	$ 0.02	$ (0.16)	$ (0.04)	$ (0.27)
Discontinued operations (in dollars per share)	0.01	0.05	(0.22)	0.12
Net income (loss) per share (in dollars per share)	$ 0.03	$ (0.11)	$ (0.26)	$ (0.15)
Shares used in per share calculation - basic (in shares)	234.9	232.1	235.5	231.5
Shares used in per share calculation - diluted (in shares)	237.1	232.1	235.5	231.5

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014
Statement of Comprehensive Income [Abstract]
Net loss	$ 6.3	$ (25.1)	$ (60.7)	$ (34.8)
Other comprehensive income (loss):
Net change in cumulative translation adjustment, net of tax	(11.8)	(17.4)	(21.8)	(35.9)
Net change in available-for-sale investments, net of tax:
Unrealized holding gains (losses) arising during period	71.4	(0.3)	153.1	(0.5)
Net change in defined benefit obligation, net of tax:
Amortization of actuarial losses	0.1	0.2	0.3	0.3
Net change in Accumulated other comprehensive income (loss)	59.7	(17.5)	131.6	(36.1)
Comprehensive income (loss)	$ 66.0	$ (42.6)	$ 70.9	$ (70.9)

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jan. 02, 2016	Jun. 27, 2015
Current assets:
Cash and cash equivalents	$ 329.0	$ 334.5
Short-term investments	585.5	464.9
Restricted cash	11.5	26.2
Accounts receivable, net (Note 6)	181.8	152.3
Inventories, net	57.6	53.8
Prepayments and other current assets	34.1	38.2
Current assets of discontinued operations	0.0	310.2
Total current assets	1,199.5	1,380.1
Property, plant and equipment, net	136.5	149.2
Goodwill	246.1	255.5
Intangibles, net	77.6	90.6
Deferred income taxes	103.3	117.3
Other non-current assets	19.4	20.9
Non-current assets of discontinued operations	0.0	204.2
Total assets	1,782.4	2,217.8
Current liabilities:
Accounts payable	37.5	42.0
Accrued payroll and related expenses	54.7	52.6
Income taxes payable	18.2	3.1
Deferred revenue	93.3	80.6
Accrued expenses	29.8	23.7
Other current liabilities	30.8	43.5
Current liabilities of discontinued operations	0.0	130.0
Total current liabilities	264.3	375.5
Long-term debt	574.8	561.6
Other non-current liabilities	162.3	168.4
Non-current liabilities of discontinued operations	$ 0.0	$ 10.9
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred Stock, $0.001 par value; 1 million shares authorized; 1 share at January 2, 2016 and June 27, 2015, issued and outstanding	$ 0.0	$ 0.0
Common Stock, $0.001 par value; 1 billion shares authorized; 233 million shares at January 2, 2016 and 235 million shares at June 27, 2015, issued and outstanding	0.2	0.2
Additional paid-in capital	70,034.3	70,022.7
Accumulated deficit	(69,329.3)	(68,873.5)
Accumulated other comprehensive income (loss)	75.8	(48.0)
Total stockholders’ equity	781.0	1,101.4
Total liabilities and stockholders’ equity	$ 1,782.4	$ 2,217.8

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jan. 02, 2016	Jun. 27, 2015
Statement of Financial Position [Abstract]
Preferred Stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred Stock, shares authorized	1,000,000	1,000,000
Preferred Stock, shares issued	1	1
Preferred Stock, shares outstanding	1	1
Common Stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, shares authorized	1,000,000,000	1,000,000,000
Common Stock, shares issued	233,000,000	235,000,000
Common Stock, shares outstanding	233,000,000	235,000,000

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jan. 02, 2016		Dec. 27, 2014
OPERATING ACTIVITIES:
Net loss	$ (60.7)		$ (34.8)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation expense	21.7		40.2
Amortization of acquired technologies and other intangibles	17.0		31.2
Stock-based compensation	26.5		30.7
Amortization of debt issuance costs and accretion of debt discount	14.2		13.5
Amortization of discount and premium on investments, net	0.8		1.9
Other	(0.2)		3.1
Changes in operating assets and liabilities, net of impact of Lumentum distribution:
Accounts receivable	(6.1)		(23.7)
Inventories	(6.5)		(2.4)
Other current and non-currents assets	2.6		(2.6)
Accounts payable	(10.9)		1.1
Income taxes payable	10.9		4.3
Deferred revenue, current and non-current	11.8		0.8
Deferred taxes, net	7.4		13.5
Accrued payroll and related expenses	(11.4)		(8.5)
Accrued expenses and other current and non-current liabilities	(18.4)		(10.9)
Net cash (used in) provided by operating activities	(1.3)		57.4
INVESTING ACTIVITIES:
Purchases of available-for-sale investments	(185.6)		(300.2)
Maturities of available-for-sale investments	250.3		265.9
Sales of available-for-sale investments	71.9		39.2
Changes in restricted cash	14.7		2.6
Capital expenditures	(19.4)		(50.4)
Proceeds from the sale of assets	3.4		4.2
Acquisition of a business	(0.9)		0.0
Net cash provided by (used in) investing activities	134.4		(38.7)
FINANCING ACTIVITIES:
Proceeds from sale of Lumentum Holdings Inc. Series A Preferred Stock	35.8		0.0
Cash contribution to Lumentum Holdings Inc.	(136.7)		0.0
Repurchase and retirement of common stock	(40.0)		(4.7)
Payment of financing obligations	(1.3)		(12.9)
Proceeds from exercise of employee stock options and employee stock purchase plan	0.8		6.9
Net cash used in financing activities	(141.4)		(10.7)
Effect of exchange rates on cash and cash equivalents	(10.6)		(11.6)
Net decrease in cash and cash equivalents	(18.9)		(3.6)
Cash and cash equivalents at the beginning of the period	347.9	[1]	297.2
Cash and cash equivalents at the end of the period	$ 329.0		$ 293.6

[1] Cash and cash equivalents at June 27, 2015 included $13.4 million in current assets of the discontinued operations of Lumentum Holdings Inc.

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) $ in Millions	Jun. 27, 2015 USD ($)
Spinoff | Lumentum
Cash and cash equivalents included in discontinued operations	$ 13.4

XML

Basis of Presentation

6 Months Ended

Jan. 02, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Note 1. Basis of Presentation

The financial information for Viavi Solutions Inc. (“Viavi” also referred to as “the Company”, “we”, “our” and “us”) as of January 2, 2016 and for the three and six months endedJanuary 2, 2016 and December 27, 2014 is unaudited, and includes all normal and recurring adjustments Company management (“Management”) considers necessary for a fair statement of the financial information set forth herein, in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, such information does not include all of the information and footnotes required by U.S. GAAP for annual financial statements. For further information, please refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 27, 2015.

The balance sheet as of June 27, 2015 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The results for the three and six months endedJanuary 2, 2016 and December 27, 2014 may not be indicative of results for the year ending July 2, 2016 or any future periods.

Fiscal Years

The Company utilizes a 52-53 week fiscal year ending on the Saturday closest to June 30th. The Company’s fiscal 2016 is a 53-week year ending on July 2, 2016. The Company’s fiscal 2015 was a 52-week year ending on June 27, 2015.

Lumentum Separation

On August 1, 2015 (the “Separation Date”), Viavi, formerly known as JDS Uniphase Corporation (“JDSU”), completed the distribution of approximately 80.1% of the outstanding shares of Lumentum Holdings Inc. (“Lumentum”) common stock (the “Distribution”). Concurrent with the Distribution, JDSU was renamed Viavi Solutions Inc. and, at the time of the Distribution, retained ownership of approximately 19.9% of Lumentum’s outstanding shares. Lumentum was formed to hold Viavi’s communications and commercial optical products business segment (“CCOP”) and the WaveReady product line and, as a result of the Distribution, is now an independent public company trading under the symbol “LITE” on The Nasdaq Stock Market (“NASDAQ”). The Distribution was made to Viavi’s stockholders of record as of the close of business on July 27, 2015 (the “Record Date”), who received one share of Lumentum common stock for every five shares of Viavi common stock held as of the close of business on the Record Date and not sold prior to August 4, 2015, the ex-dividend date. The historical results of operations and the financial position have been recasted to present the Lumentum business as discontinued operations as described in “Note 3. Discontinued Operations.” Unless noted otherwise, discussion in the Notes to Consolidated Financial Statements pertain to continuing operations.

Principles of Consolidation

The amounts presented in the consolidated financial statements have been prepared in accordance with U.S. GAAP and include the Company and its wholly-owned subsidiaries. All inter-company accounts and transactions have been eliminated.

Use of Estimates

The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires Management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements, the reported amount of Net revenues and expenses and the disclosure of commitments and contingencies during the reporting periods. The Company bases estimates on historical experience and on various assumptions about the future believed to be reasonable based on available information. The Company’s reported financial position or results of operations may be materially different under changed conditions or when using different estimates and assumptions, particularly with respect to significant accounting policies. If estimates or assumptions differ from actual results, subsequent periods are adjusted to reflect more current information.

XML

Recently Issued Accounting Pronouncements

6 Months Ended

Jan. 02, 2016

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Recently Issued Accounting Pronouncements

Note 2. Recently Issued Accounting Pronouncements

In January 2016, the FASB (“Financial Accounting Standards Board”) issued guidance that requires an entity to measure equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, it requires entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes and requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It also eliminates the requirement to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The guidance is effective for the company in the first quarter of fiscal 2019. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In November 2015, the FASB issued guidance requiring deferred tax assets and liabilities, and any related valuation allowance, to be classified as non-current on the balance sheet. This classification eliminates the need to separately identify the net current and net non-current deferred tax asset or liability in each jurisdiction. The Company elected to prospectively adopt the guidance in the beginning of the second quarter of fiscal 2016. Refer to “Note 12. Income Taxes” for more information regarding the impact of adopting this guidance.

In July 2015, the FASB issued guidance to change the subsequent measurement of inventory from lower of cost or market to lower of cost and net realizable value. The guidance is effective for the Company in the first quarter of fiscal 2018. Earlier application is permitted as of the beginning of an interim or annual reporting period. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In May 2015, the FASB issued guidance to remove the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using net asset value per share practical expedient. The guidance is effective for the Company in the first quarter of fiscal 2017 and may apply to certain pension assets. The guidance will be applied retrospectively and earlier adoption is permitted. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In April 2015, the FASB issued new authoritative guidance to provide a practical expedient that permits the entity to measure defined benefit plan assets and obligations using the month-end that is closest to the entity’s fiscal year-end and apply that practical expedient consistently from year to year. Prospective application is required and early adoption is permitted. This guidance is effective for the Company in the first quarter of fiscal 2017 and may apply to the qualified and the non-qualified pension plans in certain countries. The Company will not early adopt and is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In April 2015, the FASB issued new authoritative guidance to simplify the presentation of debt issuance costs by requiring debt issuance costs to be presented as a deduction from the corresponding liability, consistent with debt discounts or premiums. This guidance is effective for the Company in the first quarter of fiscal 2017 for its convertible debt, and will be applied retrospectively. The consolidated balance sheet of each individual period presented will be adjusted to reflect the period-specific effects of applying this new guidance.

In May 2014, the FASB issued new authoritative guidance related to revenue recognition. This guidance will replace current U.S. GAAP guidance on this topic and eliminate industry-specific guidance. The new revenue recognition guidance provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance allows for either full retrospective adoption or modified retrospective adoption. The FASB deferred the effective date for this guidance by one year to December 15, 2017 for annual reporting periods beginning after such date. Earlier application of this guidance is permitted but not before the original date of December 15, 2016. The guidance is effective for the company in the first quarter of fiscal 2019. The Company is evaluating the impact that this new accounting guidance will have on its consolidated financial statements and related disclosures.

XML

Discontinued Operations

6 Months Ended

Jan. 02, 2016

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Note 3. Discontinued Operations

On August 1, 2015, the Company completed the separation of the Lumentum business (the “Separation”) and made a tax-free distribution of approximately 80.1% of the outstanding shares of Lumentum common stock to Viavi shareholders who received one share of Lumentum common stock for every five shares of Viavi common stock held as of the close of business on July 27, 2015 (the “Record Date”) and not sold prior to August 4, 2015 (the “ex-dividend date”). In connection with the Separation Viavi agreed to contribute $137.6 million of total cash, of which $0.9 million remains to be contributed as of January 2, 2016. As of the Distribution, Viavi retained ownership of approximately 19.9%, or 11.7 million shares, of Lumentum’s outstanding shares. Lumentum was formed to hold Viavi’s CCOP business and the Waveready product line. As a result of the Distribution, Lumentum is now an independent public company.

In connection with the Separation, the Company entered into a Contribution Agreement, Separation and Distribution Agreement, a Tax Matters Agreement, Employee Matters Agreement, Securities Purchase Agreement, a Supply Agreement, and an Intellectual Property Matters Agreement with Lumentum and others.

The Contribution Agreement identifies the assets to be transferred, the liabilities to be assumed and the contracts to be assigned and it provides for when and how these transfers, assumptions and assignments will occur.

The Separation and Distribution Agreement governs the separation of the CCOP and Waveready business, the transfer of assets and other matters related to Viavi’s relationship with Lumentum.

The Tax Matters Agreement governs the respective rights, responsibilities and obligations of Lumentum and Viavi with respect to tax liabilities and benefits, tax attributes, tax contests, tax returns, and certain other tax matters.

The Employee Matters Agreement governs the compensation and employee benefit obligations with respect to the current and former employees and non-employee directors of Lumentum and Viavi, and generally allocates liabilities and responsibilities relating to employee compensation, benefit plans and programs. The Employee Matters Agreement provides that employees of Lumentum will no longer participate in benefit plans sponsored or maintained by Viavi.

The Securities Purchase Agreement with the Company, Lumentum and Amada Holdings Co., Ltd. (“Amada”) set forth terms whereby the Company received 40,000 shares of Lumentum’s Series A Preferred Stock (“Series A Preferred Stock”) pursuant to a binding commitment to sell the Series A Preferred Stock to Amada following the Separation. Upon Separation, in connection with the agreement, during the first quarter of fiscal 2016 the Company sold 35,805 shares of the Series A Preferred Stock to Amada for $35.8 million and the remaining 4,195 shares of the Series A Preferred Stock were canceled. The $35.8 million is included as a part of financing activities in the Statement of Cash Flows.

The Supply Agreement outlines that Viavi will supply test equipment to Lumentum and Lumentum will supply components related to the Company’s metro, fiber and optical product lines and development services related to smart transceivers. The most significant component of the Supply Agreement is $15 million related to the sale of certain optical test equipment to Lumentum during the 12 month period from the date of the agreement through July 31, 2016, of which the company recorded $3.8 million and $8.3 million of net revenue during the three and six months endedJanuary 2, 2016, respectively.

The Intellectual Property Matters Agreement outlines the intellectual property rights and technology transferred to Lumentum upon the Separation, as well as the intellectual property and technology both companies can license from each other. In addition it outlines non-compete restrictions between Viavi and Lumentum.

As the separation of the Lumentum business represents a strategic shift that has and will have a major effect on the Company’s operations and financial results, the results of operations and net assets of the Lumentum business are presented separately as discontinued operations for the three and six months endedJanuary 2, 2016 and December 27, 2014 and as of June 27, 2015, in accordance with the authoritative guidance.

Lumentum is now a stand-alone public company that separately reports it financial results. Due to the difference between the basis of presentation for discontinued operations and the basis of presentation as a stand-alone company, the financial results of Lumentum included within discontinued operations for the Company may not be indicative of actual financial results of Lumentum as a stand-alone company.

The following table presents the carrying amounts of the major classes of the assets and liabilities of the Lumentum business which are presented as discontinued operation on the Consolidated Balance Sheets (in millions).

	June 27, 2015
Assets:
Cash and cash equivalents	$	13.4
Accounts receivable, net	150.2
Inventories, net	100.0
Prepayments and other current assets	46.6
Current assets of discontinued operations	310.2
Property, plant and equipment, net	145.4
Goodwill	5.6
Intangibles, net	21.8
Other non-current assets	31.4
Non-current assets of discontinued operations	204.2
Total assets of discontinued operations	$	514.4
Liabilities:
Accounts payable	$	79.1
Accrued payroll and related expenses	18.3
Income taxes payable	3.7
Accrued expenses	17.5
Other current liabilities	11.4
Current liabilities of discontinued operations	130.0
Non-current liabilities of discontinued operations	10.9
Total liabilities of discontinued operations	$	140.9

In connection with the Separation, $7.8 million of accumulated other comprehensive loss, net of income taxes, related to foreign currency translation adjustments and the pension plan obligation was transferred to Lumentum on the Separation Date. Refer to “Note 5. Accumulated Other Comprehensive (Loss) Income” for more information.

The Company also transferred deferred tax assets of $29.5 million, deferred tax liabilities of $1.0 million, current income tax payables of $3.3 million, an income tax receivable of $1.3 million and other long-term liabilities related to uncertain tax positions totaling $0.1 million on the Separation date. The Company utilized approximately $1.0 billion of federal net operating losses to offset income recognized as a result of the Separation and the license of Lumentum’s intellectual property to a foreign subsidiary.

The removal of Lumentum’s net assets and equity related adjustments upon the Separation are presented as an increase of Viavi's accumulated deficit and represents a non-cash financing activity, excluding the cash transferred. Refer to “Note 14. Stock-Based Compensation” for information on modifications to stock-based compensation awards as a result of the Distribution.

The following table summarizes results from discontinued operations of the Lumentum business included in the condensed Consolidated Statement of Operations (in millions):

	Three Months Ended (1)			Six Months Ended
	December 27, 2014			January 2, 2016			December 27, 2014
Net revenues	$	210.7		$	66.5		$	429.0
Cost of revenues	141.4			49.7			287.4
Amortization of acquired technologies	1.9			0.6			3.8
Gross profit	67.4			16.2			137.8
Operating expenses:
Research and development	35.0			12.5			69.8
Selling, general and administrative	18.8			24.0			36.0
Restructuring charges	0.6			0.1			2.4
Total operating expenses	54.4			36.6			108.2
(Loss) income from operations	13.0			(20.4		)	29.6
Interest and other income (expense), net	(0.1		)	0.5			(0.3		)
(Loss) income before income taxes	12.9			(19.9		)	29.3
Income tax provision	0.3			30.5			0.6
Net (loss) income from discontinued operations	$	12.6		$	(50.4	)	$	28.7

(1)  Net income from discontinued operations for the three months endedJanuary 2, 2016 of $3.0 million is comprised of costs to complete the separation offset by a benefit from income taxes from discontinued operations of $4.5 million. No income or expense relating to the Lumentum business has been recorded after the separation from Viavi on August 1, 2015.

During the six months endedJanuary 2, 2016, the income tax provision for discontinued operation of $30.5 million, included approximately $5.6 million of cash taxes that are due to federal and state authorities as a result of the Separation. In addition, approximately $25.2 million of the income tax provision for discontinued operations related to the income tax intraperiod tax allocation rules in relation to continuing operations and other comprehensive income.

Net (loss) income from discontinued operations also includes costs incurred by the Company to separate Lumentum such as transaction charges, advisory and consulting fees. Net income (loss) from discontinued operations for the three and six months endedJanuary 2, 2016 included $1.5 million and $15.5 million of costs to complete the separation, respectively. Net income (loss) from discontinued operations for the three and six months endedDecember 27, 2014 included $3.3 million and $3.7 million of costs to complete the separation, respectively.

The following table presents supplemental cash flow information: depreciation expense, amortization expense, stock based compensation expense and capital expenditures of the Lumentum business (in millions):

	Six Months Ended
	January 2, 2016		December 27, 2014
Operating activities:
Depreciation expense	$	3.7	$	21.3
Amortization expense	0.6		4.0
Stock-based compensation expense	1.6		9.7
Investing activities:
Capital expenditures	$	5.8	$	23.1

XML

Earnings Per Share

6 Months Ended

Jan. 02, 2016

Earnings Per Share [Abstract]

Earnings Per Share

Note 4. Earnings Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share (in millions, except per share data):

	Three Months Ended					Six Months Ended
	January 2, 2016		December 27, 2014			January 2, 2016			December 27, 2014
Numerator:
Income (loss) from continuing operations, net of taxes	$	3.3	$	(37.7	)	$	(10.3	)	$	(63.5	)
Income (loss) from discontinued operations, net of taxes	3.0		12.6			(50.4		)	28.7
Net income (loss)	$	6.3	$	(25.1	)	$	(60.7	)	$	(34.8	)
Denominator:
Weighted-average number of common shares outstanding
Basic	234.9		232.1			235.5			231.5
Effect of dilutive securities from stock-based benefit plans	2.2		—			—			—
Diluted	237.1		232.1			235.5			231.5
Net income (loss) per share - basic and diluted:
Continuing operations	$	0.02	$	(0.16	)	$	(0.04	)	$	(0.27	)
Discontinued operations	0.01		0.05			(0.22		)	0.12
Net income (loss) per share	$	0.03	$	(0.11	)	$	(0.26	)	$	(0.15	)

The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net income (loss) per share because their effect would have been anti-dilutive (in millions):

	Three Months Ended		Six Months Ended
	January 2, 2016 (2)	December 27, 2014 (1)(2)	January 2, 2016 (1)(2)	December 27, 2014 (1)(2)
Stock options and ESPP	0.9	3.8	3.4	3.8
Restricted Stock Units	4.5	11.1	11.0	10.8
Total potentially dilutive securities	5.4	14.9	14.4	14.6

(1)  As the Company incurred a net loss in the period, potential dilutive securities from employee stock options, employee stock purchase plan (“ESPP”) and Restricted Stock Units (“RSUs”) have been excluded from the diluted net loss per share computations as their effects were deemed anti-dilutive.

(2)  The Company’s 0.625% Senior Convertible 2033 Notes are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $11.28 per share is payable in cash, shares of the Company’s common stock or a combination of both. Refer to “Note 10. Debts and Letters of Credit” for more details.

XML

Accumulated Other Comprehensive (Loss) Income

6 Months Ended

Jan. 02, 2016

Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]

Accumulated Other Comprehensive (Loss) Income

Note 5. Accumulated Other Comprehensive (Loss) Income

The Company’s accumulated other comprehensive income (loss) consists of the accumulated net unrealized gains and losses on available-for-sale investments, foreign currency translation adjustments and defined benefit obligations.

For the six months endedJanuary 2, 2016 the changes in accumulated other comprehensive income (loss) by component net of tax were as follows (in millions):

	Unrealized (losses) on available-for sale investments (2)			Foreign  currency translation adjustments			Defined benefit obligation, net of tax (3)			Total
Beginning balance as of June 27, 2015	$	(3.2	)	$	(29.2	)	$	(15.6	)	$	(48.0	)
Transferred to Lumentum (1)	—			(8.9		)	1.1			(7.8		)
Other comprehensive (loss) income before reclassification	153.1			(21.8		)	—			131.3
Amounts reclassified from accumulated other comprehensive income (loss)	—			—			0.3			0.3
Net current-period other comprehensive (loss) income	153.1			(21.8		)	0.3			131.6
Ending balance as of January 2, 2016	$	149.9		$	(59.9	)	$	(14.2	)	$	75.8

(1) Amount represents the transfer of accumulated other comprehensive balances to Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information.

(2) Activity during the six months ended primarily relates to a $157.2 million unrealized gain on the marketable equity securities of Lumentum held by Viavi, net of a $3.7 million income tax effect related to the intraperiod tax allocation rules.

(3) Amount represents the amortization of actuarial losses included as a component of Selling, general and administrative expense (“SG&A”) in the Consolidated Statement of Operations for the six months endedJanuary 2, 2016. There was no tax impact. Refer to “Note 15. Employee Pension and Other Benefit Plans” for more details on the computation of net periodic cost for pension plans.

XML

Balance Sheet and Other Details

6 Months Ended

Jan. 02, 2016

Balance Sheet and Other Details

Balance Sheet and Other Details

Note 6. Balance Sheet and Other Details

Accounts receivable reserves and allowances

The components of accounts receivable reserves and allowances were as follows (in millions):

	June 27, 2015		Charged to Costs and Expenses		Adjustments (1)			January 2, 2016
Allowance for doubtful accounts	$	2.4	$	0.3	$	(0.1	)	$	2.6
Allowance for sales returns	0.7		1.6		(1.2		)	1.1
Total accounts receivable reserves	$	3.1	$	1.9	$	(1.3	)	$	3.7

 (1) Represents the effect of currency translation adjustments and write-offs of uncollectible accounts, net of recoveries.

Inventories, net

The components of Inventories, net were as follows (in millions):

	January 2, 2016		June 27, 2015
Finished goods	$	33.0	$	31.5
Work in process	5.6		6.8
Raw materials	19.0		15.5
Inventories, net	$	57.6	$	53.8

Prepayments and other current assets

The components of Prepayments and other current assets were as follows (in millions):

	January 2, 2016		June 27, 2015
Prepayments	$	13.2	$	15.7
Other current assets	20.9		22.5
Prepayments and other current assets	$	34.1	$	38.2

Other current liabilities

The components of Other current liabilities were as follows (in millions):

	January 2, 2016		June 27, 2015
Deferred compensation plan	$	3.3	$	3.0
Warranty	2.5		2.3
Value-added tax	3.2		1.7
Restructuring	9.4		19.1
Deferred income taxes	—		7.1
Other	12.4		10.3
Other current liabilities	30.8		$	43.5

Other non-current liabilities

The components of Other non-current liabilities were as follows (in millions):

	January 2, 2016		June 27, 2015
Pension and post-employment benefits	$	83.3	$	86.9
Financing obligation	29.2		29.1
Restructuring accrual	5.9		8.2
Long-term deferred revenue	22.5		23.6
Other	21.4		20.6
Other non-current liabilities	$	162.3	$	168.4

XML

Investments and Fair Value Measurements

6 Months Ended

Jan. 02, 2016

Investments and Fair Value Measurements

Investments and Fair Value Measurements

Note 7. Investments and Fair Value Measurements

The Company’s investments in marketable debt and equity securities were primarily classified as available-for-sale securities. As of January 2, 2016, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Debt securities:
U.S. treasuries	$	46.3	$	—	$	—		$	46.3
U.S. agencies	59.7		—		(0.1		)	59.6
Municipal bonds and sovereign debt instruments	2.3		—		—			2.3
Asset-backed securities	49.8		—		(0.4		)	49.4
Corporate securities	183.8		—		(0.2		)	183.6
Total debt securities	341.9		—		(0.7		)	341.2
Marketable equity securities	100.3		157.2		—			257.5
Total available-for-sale securities	$	442.2	$	157.2	$	(0.7	)	$	598.7

The Company generally classifies debt securities as cash equivalents, short-term investments or other non-current assets based on the stated maturities; however, certain securities with stated maturities of longer than twelve months which are highly liquid and available to support current operations are also classified as short-term investments. As of January 2, 2016, of the total fair value, $15.8 million was classified as cash equivalents, $324.7 million was classified as short-term investments and $0.7 million was classified as other non-current assets.

Marketable equity securities consist of the Company’s ownership of 11.7 million shares of Lumentum common stock retained in connection with the Separation. These securities are stated at fair value, with unrealized gains and losses reported in other comprehensive income, net of tax and are classified as short-term investments on the Consolidated Balance Sheet as of January 2, 2016 at $257.5 million. The Company has not recognized any realized gains or losses related to these securities.

 In addition to the amounts presented above, as of January 2, 2016, the Company’s short-term investments classified as trading securities related to the deferred compensation plan were $3.3 million, of which $0.6 million was invested in debt securities, $0.7 million was invested in money market instruments and funds and $2.0 million was invested in equity securities. Trading securities are reported at fair value, with the unrealized gains or losses resulting from changes in fair value recognized in Interest and other income (expense), net.

During the three and six months endedJanuary 2, 2016 and December 27, 2014, the Company recorded no other-than-temporary impairment charges in each respective period.

As of January 2, 2016, contractual maturities of the Company’s debt securities classified as available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Estimated Fair Value
Amounts maturing in less than 1 year	$	233.9	$	233.8
Amounts maturing in 1 - 5 years	105.5		105.3
Amounts maturing in more than 5 years	2.5		2.1
Total debt available-for-sale securities	$	341.9	$	341.2

 As of June 27, 2015, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Debt securities:
U.S. treasuries	$	51.9	$	—	$	—		$	51.9
U.S. agencies	96.0		—		—			96.0
Municipal bonds and sovereign debt instruments	4.0		—		—			4.0
Asset-backed securities	70.6		—		(0.2		)	70.4
Corporate securities	274.1		0.1		(0.1		)	274.1
Total debt available-for-sale securities	$	496.6	$	0.1	$	(0.3	)	$	496.4

As of June 27, 2015, of the total fair value, $33.7 million was classified as cash equivalents, $461.9 million was classified as short-term investments and $0.8 million was classified as other non-current assets.

In addition to the amounts presented above, as of June 27, 2015, the Company’s short-term investments classified as trading securities, related to the deferred compensation plan, were $3.4 million, of which $0.6 million was invested in debt securities, $0.7 million was invested in money market instruments and funds and $2.1 million was invested in equity securities. Trading securities are reported at fair value, with the unrealized gains or losses resulting from changes in fair value recognized in Interest and other income (expense), net.

Fair Value Measurements

Assets measured at fair value as of January 2, 2016 are summarized below (in millions):

	Fair value measurement as of
	January 2, 2016
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Debt available-for-sale securities
U.S. treasuries	$	46.3	$	46.3	$	—
U.S. agencies	59.6		—		59.6
Municipal bonds and sovereign debt instruments	2.3		—		2.3
Asset-backed securities	49.4		—		49.4
Corporate securities	183.6		—		183.6
Total debt available-for-sale securities	341.2		46.3		294.9
Marketable equity securities	257.5		257.5		—
Money market funds	203.0		203.0		—
Trading securities	3.3		3.3		—
Total assets (1)	$	805.0	$	510.1	$	294.9

(1) $204.5 million in cash and cash equivalents, $585.5 million in short-term investments, $10.5 million in restricted cash, and $4.5 million in other non-current assets on the Company’s Consolidated Balance Sheets.

Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. There is an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the assumptions about the factors that market participants would use in valuing the asset or liability.

The Company’s cash and investment instruments are classified within Level 1 or Level 2 of the fair value hierarchy based on quoted prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.

• Level 1 includes financial instruments for which quoted market prices for identical instruments are available in active markets. Level 1 assets of the Company include money market funds, U.S. Treasury securities and marketable equity securities as they are traded with sufficient volume and frequency of transactions. 

• Level 2 includes financial instruments for which the valuations are based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 2 instruments of the Company generally include certain U.S. and foreign government and agency securities, commercial paper, corporate and municipal bonds and notes, asset-backed securities, and foreign currency forward contracts. To estimate their fair value, the Company utilizes pricing models based on market data. The significant inputs for the valuation model usually include benchmark yields, reported trades, broker and dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data, and industry and economic events. 

• Level 3 includes financial instruments for which fair value is derived from valuation based on inputs that are unobservable and significant to the overall fair value measurement. As of June 27, 2015 and during the three and six months endedJanuary 2, 2016 and December 27, 2014 the Company did not hold any Level 3 investment securities.

Foreign Currency Forward Contracts

The Company has foreign subsidiaries that operate and sell the Company’s products in various markets around the world. As a result, the Company is exposed to foreign exchange risks. The Company utilizes foreign exchange forward contracts and other instruments to manage foreign currency risk associated with foreign currency denominated monetary assets and liabilities, primarily certain short-term intercompany receivables and payables, and to reduce the volatility of earnings and cash flows related to foreign-currency transactions.

The forward contracts, most with a term of less than 120 days, were transacted near quarter end; therefore, the fair value of the contracts as of both January 2, 2016 and June 27, 2015 is not material. The change in the fair value of these foreign currency forward contracts is recorded as gain or loss in the Company’s Consolidated Statements of Operations as a component of Interest and other income (expense), net.

XML

Goodwill

6 Months Ended

Jan. 02, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

Note 8. Goodwill

The following table presents the changes in goodwill allocated to the Company’s reportable segments (in millions):

	Network Enablement			Service Enablement			Optical Security and Performance Products		Total
Balance as of June 27, 2015	$	154.5		$	92.7		$	8.3	$	255.5
Currency translation and other adjustments	(2.2		)	(1.2		)	—		(3.4		)
Goodwill allocation - WaveReady (1)	(6.0		)	—			—		(6.0		)
Balance as of January 2, 2016	$	146.3		$	91.5		$	8.3	$	246.1

(1) Amount represents a release of the relative fair value of goodwill in our NE reporting unit related to the WaveReady products line, which is now a part of Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information.

The Company reviews goodwill for impairment during the fourth quarter of each fiscal year, or more frequently if events or circumstances indicate that an impairment loss may have occurred. In the fourth quarter of fiscal 2015, the Company completed the annual impairment test of goodwill with no goodwill impairments. There were no events or changes in circumstances which triggered an impairment review during the three and six months ended months ended January 2, 2016.

XML

Acquired Developed Technology and Other Intangibles

6 Months Ended

Jan. 02, 2016

Acquired Developed Technology and Other Intangibles

Acquired Developed Technology and Other Intangibles

Note 9. Acquired Developed Technology and Other Intangibles

The following tables present details of the Company’s acquired developed technology, customer relationships and other intangibles (in millions):

As of January 2, 2016	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	420.6	$	(379.3	)	$	41.3
Customer relationships	174.7		(139.6		)	35.1
Other	19.2		(18.8		)	0.4
Total intangibles subject to amortization	$	614.5	$	(537.7	)	$	76.8
In-process research and development assets	$	0.8	-			$	0.8
Total intangibles	$	615.3	$	(537.7	)	$	77.6

As of June 27, 2015	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	418.9	$	(373.6	)	$	45.3
Customer relationships	178.7		(135.8		)	42.9
Other	19.5		(18.9		)	0.6
Total intangibles subject to amortization	617.1		(528.3		)	88.8
In-process research and development assets	1.8		—			1.8
Total intangibles	$	618.9	$	(528.3	)	$	90.6

During the three months ended October 3, 2015, the Company completed its in-process research and development (“IPR&D”) project related to the fiscal 2014 acquisition of Trendium. Accordingly, $1.8 million was transferred from indefinite life intangible assets to acquired developed technology intangible assets with a useful life of thirty-six months.

The following table presents the amortization recorded relating to acquired developed technology, customer relationships and other intangibles (in millions):

	Three Months Ended				Six Months Ended
	January 2, 2016		December 27, 2014		January 2, 2016		December 27, 2014
Amortization of acquired developed technologies	$	4.6	$	9.2	$	8.9	$	17.3
Amortization of other intangibles	3.7		4.9		7.5		9.9
Total amortization of intangible assets	$	8.3	$	14.1	$	16.4	$	27.2

Based on the carrying amount of acquired developed technology, customer relationships and other intangibles as of January 2, 2016, and assuming no future impairment of the underlying assets, the estimated future amortization is as follows (in millions):

Fiscal Years
Remainder of 2016	$	15.4
2017	29.5
2018	20.9
2019	9.3
2020	1.3
Thereafter	0.4
Total amortization	$	76.8

The acquired developed technology, customer relationships and other intangibles balance are adjusted quarterly to record the effect of currency translation adjustments.

XML

Debts and Letters of Credit

6 Months Ended

Jan. 02, 2016

Debt Disclosure [Abstract]

Debts and Letters of Credit

Note 10. Debts and Letters of Credit

As of January 2, 2016 and June 27, 2015, the Company’s long-term debt on the Consolidated Balance Sheets represented the carrying amount of the liability component of the 0.625% Senior Convertible Notes as discussed below. The following table presents the carrying amounts of the liability and equity components (in millions):

	January 2, 2016			June 27, 2015
Principal amount of 0.625% Senior Convertible Notes	$	650.0		$	650.0
Unamortized discount of liability component	(75.2		)	(88.4		)
Carrying amount of liability component	$	574.8		$	561.6
Carrying amount of equity component (1)	$	134.4		$	134.4

(1) Included in Accumulated paid-in-capital on the Consolidated Balance Sheets.

The Company was in compliance with all debt covenants and held no short term debt as of January 2, 2016 and June 27, 2015.

0.625% Senior Convertible Notes

On August 21, 2013, the Company issued $650.0 million aggregate principal amount of 0.625% Senior Convertible Notes due 2033 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The proceeds from the 2033 Notes amounted to $636.3 million after issuance costs. The 2033 Notes are an unsecured obligation of the Company and bear interest at an annual rate of 0.625% payable in cash semi-annually in arrears on February 15 and August 15 of each year. The 2033 Notes mature on August 15, 2033 unless earlier converted, redeemed or repurchased. The 2033 Notes and its terms are described in “Note 10. Debts and Letters of Credit” of the Company’s Annual Report on Form 10-K for the year ended June 27, 2015.

Following the separation of the Lumentum business on August 1, 2015, the conversion price per share was adjusted pursuant to the terms of the 2033 Notes relating to the occurrence of a spin-off event. Effective as of the end of the business day on August 17, 2015, the initial conversion price per share was adjusted to $11.28 per share of the Company’s common stock traded on NASDAQ under the ticker symbol “VIAV.”

In accordance with the authoritative accounting guidance, the Company separated the 2033 Notes into liability and equity components. The carrying value of the liability component at issuance was calculated as the present value of its cash flows using a discount rate of 5.4% based on the 5-year swap rate plus credit spread as of the issuance date. The credit spread for the Company is based on the historical average “yield to worst” rate for BB rated issuers. The difference between the 2033 Notes principal and the carrying value of the liability component, representing the value of conversion premium assigned to the equity component, was recorded as a debt discount on the issuance date and is being accreted using the effective interest rate of 5.4% over the period from the issuance date through August 15, 2018 as a non-cash charge to interest expense. The carrying value of the liability component was determined to be $515.6 million, and the equity component, or debt discount, of the 2033 Notes was determined to be $134.4 million. As of January 2, 2016, the expected remaining term of the 2033 Notes is 2.6 years.

In connection with the issuance of the 2033 Notes, the Company incurred $13.7 million of issuance costs, which were bifurcated into the debt issuance costs, attributable to the liability component of $10.9 million and the equity issuance costs, attributable to the equity component of $2.8 million based on their relative values. The debt issuance costs were capitalized and are being amortized to interest expense using the effective interest rate method from issuance date through August 15, 2018. The equity issuance costs were netted against the equity component in additional paid-in capital at the issuance date. As of January 2, 2016, the unamortized portion of the debt issuance costs related to the 2033 Notes was $6.1 million, which was included in Other non-current assets on the Consolidated Balance Sheets.

Based on quoted market prices as of January 2, 2016 and June 27, 2015, the fair value of the 2033 Notes was approximately $610.1 million and $644.0 million. The 2033 Notes are classified within Level 2 as they are not actively traded in markets.

The following table presents the effective interest rate and the interest expense for the contractual interest and the accretion of debt discount (in millions, except for the effective interest rate):

	Three Months Ended						Six Months Ended
	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Effective interest rate	5.4		%	5.4		%	5.4		%	5.4		%
Interest expense-contractual interest	$	1.0		$	1.0		$	2.0		$	2.0
Accretion of debt discount	6.6			6.3			13.2			12.5

Outstanding Letters of Credit

As of January 2, 2016, the Company had 10 standby letters of credit totaling $14.3 million.

XML

Restructuring and Related Charges

6 Months Ended

Jan. 02, 2016

Restructuring and Related Activities [Abstract]

Restructuring and Related Charges

Note 11. Restructuring and Related Charges

The Company has initiated various strategic restructuring events primarily intended to reduce its costs, consolidate its operations, rationalize the manufacturing of its products and align its businesses in response to market conditions. As of January 2, 2016 and June 27, 2015, the Company’s total restructuring accrual was $15.3 million and $27.2 million. During the three and six months endedJanuary 2, 2016 the Company recorded restructuring and related charges of $1.4 million and $1.8 million, respectively. During the three and six months endedDecember 27, 2014 the Company recorded restructuring and related charges of $9.1 million and $10.2 million, respectively. The Company’s restructuring charges can include severance and benefit costs to eliminate a specified number of positions, facilities and equipment costs to vacate facilities and consolidate operations, and lease termination costs. The timing of associated cash payments is dependent upon the type of restructuring charge and can extend over multiple periods.

Summary of Restructuring Plans

The adjustments to the accrued restructuring expenses related to all of the Company’s restructuring plans described below for the three and six months endedJanuary 2, 2016 were as follows (in millions):

	Balance June 27, 2015		Six Months Ended January 2, 2016 Charges			Cash Settlements			Non-cash Settlements and Other Adjustments			Balance January 2, 2016		Three Months Ended January 2, 2016 Charges
Fiscal 2016 Plan
NE and SE Agile Restructuring Plan (Workforce Reduction)	$	—	$	3.0		$	(0.4	)	$	—		$	2.6	$	3.0
Fiscal 2015 Plan
NE, SE and Shared Service Separation Restructuring Plan (Workforce Reduction)	14.9		(0.5		)	(10.3		)	(0.2		)	3.9		(0.8		)
Fiscal 2014 Plans
NE Realignment Plan (Workforce Reduction)	0.6		(0.1		)	(0.5		)	—			—		(0.1		)
Shared Services Restructuring Plan (Workforce Reduction)	0.7		—			(0.7		)	—			—		—
NE Product Strategy Restructuring Plan (Workforce Reduction)	2.3		—			(0.4		)	(0.1		)	1.8		—
NE Lease Restructuring Plan	5.2		0.2			(0.7		)	—			4.7		0.1
Central Finance and IT Restructuring Plan (Workforce Reduction)	1.1		(0.7		)	(0.1		)	—			0.3		(0.7		)
Plans Prior to Fiscal 2014	2.4		(0.1		)	(0.3		)	—			2.0		(0.1		)
Total	$	27.2	$	1.8		$	(13.4	)	$	(0.3	)	$	15.3	$	1.4

As of January 2, 2016 and June 27, 2015, $5.9 million and $8.2 million, respectively, of our restructuring liability was long-term in nature and included as a component of Other non-current liabilities, with the remaining short-term portion included as a component of Other current liabilities on the Consolidated Balance Sheets.

Fiscal 2016 Plans

NE and SE Agile Restructuring Plan

During the second quarter of fiscal 2016, Management approved a plan primarily impacting the NE and SE business segment as part of Viavi’s ongoing commitment for an agile and more efficient operating structure. As a result, a restructuring charge of $3.0 million was recorded for severance and employee benefits for approximately 50 employees primarily in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2017.

Fiscal 2015 Plans

NE, SE and Shared Service Separation Restructuring Plan

During the second, third and fourth quarters of fiscal 2015, Management approved a plan to eliminate certain positions in its shared services functions in connection with the Company’s plan to split into two separate public companies. Further, Management consolidated its operations, sales and R&D organizations and eliminated positions within the NE and SE segments to align to the Company’s product market strategy and lower manufacturing costs in connection with the separation. As a result, approximately 340 employees in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the third quarter of fiscal 2018.

Fiscal 2014 Plans

NE Realignment Plan

During the fourth quarter of fiscal 2014, Management approved a NE plan to realign its operations and strategy to allow for greater investment in high-growth areas. As a result, approximately 100 employees in manufacturing, R&D and SG&A functions located in United States, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual were paid by the end of the second quarter of fiscal 2016.

Shared Services Restructuring Plan

During the fourth quarter of fiscal 2014, Management approved a plan to eliminate positions and re-define roles and responsibilities in its shared services functions in order to reduce cost, standardize global processes and establish a more efficient organization. As a result, approximately 40 employees primarily in the general and administrative functions located in the United States, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual were paid by the end of the second quarter of fiscal 2016.

NEProduct Strategy Restructuring Plan

During the third quarter of fiscal 2014, Management approved a NE plan to realign its services, support and product resources in response to market conditions in the mobile assurance market and to increase focus on software products and next generation solutions through acquisitions and R&D. As a result, approximately 60 employees primarily in SG&A and manufacturing functions located in North America, Latin America, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2020.

NE Lease Restructuring Plan

During the second quarter of fiscal 2014, Management approved a NE plan to exit the remaining space in Germantown, Maryland. As of June 28, 2014, the Company exited the space in Germantown under the plan. The fair value of the remaining contractual obligations, net of sublease income, as of January 2, 2016 was $4.7 million. Payments related to the Germantown lease costs are expected to be paid by the end of the second quarter of fiscal 2019.

Central Finance and Information Technology (“IT”) Restructuring Plan

During the second quarter of fiscal 2014, Management approved a plan to eliminate positions and re-define roles and responsibilities in the Finance and IT organization to align with the future state of the organizations under new executive management and move positions to lower-cost locations where appropriate. As a result, approximately 20 employees primarily in SG&A functions located in North America, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the fourth quarter of fiscal 2019.

Plans Prior to Fiscal 2014

The restructuring accrual for plans that commenced prior to fiscal year 2014 was $2.0 million, which consists of immaterial accruals from various restructuring plans.

XML

Income Taxes

6 Months Ended

Jan. 02, 2016

Income Tax Disclosure [Abstract]

Income Taxes

Note 12. Income Taxes

The Company recorded an income tax benefit of $1.2 million and $0.4 million related to the income (loss) from continuing operations for the three and six months ended months ended January 2, 2016, respectively. The Company recorded an income tax expense of $8.5 million and $14.3 million related to the loss from continuing operations for the three and six months ended December 27, 2014, respectively.

The income tax benefit related to the income (loss) from continuing operations recorded for the three and six months ended January 2, 2016 and December 27, 2014 primarily relates to income tax in certain foreign and state jurisdictions based on the Company’s forecasted pre-tax income or loss for the respective year. In addition, for the three and six months ended January 2, 2016 the Company’s income tax provision includes a tax benefit of $8.8 million and $22.2 million, respectively, related to the income tax intraperiod tax allocation rules for discontinued operations and other comprehensive income. The income tax benefit related to the loss from continuing operations for the six months ended January 2, 2016 also includes a tax expense of $8.9 million related to a one-time increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the Separation.

The income tax expense (benefit) related to the income (loss) from continuing operations recorded differs from the expected tax expense (benefit) that would be calculated by applying the federal statutory rate to the Company’s income (loss) from continuing operations before taxes primarily due to the increases in valuation allowance for deferred tax assets attributable to the Company’s domestic and foreign losses from continuing operations, the income tax benefit recorded in continuing operations under the income tax intraperiod tax allocation rules, and the increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the separation.

At the beginning of the second quarter of fiscal 2016, the Company prospectively adopted the authoritative guidance on balance sheet classification of deferred taxes, which requires deferred tax assets and liabilities, and any related valuation allowance, to be classified as non-current on the balance sheet. The adoption resulted in a reclass of $3.1 million of current net deferred tax assets and $0.7 million of current net deferred tax liabilities to non-current deferred assets and liabilities netted on a jurisdiction by jurisdiction basis.

As of January 2, 2016 and June 27, 2015, the Company’s unrecognized tax benefits totaled $37.0 million and $37.4 million, respectively, and are included in deferred taxes and other non-current tax liabilities, net. The Company had $1.6 million accrued for the payment of interest and penalties at January 2, 2016. The unrecognized tax benefits that may be recognized during the next twelve months are approximately $0.1 million.

XML

Stockholders' Equity

6 Months Ended

Jan. 02, 2016

Equity [Abstract]

Stockholders' Equity

Note 13. Stockholders' Equity

Repurchase of Common Stock

In May 2014, the Company's Board of Directors authorized a stock repurchase program under which the Company may purchase shares of its common stock worth up to an aggregate purchase price of $100.0 million through open market or private transactions. In October 2015, the Board extended the previously authorized repurchase program to utilize the remaining unused dollar amount from the program of approximately $40 million.

In November 2015, the Company entered into a $40.0 million accelerated share repurchase agreement (the “ASR”) with a financial institution that was completed during the third quarter of fiscal 2016. Upon making the upfront payment of $40.0 million, the Company received an initial delivery of 5.3 million shares from the financial institution during the second quarter of fiscal 2016, which were retired and recorded as a $32.0 million reduction to stockholder’s equity on the Consolidated Balance Sheet. As of January 2, 2016, the ASR was evaluated as an unsettled forward contract indexed to the Company’s own stock, with $8.0 million classified within stockholders’ equity. The Company reflects the repurchase of common stock under the ASR in the period the shares are delivered for the purposes of calculating earnings per share and as a forward contract indexed to its own common stock. The ASR met all of the applicable criteria for equity classification and therefore was not accounted for as a derivative instrument.

During the third quarter of fiscal 2016, the ASR was completed and a final delivery of 1.3 million shares was delivered based on the final settlement price of $6.05 per share. All common shares repurchased under this program have been canceled and retired.

XML

Stock-Based Compensation

6 Months Ended

Jan. 02, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation

Note 14. Stock-Based Compensation

Overview

The impact on the Company’s results of operations of recording stock-based compensation by function for the three and six months endedJanuary 2, 2016 and December 27, 2014 was as follows (in millions):

	Three Months Ended				Six Months Ended
	January 2, 2016		December 27, 2014		January 2, 2016		December 27, 2014
Cost of sales	$	1.4	$	1.0	$	2.6	$	2.0
Research and development	1.9		2.0		4.7		3.9
Selling, general and administrative	5.6		7.5		17.6		15.1
Stock-based compensation	$	8.9	$	10.5	$	24.9	$	21.0

Approximately $0.9 million of stock-based compensation was capitalized to inventory at January 2, 2016.

Full Value Awards

Full Value Awards refer to RSUs and Performance Units that are granted with the exercise price equal to zero and are converted to shares immediately upon vesting. These Full Value Awards are performance-based, time-based or a combination of both and expected to vest over one to four years. The fair value of the time-based Full Value Awards is based on the closing market price of the Company’s common stock on the date of award.

During the six months endedJanuary 2, 2016 and December 27, 2014, the Company granted 5.3 million and 5.2 million RSUs, of which 0.5 million and 0.7 million, respectively, are performance-based RSUs with market conditions (“MSUs”). These MSU shares represent the target amount of grants, and the actual number of shares awarded upon vesting of the MSUs may be higher or lower depending upon the achievement of the relevant market conditions. The majority of MSUs vest in equal annual installments over three years based on the attainment of certain total shareholder return performance measures and the employee’s continued service through the vest date. The aggregate grant-date fair value of MSUs granted during the first quarter of fiscal 2016 and fiscal 2015 was estimated to be $2.9 million and $8.5 million, respectively, and was calculated using a Monte Carlo simulation. The remaining 4.8 million and 4.5 million granted during the six months endedJanuary 2, 2016 and December 27, 2014 are mainly time-based RSUs. The majority of these time-based RSUs vest over three years, with 33% vesting after one year and the balance vesting quarterly over the remaining two years. The grant amounts and grant-date fair values during the three and six months endedDecember 27, 2014 represent the Company’s historical grant information and have not been adjusted to remove grants made to employees who transferred to Lumentum as part of the Separation.

As of January 2, 2016, $52.3 million of unrecognized stock-based compensation cost related to Full Value Awards remains to be amortized. That cost is expected to be recognized over an estimated amortization period of 2.2 years.

Full Value Awards are converted into shares upon vesting. Shares equivalent in value to the minimum withholding taxes liability on the vested shares are withheld by the Company for the payment of such taxes. During the six months ended January 2, 2016 and December 27, 2014, the Company paid $7.8 million and $11.9 million, respectively, and classified the payments as operating cash outflows in the Consolidated Statement of Cash Flows.

Impact on Stock-based Compensation Due to Separation

In connection with the separation of the Lumentum business on August 1, 2015 and in accordance with the Employee Matters Agreement, the Company made certain adjustments to the exercise price and number of shares underlying stock-based compensation awards with the intention of preserving the economic value of the awards for Viavi employees. These adjustments resulted in a modification of equity awards with total incremental stock-based compensation of $13.6 million, of which $8.3 million was expensed in the first two quarters of fiscal 2016. The remaining $5.3 million will be amortized over the remaining requisite service period from Separation Date to the end of the vesting term.

Valuation Assumptions

The Company estimates the fair value of the new MSUs granted using a Monte Carlo simulation based on the assumptions described below for the following periods:

	Six Months Ended
	January 2, 2016		December 27, 2014
Volatility of common stock	33.0	%	40.8	%
Average volatility of peer companies	52.6	%	53.4	%
Average correlation coefficient of peer companies	0.0887		0.2156
Risk-free interest rate	0.8	%	0.6	%

XML

Employee Pension and Other Benefit Plans

6 Months Ended

Jan. 02, 2016

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Employee Benefit Plans

Note 15. Employee Pension and Other Benefit Plans

In connection with the separation of Lumentum on August 1, 2015, the Company transferred the liabilities and assets of the Switzerland defined benefit pension plans to Lumentum in the amount of $6.7 million and $4.6 million, respectively.

The Company sponsors significant qualified and non-qualified pension plans for certain past and present employees in the United Kingdom (“U.K.”) and Germany. The Company also is responsible for the non-pension post-retirement benefit obligation assumed from a past acquisition. Most of the plans have been closed to new participants and no additional service costs are being accrued, except for certain plans in Germany assumed in connection with acquisitions during fiscal 2010. Benefits are generally based upon years of service and compensation or stated amounts for each year of service.

As of January 2, 2016 the U.K. plan was partially funded while the other plans were unfunded. The Company’s policy for funded plans is to make contributions equal to or greater than the requirements prescribed by law or regulation. For unfunded plans, the Company pays the post-retirement benefits when due. During the six months ended January 2, 2016, the Company contributed $0.7 million to the U.K. plan. The funded plans assets consist primarily of managed investments.

The following table presents the components of the net periodic cost for the pension and benefits plans (in millions):

	Three Months Ended						Six Months Ended
Pension Benefits	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Service cost	$	0.1		$	—		$	0.2		$	0.1
Interest cost	0.7			1.0			1.5			2.0
Expected return on plan assets	(0.4		)	(0.4		)	(0.8		)	(0.8		)
Recognized net actuarial losses	0.1			0.1			0.3			0.2
Net periodic benefit cost	$	0.5		$	0.7		$	1.2		$	1.5

Both the calculation of the projected benefit obligation and net periodic cost are based upon actuarial valuations. These valuations use participant-specific information such as salary, age, years of service, and assumptions about interest rates, pension increases and other factors. At a minimum, the Company evaluates these assumptions annually and makes changes as necessary.

The Company expects to incur cash outlays of approximately $5.9 million related to its defined benefit pension plans during fiscal 2016 to make current benefit payments and fund future obligations. As of January 2, 2016, approximately $2.3 million had been incurred. These payments have been estimated based on the same assumptions used to measure the Company’s projected benefit obligation at June 27, 2015.

XML

Commitments and Contingencies

6 Months Ended

Jan. 02, 2016

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 16. Commitments and Contingencies

Legal Proceedings

The Company is subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against the Company, individually or in aggregate, will not have a material adverse impact on its financial position, results of operations or statement of cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. Were an unfavorable final outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

Guarantees

In accordance with authoritative guidance which requires that upon issuance of a guarantee, the guarantor must recognize a liability for the fair value of the obligation it assumes under that guarantee. In addition, disclosures about the guarantees that an entity has issued, including a tabular reconciliation of the changes of the entity’s product warranty liabilities, are required.

The Company from time to time enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. These contracts primarily relate to: (i) divestiture agreements, under which the Company may provide customary indemnifications to purchasers of the Company’s businesses or assets; (ii) certain real estate leases, under which the Company may be required to indemnify property owners for environmental and other liabilities, and other claims arising from the Company’s use of the applicable premises; and (iii) certain agreements with the Company’s officers, directors and employees, under which the Company may be required to indemnify such persons for liabilities arising out of their employment relationship.

The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, the Company has not been obligated to make significant payments for these obligations, and no liabilities have been recorded for these obligations on the consolidated balance sheet as of January 2, 2016 and June 27, 2015.

Product Warranties

In general, the Company offers a three-year warranty for most of its products. The Company provides reserves for the estimated costs of product warranties at the time revenue is recognized. The Company estimates the costs of its warranty obligations based on its historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise with specific products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.

The following table presents the changes in the Company’s warranty reserve during fiscal 2016 and fiscal 2015 (in millions):

	Three Months Ended						Six Months Ended
	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Balance as of beginning of period	$	4.0		$	3.6		$	3.7		$	3.6
Provision for warranty	0.8			1.0			1.7			1.9
Utilization of reserve	(0.7		)	(1.2		)	(1.5		)	(2.1		)
Adjustments related to pre-existing warranties (including changes in estimates)	0.2			0.1			0.4			0.1
Balance as of end of period	$	4.3		$	3.5		$	4.3		$	3.5

XML

Operating Segments and Geographic Information

6 Months Ended

Jan. 02, 2016

Segment Reporting [Abstract]

Operating Segments and Geographic Information

Note 17. Operating Segments

The Company evaluates its reportable segments in accordance with the authoritative guidance on segment reporting. The Company’s Interim Chief Executive Officer, Richard Belluzzo, is the Company’s Chief Operating Decision Maker (“CODM”) pursuant to the guidance. The CODM allocates resources to the segments based on their business prospects, competitive factors, net revenue and operating results.

The Company provides software and hardware platforms and instruments that deliver end-to-end visibility across physical, virtual and hybrid networks. Viavi’s solutions provide intelligence and insight across the network ecosystem to optimize networks and support more profitable, higher-performing networks for our customers. Viavi is also a leader in anti-counterfeiting solutions for currency authentication and high-value optical components and instruments for diverse government and commercial applications.

The Company’s reportable segments are:

(i) Network Enablement (“NE”):

NE provides testing solutions that access the network to perform build out and maintenance tasks. These solutions include instruments and software to design, build, turn-up, certify, troubleshoot, and optimize networks.

(ii) Service Enablement (“SE”):

SE solutions are embedded systems that yield network, service and application performance data. These solutions—including microprobes and software—monitor, collect and analyze network data to reveal the actual customer experience and to identify opportunities for new revenue streams and network optimization.

(iii) Optical Security and Performance Products (“OSP”):

OSP provides innovative optical security solutions, with a strategic focus on serving the anti-counterfeiting market through advanced security pigments, thread substrates and printed features for the currency, pharmaceutical and consumer electronic segments. OSP also provides thin-film coating solutions for 3D sensing applications.

Changes to Segment Reporting

Following the Separation in the first quarter of fiscal 2016, the Company made changes to its segment measures to reflect how the CODM manages the business post-separation as described below.

The CODM manages the Company in two broad business categories: Network and Service Enablement ("NSE") and OSP. NSE operates in two segments, NE and SE, whereas OSP operates as a single segment. The CODM evaluates segment performance of the NSE business based on NE and SE segment gross margin and NSE operating margin as a whole. Operating expenses associated with the NSE business are not allocated to the NE and SE segments within NSE, as they are managed centrally at the business unit level. The CODM evaluates segment performance of the OSP business based on OSP segment operating margin. In addition, prior to the first quarter of fiscal 2016 the Company did not allocate certain corporate-level operating expenses associated with its shared-service function to its segment results. Beginning in the first quarter of fiscal 2016, the Company has allocated these corporate-level operating expenses to its segment results, with the exception of certain non-recurring activities and other items as discussed below.

The Company does not allocate stock-based compensation, acquisition-related charges and amortization of intangibles, restructuring and related charges, non-operating income and expenses, or other non-recurring charges to our segments because Management does not include this information in its measurement of the performance of the operating segments. These items are presented as “Reconciling Items” in the table below.

As a result of the Separation, the Company excluded the results of the Lumentum business which historically consisted of the CCOP segment and the WaveReady product line within the NE segment for all periods presented. Refer to “Note 3. Discontinued Operations” for more information on the Separation. Additionally, the Company’s Video Assurance product line was moved out of its NE segment and into its SE segment during the first quarter of fiscal 2016.

The segment information for all periods presented has been revised to be comparable with the changes in the Company’s segment reporting measures.

Information on reportable segments is as follows (in millions):

	Three Months Ended January 2, 2016
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	136.4		$	36.9		$	173.3		$	58.8		$	232.1		$	—		$	232.1
Gross profit	90.6			24.5			115.1			32.8			147.9			(6.1		)	141.8
Gross margin	66.4		%	66.4		%	66.4		%	55.8		%	63.7		%				61.1		%
Operating income (loss)							8.0			22.5			30.5			(21.3		)	9.2
Operating margin							4.6		%	38.3		%	13.1		%				4.0		%

	Three Months Ended December 27, 2014
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	129.0		$	46.8		$	175.8		$	50.6		$	226.4		$	—		$	226.4
Gross profit	84.6			32.4			117.0			26.7			143.7			(10.6		)	133.1
Gross margin	65.6		%	69.2		%	66.6		%	52.8		%	63.5		%				58.8		%
Operating income (loss)							2.0			17.1			19.1			(40.3		)	(21.2		)
Operating margin							1.1		%	33.8		%	8.4		%				(9.4		)%

	Three Months Ended
	January 2, 2016			December 27, 2014
Corporate reconciling items impacting gross profit:
Total segment gross profit	$	147.9		$	143.7
Stock-based compensation	(1.4		)	(1.0		)
Amortization of intangibles	(4.6		)	(9.2		)
Other charges related to non-recurring activities	(0.1		)	(0.4		)
GAAP gross profit	$	141.8		133.1
Corporate reconciling items impacting operating income (loss):
Total segment operating income	$	30.5		$	19.1
Stock-based compensation	(8.9		)	(10.5		)
Amortization of intangibles	(8.3		)	(14.1		)
Other charges related to non-recurring activities (1)	(2.7		)	(6.6		)
Restructuring and related charges	(1.4		)	(9.1		)
GAAP operating income (loss) from continuing operations	$	9.2		$	(21.2	)

(1) During the three months endedJanuary 2, 2016, other charges related to non-recurring activities primarily consisted of incremental expenses related to post-separation activities such as site consolidations, reorganizations, insourcing or outsourcing of activities. During the three months endedDecember 27, 2014, other charges related to non-recurring activities primarily consisted of incremental expenses related to Viavi-specific activities to complete the separation such as professional fees and additional personnel and related costs.

	Six Months Ended January 2, 2016
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	254.0		$	84.8		$	338.8		$	123.0		$	461.8		$	—		$	461.8
Gross profit	166.3			57.9			224.2			69.8			294.0			(11.7		)	282.3
Gross margin	65.5		%	68.3		%	66.2		%	56.7		%	63.7		%				61.1		%
Operating income (loss)							10.4			48.8			59.2			(52.9		)	6.3
Operating margin							3.1		%	39.7		%	12.8		%				1.4		%

	Six Months Ended December 27, 2014
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	250.5		$	97.3		$	347.8		$	93.9		$	441.7		$	—		$	441.7
Gross profit	164.8			67.4			232.2			49.8			282.0			(20.0		)	262.0
Gross margin	65.8		%	69.3		%	66.8		%	53.0		%	63.8		%				59.3		%
Operating income (loss)							0.7			31.4			32.1			(65.7		)	(33.6		)
Operating margin							0.2		%	33.4		%	7.3		%				(7.6		)%

	Six Months Ended
	January 2, 2016			December 27, 2014
Corporate reconciling items impacting gross profit:
Total segment gross profit	$	294.0		$	282.0
Stock-based compensation	(2.6		)	(2.0		)
Amortization of intangibles	(8.9		)	(17.3		)
Other charges related to non-recurring activities	(0.2		)	(0.7		)
GAAP gross profit	$	282.3		262.0
Corporate reconciling items impacting operating income (loss):
Total segment operating income	$	59.2		$	32.1
Stock-based compensation	(24.9		)	(21.0		)
Amortization of intangibles	(16.4		)	(27.2		)
Other charges related to non-recurring activities (1)	(9.8		)	(7.3		)
Restructuring and related charges	(1.8		)	(10.2		)
GAAP operating income (loss) from continuing operations	$	6.3		$	(33.6	)

(1) During the six months endedJanuary 2, 2016, other charges related to non-recurring activities primarily consisted of a) incremental expenses of $5.6 million related to post-separation activities such as site consolidations, reorganizations, insourcing or outsourcing of activities and b) $3.5 million of non-recurring incremental severance and related costs upon the exit of a key executive. During the six months endedDecember 27, 2014, other charges related to non-recurring activities primarily consisted of incremental expenses related to Viavi-specific activities to complete the separation, such as professional fees and additional personnel and related costs.

XML

Basis of Presentation (Policies)

6 Months Ended

Jan. 02, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Fiscal Years

Fiscal Years

The Company utilizes a 52-53 week fiscal year ending on the Saturday closest to June 30th. The Company’s fiscal 2016 is a 53-week year ending on July 2, 2016. The Company’s fiscal 2015 was a 52-week year ending on June 27, 2015.

Principles of Consolidation

Principles of Consolidation

The amounts presented in the consolidated financial statements have been prepared in accordance with U.S. GAAP and include the Company and its wholly-owned subsidiaries. All inter-company accounts and transactions have been eliminated.

Use of Estimates

Use of Estimates

The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires Management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements, the reported amount of Net revenues and expenses and the disclosure of commitments and contingencies during the reporting periods. The Company bases estimates on historical experience and on various assumptions about the future believed to be reasonable based on available information. The Company’s reported financial position or results of operations may be materially different under changed conditions or when using different estimates and assumptions, particularly with respect to significant accounting policies. If estimates or assumptions differ from actual results, subsequent periods are adjusted to reflect more current information.

Recently Issued Accounting Pronouncements

In January 2016, the FASB (“Financial Accounting Standards Board”) issued guidance that requires an entity to measure equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, it requires entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes and requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It also eliminates the requirement to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The guidance is effective for the company in the first quarter of fiscal 2019. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In November 2015, the FASB issued guidance requiring deferred tax assets and liabilities, and any related valuation allowance, to be classified as non-current on the balance sheet. This classification eliminates the need to separately identify the net current and net non-current deferred tax asset or liability in each jurisdiction. The Company elected to prospectively adopt the guidance in the beginning of the second quarter of fiscal 2016. Refer to “Note 12. Income Taxes” for more information regarding the impact of adopting this guidance.

In July 2015, the FASB issued guidance to change the subsequent measurement of inventory from lower of cost or market to lower of cost and net realizable value. The guidance is effective for the Company in the first quarter of fiscal 2018. Earlier application is permitted as of the beginning of an interim or annual reporting period. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In May 2015, the FASB issued guidance to remove the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using net asset value per share practical expedient. The guidance is effective for the Company in the first quarter of fiscal 2017 and may apply to certain pension assets. The guidance will be applied retrospectively and earlier adoption is permitted. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In April 2015, the FASB issued new authoritative guidance to provide a practical expedient that permits the entity to measure defined benefit plan assets and obligations using the month-end that is closest to the entity’s fiscal year-end and apply that practical expedient consistently from year to year. Prospective application is required and early adoption is permitted. This guidance is effective for the Company in the first quarter of fiscal 2017 and may apply to the qualified and the non-qualified pension plans in certain countries. The Company will not early adopt and is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In April 2015, the FASB issued new authoritative guidance to simplify the presentation of debt issuance costs by requiring debt issuance costs to be presented as a deduction from the corresponding liability, consistent with debt discounts or premiums. This guidance is effective for the Company in the first quarter of fiscal 2017 for its convertible debt, and will be applied retrospectively. The consolidated balance sheet of each individual period presented will be adjusted to reflect the period-specific effects of applying this new guidance.

In May 2014, the FASB issued new authoritative guidance related to revenue recognition. This guidance will replace current U.S. GAAP guidance on this topic and eliminate industry-specific guidance. The new revenue recognition guidance provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance allows for either full retrospective adoption or modified retrospective adoption. The FASB deferred the effective date for this guidance by one year to December 15, 2017 for annual reporting periods beginning after such date. Earlier application of this guidance is permitted but not before the original date of December 15, 2016. The guidance is effective for the company in the first quarter of fiscal 2019. The Company is evaluating the impact that this new accounting guidance will have on its consolidated financial statements and related disclosures.

XML

Discontinued Operations (Tables)

6 Months Ended

Jan. 02, 2016

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Discontinued Operations

The following table presents the carrying amounts of the major classes of the assets and liabilities of the Lumentum business which are presented as discontinued operation on the Consolidated Balance Sheets (in millions).

	June 27, 2015
Assets:
Cash and cash equivalents	$	13.4
Accounts receivable, net	150.2
Inventories, net	100.0
Prepayments and other current assets	46.6
Current assets of discontinued operations	310.2
Property, plant and equipment, net	145.4
Goodwill	5.6
Intangibles, net	21.8
Other non-current assets	31.4
Non-current assets of discontinued operations	204.2
Total assets of discontinued operations	$	514.4
Liabilities:
Accounts payable	$	79.1
Accrued payroll and related expenses	18.3
Income taxes payable	3.7
Accrued expenses	17.5
Other current liabilities	11.4
Current liabilities of discontinued operations	130.0
Non-current liabilities of discontinued operations	10.9
Total liabilities of discontinued operations	$	140.9

The following table presents supplemental cash flow information: depreciation expense, amortization expense, stock based compensation expense and capital expenditures of the Lumentum business (in millions):

	Six Months Ended
	January 2, 2016		December 27, 2014
Operating activities:
Depreciation expense	$	3.7	$	21.3
Amortization expense	0.6		4.0
Stock-based compensation expense	1.6		9.7
Investing activities:
Capital expenditures	$	5.8	$	23.1

The following table summarizes results from discontinued operations of the Lumentum business included in the condensed Consolidated Statement of Operations (in millions):

	Three Months Ended (1)			Six Months Ended
	December 27, 2014			January 2, 2016			December 27, 2014
Net revenues	$	210.7		$	66.5		$	429.0
Cost of revenues	141.4			49.7			287.4
Amortization of acquired technologies	1.9			0.6			3.8
Gross profit	67.4			16.2			137.8
Operating expenses:
Research and development	35.0			12.5			69.8
Selling, general and administrative	18.8			24.0			36.0
Restructuring charges	0.6			0.1			2.4
Total operating expenses	54.4			36.6			108.2
(Loss) income from operations	13.0			(20.4		)	29.6
Interest and other income (expense), net	(0.1		)	0.5			(0.3		)
(Loss) income before income taxes	12.9			(19.9		)	29.3
Income tax provision	0.3			30.5			0.6
Net (loss) income from discontinued operations	$	12.6		$	(50.4	)	$	28.7

XML

Earnings Per Share (Tables)

6 Months Ended

Jan. 02, 2016

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net (loss) income per share

The following table sets forth the computation of basic and diluted net income (loss) per share (in millions, except per share data):

	Three Months Ended					Six Months Ended
	January 2, 2016		December 27, 2014			January 2, 2016			December 27, 2014
Numerator:
Income (loss) from continuing operations, net of taxes	$	3.3	$	(37.7	)	$	(10.3	)	$	(63.5	)
Income (loss) from discontinued operations, net of taxes	3.0		12.6			(50.4		)	28.7
Net income (loss)	$	6.3	$	(25.1	)	$	(60.7	)	$	(34.8	)
Denominator:
Weighted-average number of common shares outstanding
Basic	234.9		232.1			235.5			231.5
Effect of dilutive securities from stock-based benefit plans	2.2		—			—			—
Diluted	237.1		232.1			235.5			231.5
Net income (loss) per share - basic and diluted:
Continuing operations	$	0.02	$	(0.16	)	$	(0.04	)	$	(0.27	)
Discontinued operations	0.01		0.05			(0.22		)	0.12
Net income (loss) per share	$	0.03	$	(0.11	)	$	(0.26	)	$	(0.15	)

Schedule of weighted average potentially dilutive securities excluded from the computation because their effect would have been anti-dilutive

The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net income (loss) per share because their effect would have been anti-dilutive (in millions):

	Three Months Ended		Six Months Ended
	January 2, 2016 (2)	December 27, 2014 (1)(2)	January 2, 2016 (1)(2)	December 27, 2014 (1)(2)
Stock options and ESPP	0.9	3.8	3.4	3.8
Restricted Stock Units	4.5	11.1	11.0	10.8
Total potentially dilutive securities	5.4	14.9	14.4	14.6

(1)  As the Company incurred a net loss in the period, potential dilutive securities from employee stock options, employee stock purchase plan (“ESPP”) and Restricted Stock Units (“RSUs”) have been excluded from the diluted net loss per share computations as their effects were deemed anti-dilutive.

(2)  The Company’s 0.625% Senior Convertible 2033 Notes are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $11.28 per share is payable in cash, shares of the Company’s common stock or a combination of both. Refer to “Note 10. Debts and Letters of Credit” for more details.

XML

Accumulated Other Comprehensive (Loss) Income (Tables)

6 Months Ended

Jan. 02, 2016

Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]

Schedule of components of Accumulated other comprehensive income

For the six months endedJanuary 2, 2016 the changes in accumulated other comprehensive income (loss) by component net of tax were as follows (in millions):

	Unrealized (losses) on available-for sale investments (2)			Foreign  currency translation adjustments			Defined benefit obligation, net of tax (3)			Total
Beginning balance as of June 27, 2015	$	(3.2	)	$	(29.2	)	$	(15.6	)	$	(48.0	)
Transferred to Lumentum (1)	—			(8.9		)	1.1			(7.8		)
Other comprehensive (loss) income before reclassification	153.1			(21.8		)	—			131.3
Amounts reclassified from accumulated other comprehensive income (loss)	—			—			0.3			0.3
Net current-period other comprehensive (loss) income	153.1			(21.8		)	0.3			131.6
Ending balance as of January 2, 2016	$	149.9		$	(59.9	)	$	(14.2	)	$	75.8

(1) Amount represents the transfer of accumulated other comprehensive balances to Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information.

(2) Activity during the six months ended primarily relates to a $157.2 million unrealized gain on the marketable equity securities of Lumentum held by Viavi, net of a $3.7 million income tax effect related to the intraperiod tax allocation rules.

(3) Amount represents the amortization of actuarial losses included as a component of Selling, general and administrative expense (“SG&A”) in the Consolidated Statement of Operations for the six months endedJanuary 2, 2016. There was no tax impact. Refer to “Note 15. Employee Pension and Other Benefit Plans” for more details on the computation of net periodic cost for pension plans.

XML

Balance Sheet and Other Details (Tables)

6 Months Ended

Jan. 02, 2016

Balance Sheet and Other Details

Schedule of components of accounts receivable reserves and allowances

The components of accounts receivable reserves and allowances were as follows (in millions):

	June 27, 2015		Charged to Costs and Expenses		Adjustments (1)			January 2, 2016
Allowance for doubtful accounts	$	2.4	$	0.3	$	(0.1	)	$	2.6
Allowance for sales returns	0.7		1.6		(1.2		)	1.1
Total accounts receivable reserves	$	3.1	$	1.9	$	(1.3	)	$	3.7

 (1) Represents the effect of currency translation adjustments and write-offs of uncollectible accounts, net of recoveries.

Schedule of components of Inventories

The components of Inventories, net were as follows (in millions):

	January 2, 2016		June 27, 2015
Finished goods	$	33.0	$	31.5
Work in process	5.6		6.8
Raw materials	19.0		15.5
Inventories, net	$	57.6	$	53.8

Schedule of components of Prepayments and other current assets

The components of Prepayments and other current assets were as follows (in millions):

	January 2, 2016		June 27, 2015
Prepayments	$	13.2	$	15.7
Other current assets	20.9		22.5
Prepayments and other current assets	$	34.1	$	38.2

Schedule of components of Other current liabilities

The components of Other current liabilities were as follows (in millions):

	January 2, 2016		June 27, 2015
Deferred compensation plan	$	3.3	$	3.0
Warranty	2.5		2.3
Value-added tax	3.2		1.7
Restructuring	9.4		19.1
Deferred income taxes	—		7.1
Other	12.4		10.3
Other current liabilities	30.8		$	43.5

Schedule of components of Other non-current liabilities

The components of Other non-current liabilities were as follows (in millions):

	January 2, 2016		June 27, 2015
Pension and post-employment benefits	$	83.3	$	86.9
Financing obligation	29.2		29.1
Restructuring accrual	5.9		8.2
Long-term deferred revenue	22.5		23.6
Other	21.4		20.6
Other non-current liabilities	$	162.3	$	168.4

XML

Investments and Fair Value Measurements (Tables)

6 Months Ended

Jan. 02, 2016

Investments and Fair Value Measurements

Schedule of available-for-sale securities

As of January 2, 2016, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Debt securities:
U.S. treasuries	$	46.3	$	—	$	—		$	46.3
U.S. agencies	59.7		—		(0.1		)	59.6
Municipal bonds and sovereign debt instruments	2.3		—		—			2.3
Asset-backed securities	49.8		—		(0.4		)	49.4
Corporate securities	183.8		—		(0.2		)	183.6
Total debt securities	341.9		—		(0.7		)	341.2
Marketable equity securities	100.3		157.2		—			257.5
Total available-for-sale securities	$	442.2	$	157.2	$	(0.7	)	$	598.7

 As of June 27, 2015, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Debt securities:
U.S. treasuries	$	51.9	$	—	$	—		$	51.9
U.S. agencies	96.0		—		—			96.0
Municipal bonds and sovereign debt instruments	4.0		—		—			4.0
Asset-backed securities	70.6		—		(0.2		)	70.4
Corporate securities	274.1		0.1		(0.1		)	274.1
Total debt available-for-sale securities	$	496.6	$	0.1	$	(0.3	)	$	496.4

Schedule of contractual maturities of available-for-sale securities

As of January 2, 2016, contractual maturities of the Company’s debt securities classified as available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Estimated Fair Value
Amounts maturing in less than 1 year	$	233.9	$	233.8
Amounts maturing in 1 - 5 years	105.5		105.3
Amounts maturing in more than 5 years	2.5		2.1
Total debt available-for-sale securities	$	341.9	$	341.2

Schedule of assets measured at fair value

Assets measured at fair value as of January 2, 2016 are summarized below (in millions):

	Fair value measurement as of
	January 2, 2016
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Debt available-for-sale securities
U.S. treasuries	$	46.3	$	46.3	$	—
U.S. agencies	59.6		—		59.6
Municipal bonds and sovereign debt instruments	2.3		—		2.3
Asset-backed securities	49.4		—		49.4
Corporate securities	183.6		—		183.6
Total debt available-for-sale securities	341.2		46.3		294.9
Marketable equity securities	257.5		257.5		—
Money market funds	203.0		203.0		—
Trading securities	3.3		3.3		—
Total assets (1)	$	805.0	$	510.1	$	294.9

(1) $204.5 million in cash and cash equivalents, $585.5 million in short-term investments, $10.5 million in restricted cash, and $4.5 million in other non-current assets on the Company’s Consolidated Balance Sheets.

XML

Goodwill (Tables)

6 Months Ended

Jan. 02, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of changes in goodwill

The following table presents the changes in goodwill allocated to the Company’s reportable segments (in millions):

	Network Enablement			Service Enablement			Optical Security and Performance Products		Total
Balance as of June 27, 2015	$	154.5		$	92.7		$	8.3	$	255.5
Currency translation and other adjustments	(2.2		)	(1.2		)	—		(3.4		)
Goodwill allocation - WaveReady (1)	(6.0		)	—			—		(6.0		)
Balance as of January 2, 2016	$	146.3		$	91.5		$	8.3	$	246.1

(1) Amount represents a release of the relative fair value of goodwill in our NE reporting unit related to the WaveReady products line, which is now a part of Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information.

XML

Acquired Developed Technology and Other Intangibles (Tables)

6 Months Ended

Jan. 02, 2016

Acquired Developed Technology and Other Intangibles

Schedule of acquired developed technology and other intangibles

The following tables present details of the Company’s acquired developed technology, customer relationships and other intangibles (in millions):

As of January 2, 2016	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	420.6	$	(379.3	)	$	41.3
Customer relationships	174.7		(139.6		)	35.1
Other	19.2		(18.8		)	0.4
Total intangibles subject to amortization	$	614.5	$	(537.7	)	$	76.8
In-process research and development assets	$	0.8	-			$	0.8
Total intangibles	$	615.3	$	(537.7	)	$	77.6

As of June 27, 2015	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	418.9	$	(373.6	)	$	45.3
Customer relationships	178.7		(135.8		)	42.9
Other	19.5		(18.9		)	0.6
Total intangibles subject to amortization	617.1		(528.3		)	88.8
In-process research and development assets	1.8		—			1.8
Total intangibles	$	618.9	$	(528.3	)	$	90.6

Finite-lived intangible assets amortization expense

The following table presents the amortization recorded relating to acquired developed technology, customer relationships and other intangibles (in millions):

	Three Months Ended				Six Months Ended
	January 2, 2016		December 27, 2014		January 2, 2016		December 27, 2014
Amortization of acquired developed technologies	$	4.6	$	9.2	$	8.9	$	17.3
Amortization of other intangibles	3.7		4.9		7.5		9.9
Total amortization of intangible assets	$	8.3	$	14.1	$	16.4	$	27.2

Schedule of estimated future amortization

Based on the carrying amount of acquired developed technology, customer relationships and other intangibles as of January 2, 2016, and assuming no future impairment of the underlying assets, the estimated future amortization is as follows (in millions):

Fiscal Years
Remainder of 2016	$	15.4
2017	29.5
2018	20.9
2019	9.3
2020	1.3
Thereafter	0.4
Total amortization	$	76.8

XML

Debts and Letters of Credit (Tables)

6 Months Ended

Jan. 02, 2016

Debt Disclosure [Abstract]

Schedule of carrying amounts of the liability and equity components of convertible debt

The following table presents the carrying amounts of the liability and equity components (in millions):

	January 2, 2016			June 27, 2015
Principal amount of 0.625% Senior Convertible Notes	$	650.0		$	650.0
Unamortized discount of liability component	(75.2		)	(88.4		)
Carrying amount of liability component	$	574.8		$	561.6
Carrying amount of equity component (1)	$	134.4		$	134.4

(1) Included in Accumulated paid-in-capital on the Consolidated Balance Sheets.

Summary of effective interest rate and the interest expense for the contractual interest and the accretion of debt discount

The following table presents the effective interest rate and the interest expense for the contractual interest and the accretion of debt discount (in millions, except for the effective interest rate):

	Three Months Ended						Six Months Ended
	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Effective interest rate	5.4		%	5.4		%	5.4		%	5.4		%
Interest expense-contractual interest	$	1.0		$	1.0		$	2.0		$	2.0
Accretion of debt discount	6.6			6.3			13.2			12.5

XML

Restructuring and Related Charges (Tables)

6 Months Ended

Jan. 02, 2016

Restructuring and Related Activities [Abstract]

Schedule of various restructuring plans

The adjustments to the accrued restructuring expenses related to all of the Company’s restructuring plans described below for the three and six months endedJanuary 2, 2016 were as follows (in millions):

	Balance June 27, 2015		Six Months Ended January 2, 2016 Charges			Cash Settlements			Non-cash Settlements and Other Adjustments			Balance January 2, 2016		Three Months Ended January 2, 2016 Charges
Fiscal 2016 Plan
NE and SE Agile Restructuring Plan (Workforce Reduction)	$	—	$	3.0		$	(0.4	)	$	—		$	2.6	$	3.0
Fiscal 2015 Plan
NE, SE and Shared Service Separation Restructuring Plan (Workforce Reduction)	14.9		(0.5		)	(10.3		)	(0.2		)	3.9		(0.8		)
Fiscal 2014 Plans
NE Realignment Plan (Workforce Reduction)	0.6		(0.1		)	(0.5		)	—			—		(0.1		)
Shared Services Restructuring Plan (Workforce Reduction)	0.7		—			(0.7		)	—			—		—
NE Product Strategy Restructuring Plan (Workforce Reduction)	2.3		—			(0.4		)	(0.1		)	1.8		—
NE Lease Restructuring Plan	5.2		0.2			(0.7		)	—			4.7		0.1
Central Finance and IT Restructuring Plan (Workforce Reduction)	1.1		(0.7		)	(0.1		)	—			0.3		(0.7		)
Plans Prior to Fiscal 2014	2.4		(0.1		)	(0.3		)	—			2.0		(0.1		)
Total	$	27.2	$	1.8		$	(13.4	)	$	(0.3	)	$	15.3	$	1.4

XML

Stock-Based Compensation (Tables)

6 Months Ended

Jan. 02, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of the impact on the entity's results of operations of recording stock-based compensation by function

The impact on the Company’s results of operations of recording stock-based compensation by function for the three and six months endedJanuary 2, 2016 and December 27, 2014 was as follows (in millions):

	Three Months Ended				Six Months Ended
	January 2, 2016		December 27, 2014		January 2, 2016		December 27, 2014
Cost of sales	$	1.4	$	1.0	$	2.6	$	2.0
Research and development	1.9		2.0		4.7		3.9
Selling, general and administrative	5.6		7.5		17.6		15.1
Stock-based compensation	$	8.9	$	10.5	$	24.9	$	21.0

Schedule of assumptions used to estimate the fair value of new MSU awards on the date of grant

The Company estimates the fair value of the new MSUs granted using a Monte Carlo simulation based on the assumptions described below for the following periods:

	Six Months Ended
	January 2, 2016		December 27, 2014
Volatility of common stock	33.0	%	40.8	%
Average volatility of peer companies	52.6	%	53.4	%
Average correlation coefficient of peer companies	0.0887		0.2156
Risk-free interest rate	0.8	%	0.6	%

XML

Employee Pension and Other Benefit Plans (Tables)

6 Months Ended

Jan. 02, 2016

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Schedule of net periodic cost for the pension and benefits plans

The following table presents the components of the net periodic cost for the pension and benefits plans (in millions):

	Three Months Ended						Six Months Ended
Pension Benefits	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Service cost	$	0.1		$	—		$	0.2		$	0.1
Interest cost	0.7			1.0			1.5			2.0
Expected return on plan assets	(0.4		)	(0.4		)	(0.8		)	(0.8		)
Recognized net actuarial losses	0.1			0.1			0.3			0.2
Net periodic benefit cost	$	0.5		$	0.7		$	1.2		$	1.5

XML

Commitments and Contingencies (Tables)

6 Months Ended

Jan. 02, 2016

Commitments and Contingencies Disclosure [Abstract]

Schedule of changes in the entity's warranty reserve

The following table presents the changes in the Company’s warranty reserve during fiscal 2016 and fiscal 2015 (in millions):

	Three Months Ended						Six Months Ended
	January 2, 2016			December 27, 2014			January 2, 2016			December 27, 2014
Balance as of beginning of period	$	4.0		$	3.6		$	3.7		$	3.6
Provision for warranty	0.8			1.0			1.7			1.9
Utilization of reserve	(0.7		)	(1.2		)	(1.5		)	(2.1		)
Adjustments related to pre-existing warranties (including changes in estimates)	0.2			0.1			0.4			0.1
Balance as of end of period	$	4.3		$	3.5		$	4.3		$	3.5

XML

Operating Segments and Geographic Information (Tables)

6 Months Ended

Jan. 02, 2016

Segment Reporting [Abstract]

Schedule of information on reportable segments

Information on reportable segments is as follows (in millions):

	Three Months Ended January 2, 2016
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	136.4		$	36.9		$	173.3		$	58.8		$	232.1		$	—		$	232.1
Gross profit	90.6			24.5			115.1			32.8			147.9			(6.1		)	141.8
Gross margin	66.4		%	66.4		%	66.4		%	55.8		%	63.7		%				61.1		%
Operating income (loss)							8.0			22.5			30.5			(21.3		)	9.2
Operating margin							4.6		%	38.3		%	13.1		%				4.0		%

	Three Months Ended December 27, 2014
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	129.0		$	46.8		$	175.8		$	50.6		$	226.4		$	—		$	226.4
Gross profit	84.6			32.4			117.0			26.7			143.7			(10.6		)	133.1
Gross margin	65.6		%	69.2		%	66.6		%	52.8		%	63.5		%				58.8		%
Operating income (loss)							2.0			17.1			19.1			(40.3		)	(21.2		)
Operating margin							1.1		%	33.8		%	8.4		%				(9.4		)%

	Three Months Ended
	January 2, 2016			December 27, 2014
Corporate reconciling items impacting gross profit:
Total segment gross profit	$	147.9		$	143.7
Stock-based compensation	(1.4		)	(1.0		)
Amortization of intangibles	(4.6		)	(9.2		)
Other charges related to non-recurring activities	(0.1		)	(0.4		)
GAAP gross profit	$	141.8		133.1
Corporate reconciling items impacting operating income (loss):
Total segment operating income	$	30.5		$	19.1
Stock-based compensation	(8.9		)	(10.5		)
Amortization of intangibles	(8.3		)	(14.1		)
Other charges related to non-recurring activities (1)	(2.7		)	(6.6		)
Restructuring and related charges	(1.4		)	(9.1		)
GAAP operating income (loss) from continuing operations	$	9.2		$	(21.2	)

(1) During the three months endedJanuary 2, 2016, other charges related to non-recurring activities primarily consisted of incremental expenses related to post-separation activities such as site consolidations, reorganizations, insourcing or outsourcing of activities. During the three months endedDecember 27, 2014, other charges related to non-recurring activities primarily consisted of incremental expenses related to Viavi-specific activities to complete the separation such as professional fees and additional personnel and related costs.

	Six Months Ended January 2, 2016
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	254.0		$	84.8		$	338.8		$	123.0		$	461.8		$	—		$	461.8
Gross profit	166.3			57.9			224.2			69.8			294.0			(11.7		)	282.3
Gross margin	65.5		%	68.3		%	66.2		%	56.7		%	63.7		%				61.1		%
Operating income (loss)							10.4			48.8			59.2			(52.9		)	6.3
Operating margin							3.1		%	39.7		%	12.8		%				1.4		%

	Six Months Ended December 27, 2014
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Corporate Reconciling Items			Consolidated GAAP Measures
Net revenue	$	250.5		$	97.3		$	347.8		$	93.9		$	441.7		$	—		$	441.7
Gross profit	164.8			67.4			232.2			49.8			282.0			(20.0		)	262.0
Gross margin	65.8		%	69.3		%	66.8		%	53.0		%	63.8		%				59.3		%
Operating income (loss)							0.7			31.4			32.1			(65.7		)	(33.6		)
Operating margin							0.2		%	33.4		%	7.3		%				(7.6		)%

	Six Months Ended
	January 2, 2016			December 27, 2014
Corporate reconciling items impacting gross profit:
Total segment gross profit	$	294.0		$	282.0
Stock-based compensation	(2.6		)	(2.0		)
Amortization of intangibles	(8.9		)	(17.3		)
Other charges related to non-recurring activities	(0.2		)	(0.7		)
GAAP gross profit	$	282.3		262.0
Corporate reconciling items impacting operating income (loss):
Total segment operating income	$	59.2		$	32.1
Stock-based compensation	(24.9		)	(21.0		)
Amortization of intangibles	(16.4		)	(27.2		)
Other charges related to non-recurring activities (1)	(9.8		)	(7.3		)
Restructuring and related charges	(1.8		)	(10.2		)
GAAP operating income (loss) from continuing operations	$	6.3		$	(33.6	)

(1) During the six months endedJanuary 2, 2016, other charges related to non-recurring activities primarily consisted of a) incremental expenses of $5.6 million related to post-separation activities such as site consolidations, reorganizations, insourcing or outsourcing of activities and b) $3.5 million of non-recurring incremental severance and related costs upon the exit of a key executive. During the six months endedDecember 27, 2014, other charges related to non-recurring activities primarily consisted of incremental expenses related to Viavi-specific activities to complete the separation, such as professional fees and additional personnel and related costs.

XML

Basis of Presentation (Details)		6 Months Ended	12 Months Ended
	Aug. 01, 2015	Jan. 02, 2016	Jul. 02, 2016	Jun. 27, 2015
Property, Plant and Equipment
Fiscal period duration				364 days
Percentage of outstanding shares distributed	80.10%
Stock conversion ratio in distribution	0.2
Lumentum
Property, Plant and Equipment
Ownership percentage	19.90%
Forecast
Property, Plant and Equipment
Fiscal period duration			371 days
Minimum
Property, Plant and Equipment
Fiscal period duration		364 days
Maximum
Property, Plant and Equipment
Fiscal period duration		371 days

XML

Discontinued Operations (Details) - USD ($)		3 Months Ended			6 Months Ended
	Aug. 01, 2015	Jan. 02, 2016	Oct. 03, 2015	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014	Jul. 31, 2015	Jun. 27, 2015
Discontinued Operations
Percentage of outstanding shares distributed	80.10%
Stock conversion ratio in distribution	0.2
Cash contributions agreed to in spin-off	$ 137,600,000
Cash contributions remaining		$ 900,000			$ 900,000
Proceeds from sale of Lumentum Holdings Inc. Series A Preferred Stock					35,800,000	$ 0
Net revenue under Supply Agreement		232,100,000		$ 226,400,000	461,800,000	441,700,000
Accumulated other comprehensive loss transferred to Lumentum	7,800,000				7,800,000
Net operating losses used to offset income and gain recognized on separation					1,000,000,000
Income (loss) from discontinued operations, net of taxes		3,000,000		12,600,000	(50,400,000)	28,700,000
Tax benefit from discontinued operations		4,500,000
Spinoff | Lumentum
Discontinued Operations
Deferred tax assets	29,500,000
Deferred tax liabilities	1,000,000
Income taxes payable	3,300,000							$ 3,700,000
Current income tax receivables	1,300,000
Other long-term liabilities related to uncertain tax positions	$ 100,000
Net income tax provision for discontinued operations				300,000	30,500,000	600,000
Transaction, advisory and other costs to effect the separation		1,500,000		$ 3,300,000	15,500,000	$ 3,700,000
Spinoff | Lumentum | Discontinued Operations
Discontinued Operations
Net income tax provision					25,200,000
Spinoff | Lumentum | Federal and State
Discontinued Operations
Net income tax provision for discontinued operations					5,600,000
Lumentum
Discontinued Operations
Retained ownership percentage	19.90%
Series A Preferred Stock
Discontinued Operations
Proceeds from sale of Lumentum Holdings Inc. Series A Preferred Stock			$ 35,800,000
Shares canceled in transaction (in shares)			4,195
Viavi Solutions | Series A Preferred Stock | Lumentum
Discontinued Operations
Number of shares sold (in shares)	40,000
Lumentum | Supply Commitment
Discontinued Operations
Supply Agreement with Lumentum amount							$ 15,000,000
Net revenue under Supply Agreement		$ 3,800,000			$ 8,300,000
Amada | Series A Preferred Stock
Discontinued Operations
Number of shares sold (in shares)			35,805
Lumentum
Discontinued Operations
Retained ownership percentage	19.90%
Shares held in investment	11,700,000	11,700,000			11,700,000

XML

Discontinued Operations (Details 1) - USD ($) $ in Millions	Jan. 02, 2016	Aug. 01, 2015	Jun. 27, 2015
Assets:
Current assets of discontinued operations	$ 0.0		$ 310.2
Non-current assets of discontinued operations	0.0		204.2
Liabilities:
Current liabilities of discontinued operations	0.0		130.0
Non-current liabilities of discontinued operations	$ 0.0		10.9
Spinoff | Lumentum
Assets:
Cash and cash equivalents			13.4
Accounts receivable, net			150.2
Inventories, net			100.0
Prepayments and other current assets			46.6
Current assets of discontinued operations			310.2
Property, plant and equipment, net			145.4
Goodwill			5.6
Intangibles, net			21.8
Other non-current assets			31.4
Non-current assets of discontinued operations			204.2
Total assets of discontinued operations			514.4
Liabilities:
Accounts payable			79.1
Accrued payroll and related expenses			18.3
Income taxes payable		$ 3.3	3.7
Accrued expenses			17.5
Other current liabilities			11.4
Current liabilities of discontinued operations			130.0
Non-current liabilities of discontinued operations			10.9
Total liabilities of discontinued operations			$ 140.9

XML

Discontinued Operations (Details 2) - Spinoff - Lumentum - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014
Discontinued Operations
Net revenues	$ 210.7	$ 66.5	$ 429.0
Cost of revenues	141.4	49.7	287.4
Amortization of acquired technologies	1.9	0.6	3.8
Gross profit	67.4	16.2	137.8
Research and development	35.0	12.5	69.8
Selling, general and administrative	18.8	24.0	36.0
Restructuring charges	0.6	0.1	2.4
Total operating expenses	54.4	36.6	108.2
(Loss) income from operations	13.0	(20.4)	29.6
Interest and other income (expense), net	(0.1)	0.5	(0.3)
(Loss) income before income taxes	12.9	(19.9)	29.3
Income tax provision	0.3	30.5	0.6
Net (loss) income from discontinued operations	$ 12.6	$ (50.4)	$ 28.7

XML

Discontinued Operations (Details 3) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014
Discontinued Operations
Depreciation expense			$ 21.7	$ 40.2
Amortization of other intangibles	$ 3.7	$ 4.9	7.5	9.9
Stock-based compensation expense	$ 8.9	$ 10.5	24.9	21.0
Spinoff | Discontinued Operations | Lumentum
Discontinued Operations
Depreciation expense			3.7	21.3
Amortization of other intangibles			0.6	4.0
Stock-based compensation expense			1.6	9.7
Capital expenditures			$ 5.8	$ 23.1

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended		6 Months Ended
	Aug. 17, 2015	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014	Aug. 21, 2013
Numerator:
Income (loss) from continuing operations, net of taxes		$ 3.3	$ (37.7)	$ (10.3)	$ (63.5)
Income (loss) from discontinued operations, net of taxes		3.0	12.6	(50.4)	28.7
Net income (loss)		$ 6.3	$ (25.1)	$ (60.7)	$ (34.8)
Denominator:
Weighted-average number of common shares outstanding - basic (in shares)		234.9	232.1	235.5	231.5
Effect of dilutive securities from stock-based benefit plans - Diluted (in shares)		2.2	0.0	0.0	0.0
Shares used in per share calculation - diluted (in shares)		237.1	232.1	235.5	231.5
Net income (loss) per share from - basic and diluted:
Continuing operations (in dollars per share)		$ 0.02	$ (0.16)	$ (0.04)	$ (0.27)
Discontinued operations (in dollars per share)		0.01	0.05	(0.22)	0.12
Net income (loss) per share (in dollars per share)		$ 0.03	$ (0.11)	$ (0.26)	$ (0.15)
Anti-dilutive securities excluded from computation of earnings per share
Total potentially dilutive securities (in shares)		5.4	14.9	14.4	14.6
2033 Notes
Convertible notes
Interest rate on senior convertible notes (as a percent)		0.625%	0.625%	0.625%	0.625%	0.625%
Conversion price of debt (in dollars per share)	$ 11.28	$ 11.28	$ 11.28	$ 11.28	$ 11.28
Stock options and ESPP
Anti-dilutive securities excluded from computation of earnings per share
Total potentially dilutive securities (in shares)		0.9	3.8	3.4	3.8
Restricted Stock Units
Anti-dilutive securities excluded from computation of earnings per share
Total potentially dilutive securities (in shares)		4.5	11.1	11.0	10.8

XML

Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Millions		6 Months Ended
	Aug. 01, 2015	Jan. 02, 2016
Changes in accumulated other comprehensive income (loss) by component
Balance at the beginning of the period		$ (48.0)
Transfer to Lumentum	$ (7.8)	(7.8)
Other comprehensive (loss) income before reclassification		131.3
Amounts reclassified from accumulated other comprehensive income (loss)		0.3
Net current-period other comprehensive (loss) income		131.6
Balance at the end of the period		75.8
Tax impact of amortization of actuarial losses		0.0
Marketable equity securities | Lumentum
Changes in accumulated other comprehensive income (loss) by component
Unrealized gain on marketable equity securities		157.2
Income tax expense impact from unrealized holding gains on marketable equity securities		3.7
Unrealized gains (losses) on available-for-sale investments
Changes in accumulated other comprehensive income (loss) by component
Balance at the beginning of the period		(3.2)
Transfer to Lumentum		0.0
Other comprehensive (loss) income before reclassification		153.1
Amounts reclassified from accumulated other comprehensive income (loss)		0.0
Net current-period other comprehensive (loss) income		153.1
Balance at the end of the period		149.9
Foreign currency translation adjustments
Changes in accumulated other comprehensive income (loss) by component
Balance at the beginning of the period		(29.2)
Transfer to Lumentum		(8.9)
Other comprehensive (loss) income before reclassification		(21.8)
Amounts reclassified from accumulated other comprehensive income (loss)		0.0
Net current-period other comprehensive (loss) income		(21.8)
Balance at the end of the period		(59.9)
Defined benefit obligation, net of tax
Changes in accumulated other comprehensive income (loss) by component
Balance at the beginning of the period		(15.6)
Transfer to Lumentum		1.1
Other comprehensive (loss) income before reclassification		0.0
Amounts reclassified from accumulated other comprehensive income (loss)		0.3
Net current-period other comprehensive (loss) income		0.3
Balance at the end of the period		$ (14.2)

XML

Balance Sheet and Other Details (Details) - USD ($) $ in Millions	6 Months Ended
	Jan. 02, 2016	Jan. 02, 2016	Jun. 27, 2015
Accounts receivable reserves and allowances
Total accounts receivable reserves and allowances	$ 3.1	$ 3.7	$ 3.1
Activities and balances for allowance for doubtful accounts and allowance for sales returns
Balance at Beginning of Period	3.1
Charged to Costs and Expenses	1.9
Adjustments	(1.3)
Balance at End of Period	3.7
Inventories, net
Finished goods		33.0	31.5
Work in process		5.6	6.8
Raw materials		19.0	15.5
Inventories, net		57.6	53.8
Allowance for doubtful accounts
Accounts receivable reserves and allowances
Total accounts receivable reserves and allowances	2.4	2.6	2.4
Activities and balances for allowance for doubtful accounts and allowance for sales returns
Balance at Beginning of Period	2.4
Charged to Costs and Expenses	0.3
Adjustments	(0.1)
Balance at End of Period	2.6
Allowance for sales returns
Accounts receivable reserves and allowances
Total accounts receivable reserves and allowances	0.7	$ 1.1	$ 0.7
Activities and balances for allowance for doubtful accounts and allowance for sales returns
Balance at Beginning of Period	0.7
Charged to Costs and Expenses	1.6
Adjustments	(1.2)
Balance at End of Period	$ 1.1

XML

Balance Sheet and Other Details (Details 2) - USD ($) $ in Millions	Jan. 02, 2016	Jun. 27, 2015
Prepayments and other current assets
Prepayments	$ 13.2	$ 15.7
Other current assets	20.9	22.5
Prepayments and other current assets	34.1	38.2
Other current liabilities
Deferred compensation plan	3.3	3.0
Warranty	2.5	2.3
Value-added tax	3.2	1.7
Restructuring	9.4	19.1
Deferred income taxes	0.0	7.1
Other	12.4	10.3
Other current liabilities	30.8	43.5
Other non-current liabilities
Pension and post-employment benefits	83.3	86.9
Financing obligation	29.2	29.1
Restructuring accrual	5.9	8.2
Long-term deferred revenue	22.5	23.6
Other	21.4	20.6
Other non-current liabilities	$ 162.3	$ 168.4

XML

Investments and Fair Value Measurements (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014	Aug. 01, 2015	Jun. 27, 2015
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	$ 442.2		$ 442.2			$ 496.6
Gross Unrealized Gains	157.2		157.2			0.1
Gross Unrealized Losses	(0.7)		(0.7)			(0.3)
Fair Value	598.7		$ 598.7			496.4
Term of maturities of securities classified as current assets included in short-term investments			12 months
Other-than-temporary impairment loss	$ 0.0	$ 0.0	$ 0.0	$ 0.0
Lumentum
Available-For-Sale Investments
Shares held in investment (in shares)	11.7		11.7		11.7
Cash equivalents
Available-For-Sale Investments
Fair Value	$ 15.8		$ 15.8			33.7
Short-term investments
Available-For-Sale Investments
Fair Value	324.7		324.7			461.9
Other non-current assets
Available-For-Sale Investments
Fair Value	0.7		0.7			0.8
Debt securities
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	341.9		341.9
Gross Unrealized Gains	0.0		0.0
Gross Unrealized Losses	(0.7)		(0.7)
Fair Value	341.2		341.2
Contractual maturities of debt securities classified as available-for-sale securities, Amortized Cost/Carrying Cost
Amortized cost of amounts maturing in less than 1 year	233.9		233.9
Amortized cost of amounts maturing in 1-5 years	105.5		105.5
Amortized cost of amounts maturing in more than 5 years	2.5		2.5
Total amortized cost of debt available-for-sale securities	341.9		341.9
Contractual maturities of the debt securities classified as available-for-sale securities, Estimated Fair Value
Estimated fair value amounts maturing in less than 1 year	233.8		233.8
Estimated fair value amounts maturing in 1 -5 years	105.3		105.3
Estimated fair value amounts maturing in more than 5 years	2.1		2.1
Total estimated fair value of debt available-for-sale securities	341.2		341.2
U.S. treasuries
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	46.3		46.3			51.9
Gross Unrealized Gains	0.0		0.0			0.0
Gross Unrealized Losses	0.0		0.0			0.0
Fair Value	46.3		46.3			51.9
U.S. agencies
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	59.7		59.7			96.0
Gross Unrealized Gains	0.0		0.0			0.0
Gross Unrealized Losses	(0.1)		(0.1)			0.0
Fair Value	59.6		59.6			96.0
Municipal bonds and sovereign debt instruments
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	2.3		2.3			4.0
Gross Unrealized Gains	0.0		0.0			0.0
Gross Unrealized Losses	0.0		0.0			0.0
Fair Value	2.3		2.3			4.0
Asset-backed securities
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	49.8		49.8			70.6
Gross Unrealized Gains	0.0		0.0			0.0
Gross Unrealized Losses	(0.4)		(0.4)			(0.2)
Fair Value	49.4		49.4			70.4
Corporate securities
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	183.8		183.8			274.1
Gross Unrealized Gains	0.0		0.0			0.1
Gross Unrealized Losses	(0.2)		(0.2)			(0.1)
Fair Value	183.6		183.6			$ 274.1
Marketable equity securities
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	100.3		100.3
Gross Unrealized Gains	157.2		157.2
Gross Unrealized Losses	0.0		0.0
Fair Value	257.5		257.5
Marketable equity securities | Short-term investments
Available-For-Sale Investments
Fair Value	$ 257.5		$ 257.5

XML

Investments and Fair Value Measurements (Details 2) - Short-term investments - Trading securities - USD ($) $ in Millions	Jan. 02, 2016	Jun. 27, 2015
Trading securities related to deferred compensation plan
Deferred compensation plan assets	$ 3.3	$ 3.4
Debt securities
Trading securities related to deferred compensation plan
Deferred compensation plan assets	0.6	0.6
Money market instruments and funds
Trading securities related to deferred compensation plan
Deferred compensation plan assets	0.7	0.7
Marketable equity investments
Trading securities related to deferred compensation plan
Deferred compensation plan assets	$ 2.0	$ 2.1

XML

Investments and Fair Value Measurements (Details 3) - USD ($) $ in Millions	6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014
Maximum
Foreign Currency Forward Contracts
Foreign currency forward contracts, expiration period	120 days	120 days
Recurring basis | Total fair value
Fair Value Measurements
Total debt available-for-sale securities	$ 341.2
Marketable equity securities	257.5
Money market funds	203.0
Trading securities	3.3
Total assets	805.0
Recurring basis | Cash and cash equivalents
Fair Value Measurements
Total assets	204.5
Recurring basis | Short-term investments
Fair Value Measurements
Total assets	585.5
Recurring basis | Restricted cash
Fair Value Measurements
Total assets	10.5
Recurring basis | Other non-current assets
Fair Value Measurements
Total assets	4.5
Recurring basis | U.S. treasuries | Total fair value
Fair Value Measurements
Total debt available-for-sale securities	46.3
Recurring basis | U.S. agencies | Total fair value
Fair Value Measurements
Total debt available-for-sale securities	59.6
Recurring basis | Municipal bonds and sovereign debt instruments | Total fair value
Fair Value Measurements
Total debt available-for-sale securities	2.3
Recurring basis | Asset-backed securities | Total fair value
Fair Value Measurements
Total debt available-for-sale securities	49.4
Recurring basis | Corporate securities | Total fair value
Fair Value Measurements
Total debt available-for-sale securities	183.6
Recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value Measurements
Total debt available-for-sale securities	46.3
Marketable equity securities	257.5
Money market funds	203.0
Trading securities	3.3
Total assets	510.1
Recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. treasuries
Fair Value Measurements
Total debt available-for-sale securities	46.3
Recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. agencies
Fair Value Measurements
Total debt available-for-sale securities	0.0
Recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Municipal bonds and sovereign debt instruments
Fair Value Measurements
Total debt available-for-sale securities	0.0
Recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Asset-backed securities
Fair Value Measurements
Total debt available-for-sale securities	0.0
Recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate securities
Fair Value Measurements
Total debt available-for-sale securities	0.0
Recurring basis | Significant Other Observable Inputs (Level 2)
Fair Value Measurements
Total debt available-for-sale securities	294.9
Marketable equity securities	0.0
Money market funds	0.0
Trading securities	0.0
Total assets	294.9
Recurring basis | Significant Other Observable Inputs (Level 2) | U.S. treasuries
Fair Value Measurements
Total debt available-for-sale securities	0.0
Recurring basis | Significant Other Observable Inputs (Level 2) | U.S. agencies
Fair Value Measurements
Total debt available-for-sale securities	59.6
Recurring basis | Significant Other Observable Inputs (Level 2) | Municipal bonds and sovereign debt instruments
Fair Value Measurements
Total debt available-for-sale securities	2.3
Recurring basis | Significant Other Observable Inputs (Level 2) | Asset-backed securities
Fair Value Measurements
Total debt available-for-sale securities	49.4
Recurring basis | Significant Other Observable Inputs (Level 2) | Corporate securities
Fair Value Measurements
Total debt available-for-sale securities	$ 183.6

XML

Goodwill (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jan. 02, 2016	Jun. 27, 2015
Changes in goodwill
Balance at the beginning of the period	$ 255.5
Currency translation and other adjustments	(3.4)
Goodwill allocation - WaveReady	(6.0)
Balance at the end of the period	246.1	$ 255.5
Goodwill impairment		0.0
Network Enablement
Changes in goodwill
Balance at the beginning of the period	154.5
Currency translation and other adjustments	(2.2)
Goodwill allocation - WaveReady	(6.0)
Balance at the end of the period	146.3	154.5
Service Enablement
Changes in goodwill
Balance at the beginning of the period	92.7
Currency translation and other adjustments	(1.2)
Goodwill allocation - WaveReady	0.0
Balance at the end of the period	91.5	92.7
Optical Security and Performance Products
Changes in goodwill
Balance at the beginning of the period	8.3
Currency translation and other adjustments	0.0
Goodwill allocation - WaveReady	0.0
Balance at the end of the period	$ 8.3	$ 8.3

XML

Acquired Developed Technology and Other Intangibles (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jan. 02, 2016	Oct. 03, 2015	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014	Jun. 27, 2015
Acquired developed technology, customer relationships and other intangibles
Gross carrying amount of finite lived intangibles	$ 614.5			$ 614.5		$ 617.1
Accumulated Amortization	(537.7)			(537.7)		(528.3)
Net carrying amount of finite lived intangibles	76.8			76.8		88.8
Net carrying amount of in-process research and development intangibles	0.8			0.8		1.8
Gross Carrying Amount	615.3			615.3		618.9
Net carrying amount of intangibles	77.6			77.6		90.6
Amortization of acquired developed technologies	4.6		$ 9.2	8.9	$ 17.3
Amortization of other intangibles	3.7		4.9	7.5	9.9
Total amortization of intangible assets	8.3		$ 14.1	16.4	$ 27.2
Estimated future amortization expense
Remainder of 2016	15.4			15.4
2017	29.5			29.5
2018	20.9			20.9
2019	9.3			9.3
2020	1.3			1.3
Thereafter	0.4			0.4
Total amortization	76.8			76.8
Acquired developed technology
Acquired developed technology, customer relationships and other intangibles
Gross carrying amount of finite lived intangibles	420.6			420.6		418.9
Accumulated Amortization	(379.3)			(379.3)		(373.6)
Net carrying amount of finite lived intangibles	41.3			41.3		45.3
Transfer from indefinite to finite lived intangible assets		$ 1.8
Useful life		36 months
Customer relationships
Acquired developed technology, customer relationships and other intangibles
Gross carrying amount of finite lived intangibles	174.7			174.7		178.7
Accumulated Amortization	(139.6)			(139.6)		(135.8)
Net carrying amount of finite lived intangibles	35.1			35.1		42.9
Other
Acquired developed technology, customer relationships and other intangibles
Gross carrying amount of finite lived intangibles	19.2			19.2		19.5
Accumulated Amortization	(18.8)			(18.8)		(18.9)
Net carrying amount of finite lived intangibles	$ 0.4			$ 0.4		$ 0.6

XML

Debts and Letters of Credit (Details)			3 Months Ended		6 Months Ended
	Aug. 17, 2015 $ / shares	Aug. 21, 2013 USD ($)	Jan. 02, 2016 USD ($) letter_of_credit $ / shares	Dec. 27, 2014 USD ($) $ / shares	Jan. 02, 2016 USD ($) letter_of_credit $ / shares	Dec. 27, 2014 USD ($) $ / shares	Jun. 27, 2015 USD ($)
Carrying amounts of the liability and equity components:
Short-term debt			$ 0		$ 0		$ 0
Outstanding Letters of Credit
Number of standby letters of credit | letter_of_credit			10		10
Letters of credit outstanding			$ 14,300,000		$ 14,300,000
0.625% Senior Convertible Notes
Carrying amounts of the liability and equity components:
Principal amount of notes			650,000,000		650,000,000		650,000,000
Unamortized discount of liability component			(75,200,000)		(75,200,000)		(88,400,000)
Carrying value of the liability component		$ 515,600,000	574,800,000		574,800,000		561,600,000
Carrying amount of equity component		134,400,000	$ 134,400,000		$ 134,400,000		134,400,000
Aggregate principal amount of convertible debt		$ 650,000,000.0
Interest rate on senior convertible notes (as a percent)		0.625%	0.625%	0.625%	0.625%	0.625%
Proceeds from issuance of convertible notes after issuance costs		$ 636,300,000
Conversion price of debt (in dollars per share) | $ / shares	$ 11.28		$ 11.28	$ 11.28	$ 11.28	$ 11.28
Discount rate used to calculate the carrying value of the liability component of the convertible debt (as a percent)		5.40%
Variable rate basis term on which discount rate is based		5 years
Remaining term of convertible notes					2 years 7 months 6 days
Deferred finance costs		$ 13,700,000
Liability component, debt issuance cost		10,900,000
Equity component, debt issuance cost		$ 2,800,000
Fair market value of convertible debt			$ 610,100,000		$ 610,100,000		$ 644,000,000
Interest expense for the contractual interest and the amortization of debt discount
Effective interest rate (as a percent)		5.40%	5.40%	5.40%	5.40%	5.40%
Interest expense-contractual interest			$ 1,000,000	$ 1,000,000	$ 2,000,000	$ 2,000,000
Accretion of debt discount			6,600,000	$ 6,300,000	13,200,000	$ 12,500,000
0.625% Senior Convertible Notes | Other non-current assets
Carrying amounts of the liability and equity components:
Unamortized portion of debt issuance cost			$ 6,100,000		$ 6,100,000

XML

Restructuring and Related Charges (Details) $ in Millions	3 Months Ended					6 Months Ended		15 Months Ended
	Jan. 02, 2016 USD ($) employee	Dec. 27, 2014 USD ($)	Jun. 28, 2014 employee	Mar. 29, 2014 employee	Dec. 28, 2013 employee	Jan. 02, 2016 USD ($)	Dec. 27, 2014 USD ($)	Jan. 02, 2016 USD ($) employee	Aug. 01, 2015 company	Jun. 27, 2015 USD ($)
Summary of various restructuring plans
Accrual balance at the beginning of the period						$ 27.2
Restructuring Charges	$ 1.4	$ 9.1				1.8	$ 10.2
Cash Settlements						(13.4)
Non-cash Settlements and Other Adjustments						(0.3)
Accrual balance at the end of the period	15.3					15.3		$ 15.3
Long-term restructuring accrual	5.9					5.9		5.9		$ 8.2
Number of new public entities | company									2
NE Realignment Plan
Summary of various restructuring plans
Number of employees expected to be reduced (employee) | employee			100
Shared Services Restructuring Plan
Summary of various restructuring plans
Number of employees expected to be reduced (employee) | employee			40
NE Product Strategy Restructuring Plan
Summary of various restructuring plans
Number of employees expected to be reduced (employee) | employee				60
NE Lease Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period						5.2
Restructuring Charges	0.1					0.2
Cash Settlements						(0.7)
Non-cash Settlements and Other Adjustments						0.0
Accrual balance at the end of the period	4.7					4.7		4.7
Contractual obligations under the operating lease, net of sublease income, fair value	4.7					4.7		4.7
Central Finance and IT Restructuring Plan
Summary of various restructuring plans
Number of employees expected to be reduced (employee) | employee					20
Plans Prior to Fiscal 2014
Summary of various restructuring plans
Accrual balance at the beginning of the period						2.4
Restructuring Charges	(0.1)					(0.1)
Cash Settlements						(0.3)
Non-cash Settlements and Other Adjustments						0.0
Accrual balance at the end of the period	2.0					2.0		2.0
Workforce Reduction | NE and SE Agile Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period						0.0
Restructuring Charges	3.0					3.0
Cash Settlements						(0.4)
Non-cash Settlements and Other Adjustments						0.0
Accrual balance at the end of the period	$ 2.6					2.6		2.6
Number of employees expected to be reduced (employee) | employee	50
Workforce Reduction | NE, SE, and Shared Separation Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period						14.9
Restructuring Charges	$ (0.8)					(0.5)
Cash Settlements						(10.3)
Non-cash Settlements and Other Adjustments						(0.2)
Accrual balance at the end of the period	3.9					3.9		$ 3.9
Number of employees expected to be reduced (employee) | employee								340
Workforce Reduction | NE Realignment Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period						0.6
Restructuring Charges	(0.1)					(0.1)
Cash Settlements						(0.5)
Non-cash Settlements and Other Adjustments						0.0
Accrual balance at the end of the period	0.0					0.0		$ 0.0
Workforce Reduction | Shared Services Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period						0.7
Restructuring Charges	0.0					0.0
Cash Settlements						(0.7)
Non-cash Settlements and Other Adjustments						0.0
Accrual balance at the end of the period	0.0					0.0		0.0
Workforce Reduction | NE Product Strategy Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period						2.3
Restructuring Charges	0.0					0.0
Cash Settlements						(0.4)
Non-cash Settlements and Other Adjustments						(0.1)
Accrual balance at the end of the period	1.8					1.8		1.8
Workforce Reduction | Central Finance and IT Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period						1.1
Restructuring Charges	(0.7)					(0.7)
Cash Settlements						(0.1)
Non-cash Settlements and Other Adjustments						0.0
Accrual balance at the end of the period	$ 0.3					$ 0.3		$ 0.3

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014	Oct. 03, 2015	Jun. 27, 2015
Income Tax Disclosure [Abstract]
(Benefit from) provision for income taxes	$ (1.2)	$ 8.5	$ (0.4)	$ 14.3
Valuation Allowance [Line Items]
Reclassification out of current deferred tax liabilities	0.0		0.0			$ (7.1)
Unrecognized tax benefits	37.0		37.0			$ 37.4
Interest and penalties accrued	1.6		1.6
Unrecognized tax benefits that may be recognized during the next twelve months	0.1		0.1
Effect of Early Adoption of Authoritative Guidance on Balance Sheet Classification of Deferred Taxes
Valuation Allowance [Line Items]
Reclassification out of current deferred tax assets					$ 3.1
Increase in noncurrent deferred tax assets					3.1
Reclassification out of current deferred tax liabilities					0.7
Increase in noncurrent deferred tax liabilities					$ 0.7
Increase in Lumentum valuation allowance
Valuation Allowance [Line Items]
Onetime increase in valuation allowance immediately before the separation transaction			8.9
Continuing operations
Valuation Allowance [Line Items]
Tax benefit from discontinued operations	$ 8.8		$ 22.2

XML

Stockholders' Equity (Details) - USD ($) $ / shares in Units, shares in Millions		3 Months Ended		6 Months Ended
	Jan. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Jan. 02, 2016	Dec. 27, 2014	Oct. 31, 2015	May. 31, 2014
Class of Stock [Line Items]
Upfront payment for share repurchase				$ 40,000,000	$ 4,700,000
Common stock
Class of Stock [Line Items]
Authorized amount under stock repurchase program						$ 40,000,000	$ 100,000,000.0
Accelerated Share Repurchase | Common stock
Class of Stock [Line Items]
Upfront payment for share repurchase			$ 40,000,000
Shares delivered and retired (in shares)			5.3
Reduction in stockholders' equity for share repurchase			$ 32,000,000
Unsettled value of share repurchase program	$ 8,000,000
Accelerated Share Repurchase | Common stock | Subsequent event
Class of Stock [Line Items]
Shares delivered and retired (in shares)		1.3
Final settlement price per share (usd per share)		$ 6.05

XML

Stock-Based Compensation (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 8.9	$ 10.5	$ 24.9	$ 21.0
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	1.4	1.0	2.6	2.0
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	1.9	2.0	4.7	3.9
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 5.6	$ 7.5	$ 17.6	$ 15.1

XML

Stock-Based Compensation (Details 1) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended		5 Months Ended	6 Months Ended
	Jan. 02, 2016	Oct. 03, 2015	Sep. 27, 2014	Jan. 02, 2016	Jan. 02, 2016	Dec. 27, 2014	Aug. 01, 2015
Stock-Based Compensation
Stock-based compensation capitalized to inventory (in dollars)					$ 0.9
Total incremental stock-based compensation related to plan modification							$ 13.6
Accelerated stock compensation expense from plan modification				$ 8.3
Full Value Awards - Total
Stock-Based Compensation
Exercise price (in dollars per share)	$ 0			$ 0	$ 0
Unrecognized stock-based compensation	$ 52.3			$ 52.3	$ 52.3
Estimated amortization period					2 years 2 months 18 days
Withholding taxes liability paid					$ 7.8	$ 11.9
Remaining incremental expense to be recognized from plan modification	$ 5.3
Full Value Awards - Total | Minimum
Stock-Based Compensation
Vesting period					1 year
Full Value Awards - Total | Maximum
Stock-Based Compensation
Vesting period					4 years
RSUs
Stock-Based Compensation
Granted (in shares)					5.3	5.2
Restricted Stock Units with Market Conditions (MSU)
Stock-Based Compensation
Vesting period					3 years
Granted (in shares)					0.5	0.7
Aggregate grant-date fair value (in dollars)		$ 2.9	$ 8.5
Restricted Stock Units with Time Based Conditions
Stock-Based Compensation
Vesting period					3 years
Granted (in shares)					4.8	4.5
Percentage of first tranche vested					33.00%
Initial vesting period					1 year
Subsequent vesting period					2 years

XML

Stock-Based Compensation (Details 2) - MSUs - Monte Carlo simulation	6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014
Valuation Assumptions
Volatility of common stock (as a percent)	33.00%	40.80%
Average volatility of peer companies (as a percent)	52.60%	53.40%
Average correlation coefficient of peer companies	0.0887	0.2156
Risk-free interest rate (as a percent)	0.80%	0.60%

XML

Employee Pension and Other Benefit Plans (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
	Aug. 01, 2015	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014
Employee Defined Benefit Plans
Employer contributions				$ 2.3
Components of the net periodic cost for the pension and benefits plans
Cash outlays expected during fiscal 2016				5.9
Pension Benefit Plans
Components of the net periodic cost for the pension and benefits plans
Service cost		$ 0.1	$ 0.0	0.2	$ 0.1
Interest cost		0.7	1.0	1.5	2.0
Expected return on plan assets		(0.4)	(0.4)	(0.8)	(0.8)
Recognized actuarial losses (gains)		0.1	0.1	0.3	0.2
Net periodic benefit cost		$ 0.5	$ 0.7	1.2	$ 1.5
Switzerland | Foreign Pension Plan
Employee Defined Benefit Plans
Liabilities transferred to Lumentum	$ 6.7
Assets transferred to Lumentum	$ 4.6
U.K. | Foreign Pension Plan
Employee Defined Benefit Plans
Employer contributions				$ 0.7

XML

Commitments and Contingencies (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014	Jun. 27, 2015
Commitments and Contingencies Disclosure [Abstract]
Guarantee liabilities	$ 0.0		$ 0.0		$ 0.0
Product Warranties
Warranty Term for most products			3 years
Changes in warranty reserve
Balance as of beginning of period	4.0	$ 3.6	$ 3.7	$ 3.6
Provision for warranty	0.8	1.0	1.7	1.9
Utilization of reserve	(0.7)	(1.2)	(1.5)	(2.1)
Adjustments related to pre-existing warranties (including changes in estimates)	0.2	0.1	0.4	0.1
Balance as of end of period	$ 4.3	$ 3.5	$ 4.3	$ 3.5

XML

Operating Segments and Geographic Information (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 02, 2016 USD ($)	Dec. 27, 2014 USD ($)	Jan. 02, 2016 USD ($) segment subsegment	Dec. 27, 2014 USD ($)
Information on reportable segments
Number of broad business categories (in segment) | segment			2
Net revenue	$ 232.1	$ 226.4	$ 461.8	$ 441.7
Gross profit	$ 141.8	$ 133.1	$ 282.3	$ 262.0
Gross margin (as a percent)	61.10%	58.80%	61.10%	59.30%
Operating income (loss)	$ 9.2	$ (21.2)	$ 6.3	$ (33.6)
Operating margin (as a percent)	4.00%	(9.40%)	1.40%	(7.60%)
Segment Measures
Information on reportable segments
Net revenue	$ 232.1	$ 226.4	$ 461.8	$ 441.7
Gross profit	$ 147.9	$ 143.7	$ 294.0	$ 282.0
Gross margin (as a percent)	63.70%	63.50%	63.70%	63.80%
Operating income (loss)	$ 30.5	$ 19.1	$ 59.2	$ 32.1
Operating margin (as a percent)	13.10%	8.40%	12.80%	7.30%
Reconciling Items
Information on reportable segments
Net revenue	$ 0.0	$ 0.0	$ 0.0	$ 0.0
Gross profit	(6.1)	(10.6)	(11.7)	(20.0)
Operating income (loss)	(21.3)	(40.3)	$ (52.9)	(65.7)
Network and Service Enablement
Information on reportable segments
Number of subsegments (in subsegment) | subsegment			2
Network and Service Enablement | Segment Measures
Information on reportable segments
Net revenue	173.3	175.8	$ 338.8	347.8
Gross profit	$ 115.1	$ 117.0	$ 224.2	$ 232.2
Gross margin (as a percent)	66.40%	66.60%	66.20%	66.80%
Operating income (loss)	$ 8.0	$ 2.0	$ 10.4	$ 0.7
Operating margin (as a percent)	4.60%	1.10%	3.10%	0.20%
Network Enablement | Segment Measures
Information on reportable segments
Net revenue	$ 136.4	$ 129.0	$ 254.0	$ 250.5
Gross profit	$ 90.6	$ 84.6	$ 166.3	$ 164.8
Gross margin (as a percent)	66.40%	65.60%	65.50%	65.80%
Service Enablement | Segment Measures
Information on reportable segments
Net revenue	$ 36.9	$ 46.8	$ 84.8	$ 97.3
Gross profit	$ 24.5	$ 32.4	$ 57.9	$ 67.4
Gross margin (as a percent)	66.40%	69.20%	68.30%	69.30%
Optical Security and Performance Products | Segment Measures
Information on reportable segments
Net revenue	$ 58.8	$ 50.6	$ 123.0	$ 93.9
Gross profit	$ 32.8	$ 26.7	$ 69.8	$ 49.8
Gross margin (as a percent)	55.80%	52.80%	56.70%	53.00%
Operating income (loss)	$ 22.5	$ 17.1	$ 48.8	$ 31.4
Operating margin (as a percent)	38.30%	33.80%	39.70%	33.40%

XML

Operating Segments and Geographic Information (Details 2) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 02, 2016	Dec. 27, 2014	Jan. 02, 2016	Dec. 27, 2014
Information on reportable segments
Amortization of acquired technologies	$ (4.6)	$ (9.2)	$ (8.9)	$ (17.3)
Gross profit	141.8	133.1	282.3	262.0
Stock-based compensation	(8.9)	(10.5)	(24.9)	(21.0)
Amortization of intangibles	(3.7)	(4.9)	(7.5)	(9.9)
Restructuring and related charges	(1.4)	(9.1)	(1.8)	(10.2)
Operating income (loss)	9.2	(21.2)	6.3	(33.6)
Post-separation expenses			5.6
Severance and related costs			3.5
Segment Measures
Information on reportable segments
Gross profit	147.9	143.7	294.0	282.0
Operating income (loss)	30.5	19.1	59.2	32.1
Reconciling Items
Information on reportable segments
Stock-based compensation	(1.4)	(1.0)	(2.6)	(2.0)
Amortization of acquired technologies	(4.6)	(9.2)	(8.9)	(17.3)
Other charges related to non-recurring activities	(0.1)	(0.4)	(0.2)	(0.7)
Gross profit	(6.1)	(10.6)	(11.7)	(20.0)
Stock-based compensation	(8.9)	(10.5)	(24.9)	(21.0)
Amortization of intangibles	(8.3)	(14.1)	(16.4)	(27.2)
Other charges related to non-recurring activities	(2.7)	(6.6)	(9.8)	(7.3)
Restructuring and related charges	(1.4)	(9.1)	(1.8)	(10.2)
Operating income (loss)	$ (21.3)	$ (40.3)	$ (52.9)	$ (65.7)